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ABSTRACT
DISEASE SELF-MANAGEMENT CAPACITY, PATIENT BURDEN, AND
MEDICATION ADHERENCE IN AFRICAN AMERICAN ADULTS WITH TYPE 2
DIABETES AND HYPERTENSION
by
Michelle R. Gaddis
African American (AA) adults are disproportionately affected by type 2
diabetes (T2D) and hypertension, with greater prevalence and disease-related
complications. Disease complications may be prevented or delayed with
adequate disease self-management (DSM). The literature indicates greater
patient activation and health literacy and lower treatment burden and illness
burden are associated with improved DSM, but AAs with comorbidities were
underrepresented in these studies. The purpose of this study was to examine
associations among patient activation, health literacy, treatment burden, illness
burden, medication workloads, and medication adherence for AA adults wi th T2D
and hypertension. This study also explored the perceived impact of COVID -19 on
medication management.
A non-experimental, predictive, correlational design was used.
Participants were recruited using social media and flyers distributed via email.
Data were collected via surveys administered through Qualtrics® and
telephone/online interviews. Spearman’s correlations and hierarchical regression
analyses were conducted to examine relationships among the study variables.

vi

Participants (N = 91) ranged in age from 25 to 73 years (M = 39.6), were
mostly male (66%), college-educated (71%), and earning incomes of $30,000 or
more (66%). Most were diagnosed with T2D and hypertension for less than five
years (respectively, 64% and 75%) and averaged four (±1.3) prescribed
medications.
On average, participants had high patient activation scores, low health
literacy scores, and moderate levels of treatment and illness burden. Overall,
medication adherence scores (M = 2.4) indicated the presence of non adherence; 66% were classified as non-adherent. The model, including all
predictor variables, was significant in predicting medication adherence,
accounting for 19% of the variance. However, patient activation was the only
significant contributor; for each one-point increase in patient activation,
medication adherence improved by .03.The perceived impact from the COVID -19
pandemic on medication management was moderate, with participants feeling
worried about leaving their homes (e.g., to get medications) and paying for
medications.
In this sample of mostly younger AA men with T2D and hypertension,
medication adherence was inadequate, but was only partially explained by
patient activation. Further research is needed on DSM in AAs with T2D and
hypertension to identify additional factors that may promote or hinder their
medication adherence.
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CHAPTER I
INTRODUCTION
Diabetes is the 7th leading cause of mortality in the United States
(Centers for Disease Control and Prevention [CDC], 2018a). The CDC (2017a)
reports that greater than 30 million individuals in the United States have diabetes,
with 95% having Type 2 Diabetes (T2D). The prevalence of diabetes continues to
increase rapidly, with a projected rise in prevalence to more than 54 million
individuals in the US by the year 2030 (Rowley et al., 2017). Adults with diabetes
have an increased susceptibility to the development of comorbidities and
associated health complications, along with a 50% greater risk of death from any
cause as compared to adults without diabetes (Rowley et al., 2017).
Most adults with diabetes have at least one coexisting chronic condition
(Lin et al., 2015). One of the more prominent comorbidities for individuals with
diabetes is hypertension (CDC, 2018c). According to national estimates, about
68% of individuals with diabetes also have hypertension (CDC, 2018c). In a
cross-sectional analysis including 161,174 adults (63% White, 20% Black, 2%
“other”, and 13% unidentified) with T2D, 36% of the sample had one to two
comorbidities, with 65% having hypertension (Lin et al., 2015). Five of the six
most common multiple morbidity clusters observed in the study included
hypertension.
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Background
Individually, Type 2 diabetes (T2D) and hypertension are associated with
elevated risks for several vascular complications including coronary artery
disease, myocardial infarction, congestive heart failure, peripheral artery disease,
retinopathy, nephropathy, neuropathy, stroke and heart disease (CDC, 2018b;
Long & Dagogo‐Jack, 2011; National Institute of Diabetes and Digestive and
Kidney Diseases [NIDDK], 2017). When diabetes and hypertension coexist, the
risks for associated vascular complications greatly increases (American Heart
Association [AHA], 2015; CDC, 2018b; Long & Dagogo-Jack, 2011; NIDDK,
2017; Petrie et al., 2018). Hypertension has been identified as a significant risk
factor in the accelerated development of vascular complications and the
progression of cardiovascular disease for individuals with diabetes (Petrie et al.,
2018). The AHA (2015) reports that the presence of comorbid diabetes and
hypertension doubles the risk of developing cardiovascular disease compared to
having only one of the diseases.
T2D and hypertension are also associated with higher rates of unplanned
healthcare utilization (e.g., emergency room visits) resulting from complications
of these diseases (CDC, 2017b; Lynch et al., 2015). Reportedly, emergency
room (ER) visits for individuals with chronic disease(s) have continued to rise
over the last decade, particularly for individuals with diabetes and hypertension
(McNaughton et al., 2015). The heightened use of unplanned healthcare services
for individuals with T2D and hypertension coincides with the estimated national
expenditure ($375 billion) for managing both diseases (ADA, 2018a; CDC,
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2016a). Additionally, on average, more than half of the total medical costs related
to diabetes management are attributed to hospital inpatient care and prescription
medications (ADA, 2018a).
Many of the disease-related complications for individuals with T2D and
hypertension can be prevented or delayed with appropriate disease management
(AHA 2016a; CDC, 2017c). Supplementary to the clinical aspect of disease
management, managing T2D and hypertension involves a significant amount of
self-management activities. Disease self-management (DSM) activities are
recommended actions for patients to take, typically on a regular basis, and
independent of their healthcare provider’s direct assistance. DSM activities that
may be recommended to patients with T2D and hypertension include healthy
eating, physical activity, monitoring blood glucose and blood pressure, taking
prescribed medications, and solving problems relating to disease management
(e.g., calculating insulin doses; Byers et al., 2016; Powers et al., 2015). DSM
activities collectively form an individual’s DSM workload. Adhering to the
recommended DSM activities within the DSM workload has been associated with
increased glycemic and blood pressure control, reductions in T2D and
cardiovascular complications, and fewer unplanned hospitalizations (Byers et al.,
2016; CDC, 2018b). The escalating number of hospitalizations for individuals
with T2D and hypertension may be associated with deficiencies in their DSM
abilities and potentially overwhelming burdens in performance of DSM activities
(CDC, 2017b; Fingar et al., 2017; McNaughton et al., 2015).
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One prominent DSM activity for adults with T2D and hypertension is the
management of prescribed medications. It has been estimated that roughly 85%
of people with T2D and 70% of people with hypertension are prescribed
medications for management of their disease (CDC, 2016b; CDC, 2019),
indicating a heavy medication workload for individuals with these diseases.
Adhering to prescribed medications is essential in achieving improvements in
patient care outcomes and reducing the potential of associated disease-related
complications (e.g., heart failure, stroke, and mortality) for individuals with T2D
and hypertension (Brown & Bussell, 2011; CDC, 2018b; NIDDK, 2017). Adhering
to prescribed medication regimens can be a complex and burdensome DSM
activity, as it requires time, resources, knowledge, skills, and motivation . Thus,
this study aimed to examine factors that had the potential to impact medication
adherence and the DSM workload associated with managing prescribed
medications for AA adults with T2D and hypertension.
Problem
African American (AA) adults are disproportionately affected by T2D and
hypertension with higher prevalence rates an d complications that result from
these diseases (ADA,2018b; CDC,2017a; Gebregziabher et al., 2018). Currently,
there is a greater prevalence of T2D among AAs (11.7%) than non-Hispanic
Whites (7.5%; CDC, 2020e). Additionally, AAs have a greater number of
diabetes-related comorbidities than other racial and ethnic groups (Lin et al.,
2015). For example, Lynch et al. (2015) conducted a retrospective cohort study
of 892,223 veterans to identify multiple morbidity patterns across ethnicities. The
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sample included 12% AAs, 61% Whites, 13% Hispanics, and 12% identified as
“other”. There were 32% of AA participants with three or more comorbid
conditions as compared to 27% of Whites, 26% of Hispanics, and 14% of the
group labeled as “other”. Hypertension, a commonly associated comorbidity of
T2D, further increases and accelerates the risks for clinical complications (e.g.,
stroke and heart disease), especially for AAs (AHA, 2016a; CDC, 2019b). Similar
to T2D, the prevalence of hypertension is greater for AA adults (40.3%) than nonHispanic Whites (27.8%) (CDC, 2017d).
AAs have also been frequently identified as having an increased risk and
higher rates of associated complications from T2D, compared to other
racial/ethnic groups (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Office of
Minority Health [OMH], 2016). The age-adjusted death rate per 100,000
attributed specifically to diabetes is higher among AA adults (38.7) as compared
to non-Hispanic White adults (18.8) and all other race/ethnicity groups (21.5;
CDC, 2019b). The CDC (2019b) also reports that the age-adjusted death rate per
100,000 from hypertension for AA adults (17.1) is higher than for non -Hispanic
White adults (8.0). Higher mortality rates for AAs with T2D and hypertension are
potentially due to the disproportionate challenges in medication adherence,
leading to uncontrolled blood glucose and blood pressure (CDC, 2017d; OMH,
2016).
Management of T2D and hypertension involves a multifaceted approach,
with self-management activities having a large role. Managing both conditions is
more challenging than managing either alone. For example, there may be more
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medications prescribed, additional self-monitoring tasks to complete (e.g., blood
glucose and blood pressure monitoring), and additional diet restrictions to follow.
DSM in T2D and hypertension requires patients to have adequate DSM capacity:
relevant knowledge, motivation, and skills (Beck, 2018; Powers, 2015). This
claim is supported by previous studies that demonstrated patient activation (i.e.,
knowledge, motivation, and skills for managing health) and health literacy (i.e.,
the skill needed to obtain, process, and understand basic health information to
make decisions) were associated with DSM performance (Beck, 2018; Bolen
et al., 2014; Mayberry et al., 2010; Powers, 2015; Weld et al., 2008; Ylitalo et al.,
2018). People with T2D and hypertension who have limited DSM capacity (i.e.,
patient activation and health literacy) may perceive their DSM activities as too
complex, leading to inadequate performance and lack of glycemic and blood
pressure goal attainments (Egan et al., 2014).
Additionally, DSM activities for T2D and hypertension, particularly
managing prescribed medications, may become overly burdensome leading to
poor adherence. The burden in performance of DSM may stem from the
complexity of the prescribed treatment plan (i.e., treatment burden) or from the
symptomology associated with the illnesses being treated (i.e., illness burden),
collectively described as patient burden. The performance of DSM activities may
be further complicated during a major crisis, such as what may occur during a
global pandemic. Presently, there is a worldwide pandemic that could be
impacting the performance of DSM activities for AAs with T2D and hypertension .
The Coronavirus Disease 2019 (COVID-19) is a life-threatening public health
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situation that is currently impacting individuals on a global scale. The incidence
and mortality for COVID-19 continue to climb at alarming rates. Recent reports
indicate that there have been more than one million cases of COVID-19 identified
in the U.S., with 68,279 deaths reported (CDC, 2020a). The CDC (2020b) states
that during a pandemic such as with COVID-19, individuals may experience large
amounts of stress which may subsequently create difficulty in concentrating (e.g.,
carrying out DSM activities) and worsen chronic health problems. The CDC
(2020c) also reports that individuals with diabetes may be at a higher risk of
experiencing a greater severity of illness from COVID-19 and have greater
difficulty in recovering from the illness. Furthermore, AAs may be
disproportionately impacted by COVID-19, with recent reports indicating that
COVID-19 related hospitalizations and death rates are higher for AAs as
compared to other ethnicities (CDC, 2020d). Thus, it is important to explore
individuals’ perceived impact of the COVID-19 pandemic on their abilities to
manage their prescribed medications.
Although literature describing the benefits of DSM exists, some individuals
with diabetes and hypertension still demonstrate poorly executed DSM (e.g.,
poor medication adherence), even with already having experienced a
cardiovascular event (Beck et al., 2018; Brown & Bussell, 2011; Fox et al., 2015;
Powers et al., 2015; Shrivastava et al., 2013; Weller et al., 2017). Considering
that AA adults have a higher prevalence of uncontrolled T2D and hypertension,
this may potentially indicate that AAs have significant DSM capacity deficiencies
and overwhelming burdens in DSM (ADA, 2018b; CDC, 2017d; OMH, 2016).
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There are no known studies that examine the combined impact of DSM
capacity and patient burden (i.e., treatment burden and illness burden) on the
performance of any DSM activities for AA adults with T2D and hypertension. The
heightened health risks associated with comorbid T2D and hypertension (e.g.,
stroke, heart disease) are further magnified in this vulnerable population when
appropriate DSM behaviors are absent (CDC, 2018b). The apparent disparity in
health outcomes for AA adults with T2D and hypertension suggests a need to
investigate factors that may impact their performance of DSM. Additionally, as
managing medications is a prominent DSM activity for individuals with T2D and
hypertension, it is also important to examine the relationships of DSM capacity
and patient burden within the context of medication adherence. Furthermore, as
no known studies have examined any DSM activities for T2D and hypertension
during a pandemic, valuable information was also gained from exploring
individuals’ perceptions of the impact of COVID-19 on their ability to manage
their prescribed medications.
Significance of the Study for Healthcare Professionals
This study is significant because it addressed existing gaps in the
literature by investigating underexamined factors potentially associated with
medication adherence for AA adults with T2D and hypertension. Healthcare
professionals are essential in providing self-management support to patients with
T2D and hypertension through the provision of education, encouragement, and
empowerment strategies relating to the performance of DSM tasks, specifically
adherence to prescribed medication regimens. This study provides a gateway to
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clinical practice improvements, specifically in the provision of care for AA adults
with T2D and hypertension. First, this study highlights factors that associate with
medication adherence (i.e., DSM capacity and patient burden). Additionally, this
study strengthens the validity and reliability for measures of DSM capacity (i.e.,
health literacy and patient activation) and patient burden (i.e., treatment burden
and illness burden). By gaining a better understanding of factors that associate
with medication adherence and having valid methods to assess those factors,
healthcare professionals can be better equipped to identify individuals at risk for
poor medication adherence and enhance the effectiveness of the treatment plans
developed for AA patients with T2D and hypertension. Ultimately, discoveries
from this study can facilitate the development of novel strategies in patient care
delivery, resulting in improved patient outcomes and reduced health care costs.
Purpose
The purpose of this study was to examine associations among patient
activation, health literacy, treatment burden, illness burden , medication workload,
and medication adherence for AA adults with comorbid T2D and hypertension.
This study also explored the perceived impact of COVID-19 on the management
of prescribed medications.
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Research Questions
For AA adults 18 years of age or older with comorbid T2D and
hypertension who have been prescribed medications for blood pressure and
glycemic control:
RQ1: Are higher levels of illness burden associated with lower levels of patient
activation and health literacy?
RQ2: Are higher levels of treatment burden associated with a higher number of
prescribed medications and greater perceived difficulty in managing prescribed
medications?
RQ3: Do patient activation, health literacy, treatment burden, and illness burden
significantly predict medication adherence?
RQ4: Which aspects of medication management are the most challenging?
RQ5: What is the perceived impact of the COVID-19 pandemic on medication
management?
Theoretical Framework
The Cumulative Complexity Model (CCM), developed by Shippee et al.,
2012, was used to guide the selection and analysis of variables in this study (See
Figure 1). The CCM provides a patient-centered framework for exploring the
complexity of disease management by illustrating: (1) how treatment burden and
illness burden impact the interaction between workload of demands and capacity,
(2) the potential imbalances that occur between individuals’ workload of demands
and their abilities to manage their workloads, and (3) how imbalances between
workloads and capacities indirectly impact health -related outcomes (Shippee et
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al., 2012). The CCM provides a mechanism for understanding the complexity of
patient care by illustrating how clinical and social factors accrue and interact,
complicating patients’ disease management experiences (Shippee et al., 2012).
The CCM incorporates interrelating concepts with feedback loops to
display disease management complexity and the ongoing consequences of
workload-capacity imbalances (Shippee et al., 2012). There are four primary
constructs within the model: workload, capacity, burden of treatment, and burden
of illness (Shippee et al., 2012). Workload is described as a collective of all the
demands (e.g., DSM, family obligations, work obligations) individuals have in
their lives (Boehmer, Shippee, et al., 2016). Capacity is defined as the abilities
and resources individuals have in meeting the demands of their workload
(Boehmer, Shippee, et al., 2016). Burden of treatment is the level of perceived
difficulty individuals have in meeting their workload demands (Rogers et al.,
2017). Lastly, burden of illness refers to th e perceived level of disruption in
aspects of day-to-day life that is attributed to a pre-existing disease process
(Shippee et al., 2012).
The CCM posits that when there is an imbalance between workload and
capacity, specifically when capacity fails to meet the demands of the workload,
individuals are more likely to have deficiencies in their disease management
performance (Boehmer, Shippee, et al., 2016). Performance deficits (e.g., poor
medication adherence) are associated with unfavorable health outcomes such as
illness leading to unplanned hospitalization (Fox et al., 2015; Leppin et al., 2015;
Shrivastava et al., 2013). Poor health outcomes may lead to greater treatment

12
and illness burdens (Bodde et al., 2013; Shippee et al., 2012;). The increased
burdens subsequently increase the demands of the workload and decrease the
capacity in meeting the increasingly demanding workload (Boehmer, Shippee, et
al., 2016).
Figure 1
Cumulative Complexity Model

Applicability of the Cumulative Complexity Model
The CCM can be applied to studies examining medication adherence for
individuals with chronic diseases, as it provides a framework to categorize patient
capacity and burden factors and examine how DSM capacities and burdens
interact. The CCM also reflects how certain attributes of a medication workload
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(i.e., number, difficulty, and route) can highlight the complexity that individuals
encounter when attempting to meet the DSM workload demand of managing
prescribed medications. The model has been used in previous studies involving
individuals with chronic illness (e.g., stroke survivors, patients on dialysis) to
explore DSM capacity (Boehmer, Shippee, et al., 2016; Gallacher et al., 2018).
Gallacher et al. (2018) conducted a qualitative study to explore patient burden
and patient capacity for stroke survivors. Findings from the study indicated a
cyclical relationship among patient workload, patient capacity, and deficiencies in
performance of DSM activities. Additionally, clinical practice implications from the
study included the need for healthcare professionals to review clinical guidelines
and healthcare delivery models, as these also have an impact on a patient’s
capacity and burden. In a cross-sectional study of adults receiving dialysis
treatments, Boehmer, Shippee, et al. (2016) sought to explore patients’
perceived burdens from dialysis and their individual capacities in coping with the
associated burdens. Findings from the study indicated that deficits in physical,
emotional, and financial capacities were the most significant factors associated
with a disruption in disease management. The CCM has also been used as a
framework for the development of a self-report tool which facilitated
communication between patients and clinicians, highlighted patients’ conflicts in
managing competing priorities in DSM, and in some cases, led to changes in
treatment plans (Boehmer, Hargraves, et al., 2016). To date, the model has not
been utilized in a study specifically for AA adults with T2D and hypertension nor
as a framework for predicting medication adherence.
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Overview of Concepts
Workload
An individual’s workload is the summation of all their competing, personal
demands (Shippee et al., 2012). Examples of workload demands include
maintaining or acquiring employment, completing disease self-management
activities, and managing household duties (Shippee et al., 2012). Workloads can
vary in several ways including in the following attributes: number of demands,
difficulty of demands, and how well each of their demands fit into an individual’s
life among their other demands (Shippee et al., 2012). In this study, “workload”
was adapted to “DSM workload” for AA adults with T2D and hypertension. DSM
workload is defined as the DSM demands that individuals have in managing their
illness(es). For T2D and hypertension, demands may include the activities
involved in exercising, acquiring and consuming healthy foods, communicating
with healthcare providers, and managing prescribed medications (Gallacher et
al., 2018). One specific DSM workload demand of interest, managing prescribed
medications, was examined in this study. The specific attributes of this DSM
workload demand that were examined in this study are number (i.e., the number
of medications prescribed), difficulty (i.e., the perceived difficulty in managing the
workload demand), and route (i.e., the routes prescribed for medication
administration). These attributes were collectively described as “medication
workload” and were used to gain additional insight into the workload demand of
managing prescribed medications for AA adults with T2D and hypertension.
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Capacity
Capacity refers to the abilities and resources individuals possess in order
to manage their workload responsibilities. Capacity includes any physical,
mental, social, financial, personal, and environmental resources, all of which may
change over an individual’s lifespan (Leppin et al., 2014). In this study, “capacity”
was adapted to “DSM capacity” and was defined and measured through two
functions: patient activation and health literacy. Patient activation is an
individual’s perceived knowledge, motivation, and DSM skills relating to
managing healthcare activities (Bolen et al., 2014). Health literacy is defined as
the ability to obtain, process, and understand health and healthcare service
information (Weld et al., 2008).
Treatment Burden
Treatment burden refers to the amount of difficulty and effort individuals
perceive is involved in meeting DSM workload demands (Boehmer, Shippee,
et al., 2016). Treatment burden is impacted by the amount and complexity of the
DSM workload demands an individual has been tasked with completing.
Treatment burden can also be impacted (positively or negatively) by other clinical
and social factors (e.g., healthcare access, presence of social support, financial
resources, physical functioning). The concept of treatment burden emphasizes
the need to consider the impact that prescribed DSM activities have on
individuals’ functioning or well-being (Boehmer, Shippee, et al., 2016).

16
Illness Burden
Illness burden refers to the perceived level of disruption in day-to-day life
that is associated with an existing disease (Shippee et al., 2012). Illness burden
may be impacted by symptoms (e.g., fatigue and pain), deterioration of functional
status, and an assortment of other health impairments relating to an individual’s
morbidity (Devins, 2010).
Conceptual Outcomes
DSM in T2D and hypertension can be very demanding for the individuals
who have these diseases, requiring completion of numerous DSM activities,
including the management of prescribed medications (Rogers et al., 2017). When
individuals with comorbid T2D and hypertension do not have the level of capacity
(e.g., adequate health literacy and patient activation) necessary to manage their
DSM demands, this may result in poor execution of DSM (e.g., poor medication
adherence). Individuals who demonstrate poor medication adherence are at risk
of experiencing negative health outcomes and may be further impacted by
diminished health and additional prescribed DSM workload demands, adding to
burdens that are likely already overwhelming (Rogers et al., 2017).
In this study, the attributes of one specific DSM workload demand (i.e.,
managing prescribed medications) was examined (i.e., number of prescribed
medications, perceived difficulty in managing prescribed medications, and the
routes prescribed for medication administration). Additionally, the relationships
among DSM capacity (i.e., patient activation and health literacy), patient burden
(i.e., treatment burden and illness burden), and medication adherence for AA
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adults with T2D and hypertension was examined. Greater illness burden was
expected to associate with lower DSM capacity. Greater treatment burden was
expected to associate with higher number of prescribed medications and greater
perceived difficulty in managing prescribed medications. The routes of
medication administration (e.g., oral, injection, topical) were also examined in this
study. An attribute of DSM workload demands is the “fit” of the workload
demands in individuals’ day-to-day lives (Shippee et al., 2012). As the specific
DSM workload demand in this study was the management of prescribed
medications, examining the routes prescribed for medication administration
provides insight into additional challenges in medication management. For the
outcome of interest in this study (i.e., medication adherence), individuals with
poorer medication adherence were expected to have higher patient burdens (i.e.,
treatment burden and illness burden) and/or lower levels of DSM capacity (i.e.,
patient activation and health literacy).
An adapted CCM model was developed to highlight the relationships that
were anticipated among the selected study variables (see Figure 2). Without
appropriate interventions, individuals who do not have the DSM capacity to
manage their DSM workload demands or have patient burdens too heavy to
overcome, may demonstrate poor medication adherence and have greater risks
of experiencing poor health outcomes. Poor health outcomes may create
additional treatment burdens and illness burdens, subsequently having additional
negative impacts on future health outcomes. As this study did not examine the
impact of DSM performance (e.g., health status, hospitalizations), researchers
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may benefit from exploring the cyclical nature of the original CCM by conducting
longitudinal studies that include objective measures of health status (e.g.,
glucose levels, HbA1c , blood pressure readings) and DSM performance, how
increased treatment burden impacts the DSM workloads, and how changes in
illness burden effect DSM capacity.
Figure 2
Adapted Cumulative Complexity Model

Note. This model was adapted for medication adherence among African
American adults with type 2 diabetes and hypertension . Adapted from Shippee et
al., 2012.
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Assumptions
The following are assumptions inherent in the Adapted Cumulative
Complexity model:
1. Managing prescribed medications is a prominent disease self-management
workload demand for African American adults with Type 2 diabetes and
hypertension.
2. The number of prescribed medications, perceived difficulty in medication
management, and the prescribed route(s) for administration of prescribed
medications are attributes that define the disease self-management workload
demand of managing prescribed medications.
3. Patient activation and health literacy are essential aspects of disease selfmanagement capacity that quantify individuals’ abilities to meet the disease
self-management workload demand of medication management.
4. Treatment burden and illness burden are specific patient burdens that may
complicate individuals’ abilities to meet the disease self-management
workload demand of medication management.
5. Treatment burden, illness burden, and disease self-management capacity
collectively impact an individual’s ability to manage their prescribed
medications and shape their medication adherence.
Summary
Although several national initiatives have been implemented to facilitate
reductions in complications from T2D and hypertension, the complications from
these diseases continue to threaten the well-being of individuals living with them,
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particularly AA adults. This study used an innovative model to examine a DSM
workload demand (i.e., managing prescribed medications), DSM capacities (i.e.,
patient activation and health literacy), patient burdens (i.e., treatment burden and
illness burden), and medication adherence for AA adults with T2D and
hypertension. Considering that managing prescribed medications is a prominent
DSM workload demand for AA adults with T2D and hypertension, it is essential to
examine underexplored factors that may have a great impact on patients’ abilities
to meet this DSM workload demand.
Examination of patient activation, health literacy, and patient burden
factors provided insight into the challenges that AAs face in meeting their DSM
workload demand of managing prescribed medications. As this entire study was
conducted remotely, this study also provides support for the feasibility of using
the respective measures as risk assessment tools in remote settings, such as
during telemedicine visits. In addition, findings from this study could potentially be
translated into enhanced clinical practice guidelines, with the goal being to
improve patients’ DSM capacities, decrease patient burdens, and improve
patients’ medication adherence. Ultimately, improvements in medication
adherence for AA adults with T2D and hypertension may lead to improvements in
overall minority health and a reduction in health disparities for a currently
vulnerable population.

CHAPTER II
REVIEW OF THE LITERATURE
This study aimed to examine the relationships among disease selfmanagement capacity, patient burden, and medication adherence for AA adults
with comorbid T2D and hypertension. The perceived impact of COVID-19 on
management of prescribed medications was also examined in this study. This
chapter presents an overview of the literature relating to the concepts that were
examined in this study. The first section of this chapter provides context for the
disease self-management workload in Type 2 diabetes and hypertension,
including the specific workload demand of managing prescribed medications.
Disease Self-Management Workload in Type 2 Diabetes and Hypertension
T2D and hypertension are chronic diseases that often require lifelong
disease management (AHA, 2016; Powers et al., 2015). Disease management in
both T2D and hypertension is largely conducted through performance of disease
self-management (DSM) activities (AHA, 2016; Powers et al., 2015). DSM
activities are the specific DSM workload demands an individual must meet in
managing their chronic conditions and preventing disease-related complications
(Beck et al., 2018). Previous reports indicate that adhering to recommended
DSM activities (e.g., medication adherence) is essential in achieving favorable
health outcomes and reducing risks for long term disease-related complications
(Fox et al., 2015; Powers et al., 2015; Shrivastava et al., 2013). Although
21
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recommended DSM activities are tailored to meet individualized needs, general
guidelines for DSM have been established and reported (Powers et al., 2015).
A joint position statement from the American Diabetes Association (ADA), the
American Association of Diabetes Educators (AADE), and the Academy of
Nutrition and Dietetics (AND) indicates that healthy eating, physical activity,
glucose monitoring, taking prescribed medications, problem-solving, and healthy
coping are general recommended DSM activities for individuals with diabetes
(Powers et al., 2015). Furthermore, the ADA affirms that the DSM aspect of
diabetes care also encompasses management of comorbidities, namely
hypertension (de Boer et al., 2017). ADA recommendations for inclusion of
hypertension for individuals with diabetes highlights the importance of home
blood pressure monitoring and medication adherence (de Boer et al., 2017).
Previous studies have highlighted the significance of DSM performance.
Weller et al. (2017) conducted a mixed-methods study to determine if the DSM
practices of adults with T2D were linked to glycemic control outcomes. A total of
56 participant interviews (29% AA) were retained from the larger study to conduct
a qualitative comparative analysis. The study revealed key themes relating to
glycemic control. Participants were then divided into three groups: good glycemic
control was indicated by HbA1c of <7.0%, fair control by a HbA1c from 7.0% to
8.0%, and poor control by a HbA1c of >8.0%. Individuals with good glycemic
control performed self-monitoring of blood glucose, rarely skipped or missed
medication doses, and followed dietary recommendations. More specifically,
individuals with good glycemic control, as compared to those with poor control,
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were less likely to report skipping medications (5% vs. 33%) and more likely to
monitor dietary sodium intake (53% vs. 6%).
Schmitt et al. (2016) also found associations between diabetes self management behaviors and glycemic control. The researchers conducted a
study to compare the efficacy of two self-report measures of diabetes selfmanagement in predicting variations in HbA1c levels. The self-report tool of
primary interest, the Diabetes Self-Management Questionnaire (DSMQ),
incorporated essential measures of disease self-management: dietary control,
medication adherence, blood glucose monitoring, physical activity, and
maintaining recommended physician contact. Using a sample of 430 patients
with diabetes (T2D patients = 182), the researchers found that the DSMQ
explained 28% of the variance in glycemic levels, with higher DSMQ scores (i.e.,
better DSM performance) associating with lower HbA1c levels (-0.46, p < .001).
These results highlight the importance of DSM performance in chronic disease
management. Essentially, better DSM performance lead to greater improvements
in glycemic control.
Medication Workload
An important DSM workload demand for individuals with T2D and
hypertension is managing prescribed medications. It has been estimated that
roughly 81% of individuals with T2D and 70% of individuals with hypertension are
prescribed medications for management of their disease (CDC, 2016b; CDC,
2019b). In 2018, antidiabetic medications ranked sixth out of the top 20
therapeutic classes of dispensed prescriptions, with 214 million prescriptions
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(Aitken et al., 2019). In that same year, antih ypertensives ranked first for
dispensed prescription medications, with 674 million prescriptions (Aitken et al.,
2019). The combined costs for both therapeutic classes of medications
accounted for greater than $67 billion in non-discounted U.S. spending during
2018 (Aitken et al., 2019). Furthermore, while the percentage of oral or insulin
therapy was consistent between AA and non -Hispanic White groups (respectively
47% vs 50%), AAs with diabetes were reported to have an almost two-fold
prevalence of dual pharmacologic therapy consisting of insulin and pills as
compared to their non-Hispanic White counterparts (respectively 25% vs. 13%;
CDC,2019). These data indicate a hefty DSM workload demand for managing
prescribed medications exists for AAs with T2D and hypertension.
Managing prescribed medications can be very complex, as it may require
numerous skills (e.g., health literacy, problem-solving skills). This complexity may
create challenges in meeting this DSM workload demand, leading to poor
medication adherence (Brown & Bussell, 2011; Greene et al., 2015; Ylitalo et al.,
2018). Deficiencies in DSM capacities and overwhelming burdens may exist for
individuals who demonstrate difficulty in performance of DSM. There is evidence
that knowledge deficits, the complexity of T2D management, and managing
comorbid conditions such as hypertension, create additional challenges in
performance of daily DSM activities (Akohoue et al., 2015; Bockwoldt et al.,
2017; Utz et al., 2006). While a few studies were identified that examined DSM
performance in AAs with diabetes (Al Sayah et al., 2015; Bains et al., 2011;
Bockwoldt et al., 2017; Davis et al., 2006; Skolasky et al., 2011; Weller et al.,
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2017), only one study was found that examined DSM solely in the AA population
(Bockwoldt et al., 2017) and no studies were found that examined DSM
performance exclusively in AAs with diabetes and comorbid conditions (e.g.,
hypertension). This study aimed to examine factors that potentially impact the
performance of DSM activities for AA adults with T2D and hypertension.
Additionally, the individual medication workloads (i.e. number of prescribed
medications, perceived difficulty in managing prescribed medications, prescribed
routes for medication administration) for AA adults with T2D and hypertension
were examined. By gaining a better understanding of how the capacity and
burdens of AAs with comorbid T2D and hypertension relate to performance of a
specific DSM activity (i.e., managing prescribed medications), it may be possible
to develop strategies that could improve medication adherence, and potentially,
improve health outcomes for this population.
Disease Self-Management Capacity
Individuals must have adequate DSM capacity to take the necessary
actions in meeting the demands of their DSM workloads (CDC, 2018d; Powers et
al., 2015). DSM capacity relates to the abilities and resources an individual has in
meeting disease management workload demands (Boehmer, Shippee, et al.,
2016). Considering that DSM capacity encompasses physical, mental, social,
financial, personal, and environmental resources, there are several factors
potentially related to an individual’s capacity to perform DSM activities (Leppin et
al., 2014). Multiple studies have reported on the influence of personal attributes,
physical and cognitive abilities, support networks, socioeconomic status, and
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culture on performance of DSM for individuals with chronic diseases (Akohoue et
al., 2015; Byers et al., 2016; Gallacher et al., 2018; Osborn et al., 2013; Rovner
et al., 2013). While other studies have found that even when facing substantial
challenges relating to disease management (e.g., low socioeconomic status),
some individuals maintained the capacity to remain engaged in DSM activities
(Greene et al., 2015; Keene et al., 2018). These findings highlight the importance
of exploring attributes of DSM capacity for individuals with T2D and hypertension
to gain a better understanding of factors that possibly enhance patients’
performance of DSM activities.
Patient activation and health literacy levels were used as measures of
DSM capacity in this study. Patient activation and health literacy represent an
individual’s capacity (i.e., knowledge, motivation, and skills) to manage healthrelated activities, with both patient activation and health literacy being previously
linked with the performance of DSM activities, including adhering to prescribed
medication regimens (Greene et al., 2015; Skolasky et al., 2011; Ylitalo et al.,
2018). Both measures have been used frequently in studies exploring DSM
performance for individuals with chronic diseases, and together, patient
activation and health literacy encompass the various skills required of individuals
with T2D and hypertension to perform prescribed DSM activities (Bolen et al.,
2014; Fowles et al., 2009; Greene et al., 2015; Hibbard at al., 2008; Lubetkin et
al., 2010; Mayberry et al., 2010; Weld et al., 2008; Ylitalo et al., 2018).
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Patient Activation
Patient activation represents individuals’ perceptions of their knowledge,
motivation, and skills in managing their health (Bolen et al., 2014). Patient
activation has four levels, with higher levels indicating greater patient activation:
Level 1 reflects individuals who have not realized the importance of their role in
the management of their health, Level 2 indicates individuals who lack the
knowledge and confidence to take action in managing their health, Level 3
reflects individuals who are beginning to engage in recommended health DSM
behaviors, and Level 4 reflects individuals who have a proactive approach to
managing their health and are engaging in most, if not all, recommended DSM
activities (Greene et al., 2015). High patient activation levels are associated with
greater competency in carrying out appropriate prevention measures, adequately
managing chronic conditions (e.g., adhering to prescribed medication regimens)
and having the ability to make sound decisions regarding health and health
services (Greene et al., 2015; Lubetkin et al., 2010; Skolasky et al., 2011). For
example, Skolasky et al. (2011) found in their cross-sectional study of 855
multimorbid participants (46% AA) that a 10-point increase in patient activation
scores yielded a 13% increase in odds of having increased medication
adherence (p = .025). The study used the number of missed doses to calculate
medication adherence (self-reported). No data on the specific chronic diseases
the participants had were reported.
Several other important associations have been reported for patient
activation. In a cross-sectional study, Mayberry et al. (2010) examined 48 adults
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with T2D to determine the relationships among patient activation, self-reported
DSM behavior (i.e., confidence in diabetes self-management and summary of
diabetes self-care), and glycemic control. The races of participants were only
stratified into two categories: White and non -White (14.6%). The 13-item Patient
Activation Measure® (PAM®) was used, with higher scores indicating greater
patient activation. The scores range from 0 to 100, signifying the degree of an
individuals’ active role in managing their health. Self-management behavior was
measured using a revised 13-item subscale based on the transtheoretical model
of stages of readiness for behavioral change, with higher scores indicating
greater self-management. Glycemic control was determined by the participants’
most recent HbA1c levels (i.e., HbA1c > 7% = uncontrolled diabetes; HbA1c ≤ 7% =
controlled diabetes). The researchers found a significant positive association
between DSM behavior and patient activation scores. However, this correlation
was stronger for individuals whose glycemic levels were under control (r = 0.73, p
= .01) than among patients with uncontrolled glycemia (r = 0.48, p < .001).
Additionally, there was no significant association found between patient
activation scores and glycemic control (OR 0.99; 95% CI: 0.94–1.03; p > .05). A
potential explanation offered for the lack of association between glycemic control
and patient activation was that some T2D patients potentially need to be at the
highest stage of activation (stage 4) to achieve glycemic control. Stage four of
patient activation indicates consisten cy in adequate DSM performance even
when DSM becomes problematic. Additionally, the small sample size of the study
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may have impacted the power to detect correlations between patient activation
and glycemic levels.
The effectiveness of patient activation in terventions for adults with T2D (N
=33,124) was examined in a systematic review of 138 randomized control trials
(Bolen et al., 2014). The systematic review focused on intermediate outcomes
(i.e., HbA1c , low-density lipoprotein cholesterol, high-density lipoprotein
cholesterol, triglycerides, systolic blood pressure, or bodyweight).
Results indicated patients receiving the patient activation interventions
experienced greater reductions in HbA1c (weighted mean differences [WMD] =
−0.37; 95% CI: −0.45, −0.28; I 2 = 83 %), systolic blood pressure (WMD = −2.2;
CI: −3.5, −1.0; I 2 = 72 %), body weight (WMD = −2.3; 95% CI: −3.2, −1.3; I 2 =
64 %), and triglycerides (WMD = −8.5;95% CI: −15.0, −2.3; I 2 = 64 %) than
patients randomized to the control groups. It is important to note that although
the studies yielded moderate reductions in HbA1c , a reduction as small as 1% in
HbA1c is associated with a 21% reduction in mortality for individuals with T2D
(Bolen et al., 2014). Additionally, the studies that had higher baseline means in
HbA1c , systolic blood pressure, and cholesterol levels had greater reductions in
these outcomes as compared to lower baseline means. This finding emphasizes
that individuals with the greatest need for improvements in glucose and blood
pressure control may benefit substantially from the implementation of patient
activation strategies.
Patient activation encompasses attributes considered essential to the
performance of DSM (i.e., knowledge, motivation, skills). Therefore, widening the
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breadth of knowledge on patient activation’s role in medication adherence for AA
adults with T2D and hypertension is imperative. Patient activation has been
previously described as a modifiable risk factor for poor health outcomes,
particularly for individuals with chronic diseases (Mitchell et al., 2014). For
patients with T2D and hypertension, an examination of patient activation can
provide supplementary assessment data potentially used to facilitate
improvements in patients’ DSM performance, and more specifically, in their
medication adherence. Likewise, health literacy can be considered a modifiable
risk factor for patients with chronic diseases and the DSM workload demand of
managing prescribed medications. Many activities involved in DSM, including
managing prescribed medications, require adequate health literacy to perform
properly. Exploration of health literacy provides further insight into medication
adherence for individuals with T2D and hypertension. Although much can be
gained from assessing patient activation levels, measuring patient activation is
currently highly subjective. The examination of health literacy provided the
opportunity to use more objective measures in examining patients’ DSM
capacities.
Health Literacy
Health literacy is the ability to obtain, process, and understand basic
health and service information needed to make wise decisions about healthcare
(Weld et al., 2008). Health literacy encompasses multiple skills including visual
literacy (i.e., ability to understand visual information), information literacy (i.e.,
ability to obtain and apply relevant information), numeracy (i.e., ability to
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calculate numbers), and oral language skills (i.e., ability to articulate health
concerns, ask pertinent questions, and understand verbalized information and
instructions; CDC, 2019c; Dastani & Sattari, 2016). Several DSM activities for
individuals with T2D and hypertension necessitate adequate health literacy. For
example, DSM for individuals with T2D and hypertension may involve reading
and comprehending prescription instructions, interpreting blood pressure
readings and glucose levels, and calculating medication doses.
Previous studies have described associations between health literacy and
DSM activities. In a cross-sectional study of 343 adults (83% AA), Al Sayah et al.
(2015) sought to determine associations between health literacy, behavioral
indicators (i.e., depressive symptoms, diabetes knowledge, diabetes selfefficacy, diabetes self-care, and self-reported medication adherence), and
cardiometabolic parameters (i.e., HbA1c , systolic blood pressure, and body mass
index) in individuals with T2D. Health literacy was measured using three
screening questions that assessed difficulty understanding written information,
confidence in filling out medical forms, and frequency of needing assistance
reading hospital materials. Medication adherence was assessed with Morisky
Medication Adherence Scale (MMAS), a self-report medication adherence tool.
Diabetes self-care was assessed with the Summary of Diabetes Self-Care
Activities questionnaire, another self-report tool. The researchers found that
summative health literacy scale only had significant associations with knowledge
(r = -0.34, p ≤ .05) and self-efficacy (r = -0.16, p ≤ .05). One item within the
health literacy scale, “difficulty understanding written information ”, was
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significantly associated with lower diabetes knowledge (r = 0.26, p ≤ .05.), lower
diabetes self-efficacy (r = 0.24, p ≤ .05), and worse medication adherence (r = 0.14, p ≤ .05). However, there were no significant associations between any
health literacy screening questions and any cardiometabolic parameters. The
researchers discussed that this lack of association might have resulted from the
health literacy measure used. The brief health literacy screening questions had
high specificity but were not as effective as expected in identifying individuals
with marginal health literacy due to the low sensitivity of the screening questions
(area under the ROC curve 0.62; 95% CI: 0.53, 0.72; Chew et al., 2004).
In another cross-sectional study, Bains et al. (2011) examined
associations among health literacy, diabetes knowledge, frequency of diabetes
self-care activities, medication adherence, and glycemic control. The sample
consisted of 125 adult patients with diabetes (AA = 71.4%). No data on
comorbidities was provided. The Revised Rapid Estimate of Adult Literacy in
Medicine (REALM-R) was the health literacy measure used in the study.
Diabetes knowledge was assessed with the Diabetes Knowledge Questionnaire
(DKQ). The Summary of Diabetes Self-Care Activities scale was used to
measure the frequency of diabetes self-care activities (i.e., diet, foot care,
glucose testing, and exercise). Medication adherence was measured using the
MMAS. HbA1c was the measure used to determine glycemic control. The
researchers found that higher health literacy scores associated with better
diabetes knowledge (r = 0.446, p < 0.001). Also, better diabetes knowledge was
associated with glycemic control (β = 0.12; 95% CI [0.01, 0.23], p < 0.05).
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However, no associations between health literacy and medication adherence,
frequency of diabetes self-care activities, or glycemic control were found. There
are several potential explanations for the lack of associations between health
literacy and the disease management variables (i.e., diabetes self-care activities,
medication adherence, and glycemic control). First, it is possible that other
unexamined factors have a mediating role between health literacy and
performance of DSM activities and glycemic control (e.g., patient burden).
Secondly, the study used self-report measures for all variables except for
glycemic control. Inclusion of objective measures for performance of DSM
activities would possibly provide more data on associations with health literacy.
Lastly, the study utilized the REALM-R, a health literacy measure that does not
assess numeracy or reading comprehension. By using a health literacy tool
measure that incorporates assessment of numeracy and document literacy (e.g.,
The Newest Vital Sign), more insight can be gained into the health literacy skills
necessary in the performance of DSM activities for individuals with diabetes.
Another study conducted found associations between health literacy and
other DSM activities. Ylitalo et al. (2018) found that the number of missed
medical office visits was significantly greater for patients with limited health
literacy (M = 9.8, SD = 10.4) as compared with individuals with adequate health
literacy (M = 5.0, SD = 5.7; p < .001). Additionally, the number of prescribed
medications for patients with limited health literacy (M = 10.5, SD = 7.3) was
significantly greater than for patients with adequate health literacy (M = 8.1, SD =
5.6; p = .03). This finding potentially indicates that individuals with limited health
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literacy had poorer DSM performance, requiring the need for additional
medications to sufficiently manage their disease. This phenomenon of the
accumulation of treatments for individuals who struggle with managing initial
treatments is a principal feature of the CCM. Polypharmacy is particularly
concerning for individuals with insufficient health literacy, as Davis et al. (2009)
found that the risk for misinterpreting prescription instructions was greater for
individuals with low literacy (adjusted risk ratio [RR] 2.70; 95% CI: 1.81,4.03; p <
.001) than those with adequate literacy.
While no studies were found that examined th e role of health literacy in
any DSM activities (e.g., managing prescribed medications) in an exclusive
sample of African Americans with T2D and hypertension, previous studies have
been conducted that explored the health literacy of AAs. Overall, AAs tend to
have lower healthy literacy levels than other racial/ethnic groups (Gwynn et al.,
2016; Kutner et al., 2006; Osborn et al., 2011; Rothman et al., 2004; Shiyanbola
et al., 2018). Ylitalo et al. (2018) conducted a cross-sectional study of 406
patients (39% had diabetes; 41% non -Hispanic Blacks) to assess health literacy
in a low-income adult population. The researchers used the Newest Vital Sign
(NVS) and a single-item screening question (i.e., “How confident are you filling
out medical forms by yourself?”) to measure health literacy. The NVS is a 6-item
assessment tool that incorporates a nutritional label and corresponding
questions, with scores of four or higher indicating the likelihood of adequate
health literacy. After adjusting for several covariates (i.e., age, sex, self-rated
health, BMI, diabetes status, number of medications, healthcare utilization, and
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confidence completing medical forms), findings indicated that non-Hispanic Black
patients were more likely to have inadequate health literacy (NVS < 4) compared
to non-Hispanic White patients (OR 7.32, 95% CI [2.41, 22.16], p < .001).
Additional studies have also reported similar findings supporting the disparity in
health literacy for AAs with diabetes (Gwynn et al., 2016; Osborn et al., 2011;
Rothman et al., 2004; Shiyanbola et al., 2018). Therefore, it is imperative to
conduct further exploration of health literacy for AAs with T2D and hypertension
and the potential impact on medication adherence.
Concurrent Examination of Patient Activation and Health Literacy
Individually, patient activation and health literacy are distinct, measurable
components of DSM capacity that provide insight into medication adherence for
individuals with T2D and hypertension. However, previous research suggests the
enhanced knowledge to be gained from examining patient activation and health
literacy simultaneously. For example, Gwynn et al. (2016) examined 225 adults
(67% Black) using data from a randomized controlled trial to determine the
relationships between race, health literacy, and patient activation. The
researchers also tracked participants’ number of comorbidities, which ranged
from none to more than two. No data were provided on the participants’ specific
types of comorbidities. Health literacy was measured with the short version of the
Test of Functional Health Literacy in Adults (S-TOFHLA). The S-TOFHLA is a
validated health literacy test designed to evaluate an individual’s ability to read
and understand health-related information, with higher scores indicating higher
literacy levels (Housten et al., 2018). The 21-item PAM® was used to measure
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patient activation. Health literacy was found to have a greater influence on
patient activation levels for individuals with greater comorbidities (path coefficient
= 0.420; p < .001) as compared with those with fewer comorbidities (path
coefficient = 0.119; p = .18). The researchers also found that low health literacy
was significantly higher among AA participants (54%) compared to non -Hispanic
White participants (12%); p < .0001. Furthermore, health literacy was found to
mediate the negative impact of race/ethnicity on patient activation (indirect effect
−0.139, SE = 0.036; p < .001).
Additional studies have yielded results that further support an association
between patient activation and health literacy. Lubetkin et al. (2010) conducted a
cross-sectional study to explore the relationship between patient activation and
health literacy. The researchers used a convenience sample of 454 patients
(34% Black) receiving care from one of three health centers. No data were
gathered on chronic disease status for the patients. However, patients provided
self-rated health status data (excellent: 7%; very good: 23%; good: 38%; fair:
22%; poor: 9%). The 13-item PAM® was used to measure patient activation, and
health literacy was measured with the S-TOFHLA. Lubetkin et al. (2010) found
that patients with adequate health literacy were more likely to achieve the highest
level of patient activation (i.e., Level 4; 44%) and had significantly higher patient
activation scores (M = 64.8) compared to patients with borderline or inadequate
health literacy (21%; M = 55.7 p < .01).
Mitchell et al. (2014) obtained similar results in their secondary data
analysis. Health literacy was measured by the Rapid Estimate of Adult Literacy
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Measure (REALM). Significant associations were found between patient
activation and health literacy. Specifically, patients in the lowest health literacy
category (Grade 6 and below) were more likely to be at the lowest level of patient
activation (level 1; 16%) as compared with patients at the highest patient
activation level (level 4; 9%), p < .01. Previous research has indicated that as
little as a four-point difference in patient activation scores can create a
meaningful impact on DSM behavior sustainability (Fowles et al., 2009; Hibbard
at al., 2008).
In a different study, Sheikh et al. (2016) reported on the association
between patient activation and health literacy. The researchers conducted a
cross-sectional pilot study with a sample of 108 adult patients (63% AA) to
examine patient activation and health literacy during emergency room visits. The
13-item PAM® and the REALM were used to measure patient activation and
health literacy, respectively. Higher health literacy was significantly associated
with higher levels of patient activation (rs = 0.30; p = .001).
In summary, there is insufficient evidence of the associations among
patient activation, health literacy, patient burden, and medication adherence.
While three studies found higher patient activation was associated with higher
health literacy (Gwynn et al., 2016; Lubetkin et al., 2010; Sheikh et al., 2016),
none of the studies were conducted among patients with comorbid T2D and
hypertension or focused on AAs, a group at great risk for low health literacy and
poorer health outcomes from diabetes and hypertension . A single study found a
positive relationship between patient activation and better DSM behaviors (i.e.,
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self-reported confidence in diabetes self-management and summary of diabetes
self-care) but did not include measures of the actual performance of any DSM
activities (Mayberry et al., 2010). A different cross-sectional study discovered
positive associations between patient activation and medication adherence but
did not specifically analyze the association in a sample of AA adults with
comorbid T2D and hypertension (Skolasky et al., 2011). A systematic review of
randomized controlled trials involving individuals with T2D resulted in the
discovery of the association between patient activation interventions and
improved health outcomes (i.e., < HbA1c , <systolic blood pressure). However, the
researchers did not study medication adherence (Bolen, 2014).
Four studies discussed associations between health literacy and DSM
activities. One study including AA adults with diabetes examined associations
between health literacy and attending healthcare appointments as scheduled.
The researchers found that lower health literacy associated with greater
frequency of missing medical appointments (Ylitalo et al., 2018). Another study
found the risk for misinterpreting prescription instructions was greater among
individuals with low literacy. The remaining two studies examined health literacy
along with medication adherence, with both studies including samples of AAs
with diabetes. One study examined health literacy, DSM indicators (i.e., diabetes
knowledge, diabetes self-efficacy, and depressive symptoms), self-reported
medication adherence, and health outcomes (i.e., HbA1c , systolic blood pressure,
and body mass index). No relationship between health literacy and health
outcomes were found, potentially due to the low sensitivity of the health literacy
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measured used. However, one item within the health literacy scale used,
“difficulty understanding written information”, was significantly associated with
lower diabetes knowledge and worse medication adherence (Al Sayah et al.,
2015). The other study examined associations among health literacy, diabetes
knowledge, frequency of diabetes self-care activities, medication adherence, and
glycemic control. No associations between health literacy and medication
adherence, frequency of diabetes self-care activities, or glycemic control were
found, potentially due to unexamined factors (e.g., patient burden) and exclusion
of measures of numeracy and reading comprehension from the health literacy
tool used in the study (Bains et al., 2011). Moreover, of the studies that examined
health literacy, only one study used literacy measures that assessed the
numeracy skills of the participants (Ylitalo et al., 2018) and no studies examined
the patient burden of participants. Numeracy relates to an individual’s ability to
process numeric information (Housten et al., 2018). For patients with T2D and
hypertension, numeracy skills are essential. Additionally, patient burden provides
insight into how some individuals with adequate health literacy or high patient
activation do not demonstrate expected DSM performance (e.g., good
medication adherence).
Overall, there is limited literature that suggests a relationship between
patient activation and health literacy, particularly for AAs with chronic conditions.
Moreover, the literature that describes associations among patient activation,
health literacy, and the management of prescribed medications, specifically for
AA adults with T2D and hypertension, is non -existent. Several reports indicate
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lower health literacy levels for AA adults as compared to non -Hispanic White
adults (Gwynn et al., 2016; Osborn et al., 2011; Rothman et al., 2004;
Shiyanbola et al., 2018; Ylitalo et al., 2018). However, no studies reported the
inclusion of patients with comorbid T2D and hypertension . Higher levels of
patient activation and health literacy were found to associate with improved DSM
abilities: self-efficacy in diabetes care, interpreting prescription instructions,
attending scheduled medical appointments (Al Sayah et al., 2015; Davis et al.,
2009; Mayberry et al., 2010; Ylitalo et al., 2018) ), but the limited research
conducted to examine the role of patient activation and health literacy in the
actual performance of DSM activities (e.g., managing prescribed medications) is
conflicting (Al Sayah et al., 2015; Bains et al., 2011; Skolasky et al., 2011) .
Therefore, more research is needed. This study addressed the gaps in literature
by investigating patient activation, health literacy, and medication adherence for
AA adults with T2D and hypertension. The patient burden (i.e., treatment burden
and illness burden) reported by AA adults with comorbid T2D and hypertension
was also examined. The following section describes the potential role of patient
burden (i.e., treatment burden and illness burden) in DSM.
Patient Burden
Individually, T2D diabetes and hypertension are burdensome chronic
diseases (AHA, 2016; Powers et al., 2015; Rowley et al., 2017). When these
diseases co-exist, the patient burden is further compounded (CDC, 2018b;
NIDDK, 2017). Individuals with chronic diseases often experience illness and
treatment burden. These burdens stem from the physiological impact of the
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diseases and the complexity of treatment regimens prescribed for disease
management (Brod et al., 2009; Eton et al., 2012; Gupta et al., 2016). Individuals
with comorbidities, namely T2D and hypertension, may have DSM workloads that
include completion of daily activities (i.e., taking medications), creating daily
treatment burdens for patients to overcome (Eton et al., 2012). Considering the
typical DSM workload that patients with comorbid T2D and hypertension
encounter, it is very probable that many of these patients experience treatment
burden. As treatment burden potentially impacts DSM productivity, such as what
is needed for medication adherence, it is essential to examine this burden for
patients with T2D and hypertension (Rogers et al., 2017). The following sections
describe the specific aspects of patient burden of interest in this study, treatment
burden and illness burden.
Treatment Burden
The burden of treatment has been defined as an individual’s DSM
workload and the impact that the workload has on well-being (Eton et al., 2012).
A DSM workload consists of prescribed therapies and individualized DSM
demands, which are essential activities in the effective management of T2D and
hypertension (Byers et al., 2016; CDC, 2018b; Shippee et al., 2012). Although
the benefits of proper management of T2D and hypertension are well known
(e.g., decreased risks of heart disease and stroke), the prescribed DSM activities
to manage these comorbidities can be burdensome for patients (AHA, 2016;
Brod et al., 2009; CDC, 2017c). The ADA recommends that healthcare
professionals consider patients’ overall treatment burden when engaging in
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shared decision-making with patients to establish glycemic and blood pressure
control targets (de Boer et al., 2017). The integration of minimally disruptive
medicine into patient care is an attempt to address the concerns regarding
treatment burden for patients (Eton et al., 2012). Minimally disruptive medicine
refers to the development of treatment plans and the provision of services that
are designed to facilitate patients’ healthcare goal attainments while limiting the
healthcare burden patients experience. A key aspect of effectively implementing
minimally disruptive medicine is to establish patients current and potential
treatment burdens.
Few studies have specifically explored the treatment burdens experienced
by individuals with chronic disease. Findings from two qualitative studies
described how managing prescribed medications along with other factors may
lead to increased treatment burden (Eton et al., 2012; Gallacher et al., 2018).
Gallacher et al. (2018) conducted a qualitative study to explore patient burden
and patient capacity for stroke survivors (N = 29). Findings from the study
indicated that treatment burden arose from the participants’ healthcare workloads
or the occurrences of care deficiencies. Within participants’ healthcare
workloads, several factors that added to chronic disease management treatment
burdens were reported as: (1) understanding symptoms and treatments, (2)
problem-solving, (3) goal setting and prioritizin g, (4) routine appointments, and
(5) managing medications. Additionally, specific care deficiencies that added to
treatment burdens were: (1) difficulty with understanding provided information,
(2) poorly timed information, (3) information not tailored to the individual, (4)
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complicated medication regimes, and (5) poor long-term follow-up from health
care providers. In a similar study, Eton et al. (2012) conducted semi-structured
interviews of thirty-two adults who had at least one chronic condition and were
tasked with DSM activities (i.e., taking multiple medications and monitoring their
health, diet, and exercise), to understand the perspectives of patients regarding
their treatment burden. Twelve of the participants were previously diagnosed with
diabetes and fourteen were diagnosed with hypertension. Findings revealed
several themes for treatment burden, similar to the Gallacher et al. study,
including medication adherence challenges, financial challenges, and confusion
about medical information.
In a secondary analysis of a quantitative cross-sectional study, Rogers et
al. (2017) examined 120 adults (AA = 22) with diabetes and at least one other
comorbid condition (hypertension =85% of the sample) to examine the
associations between treatment burden and disease-related outcomes. Of the
associations examined in the study, the associations between treatment burden
and two outcome measures: chronic condition distress and perceived
competence in managing health conditions are of primary interest. Treatment
burden was measured with the 48-item Patient Experience with Treatment and
Self-Management (PETS) questionnaire, with higher scores on each subscale
indicating greater perceived treatment burden in the corresponding domain.
Chronic condition distress was positively associated with multiple treatment
burden subscales: medical information burden (rs = 0.56), medication burden (rs =
0.53), monitoring health burden (rs = 0.50), health care expenses burden (rs =
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0.48), medical appointments burden (rs = 0.44), and bothersome medication side
effects (rs = 0.39); p < .001 for all associations. These findings imply that
individuals who felt more overwhelmed with their health conditions (i.e.,
experienced greater illness burden) also experienced greater treatment burdens
related to managing their chronic conditions. Additionally, perceived competence
in disease self-management was negatively associated with several treatment
burden subscales: monitoring health burden (rs = -0.50; p < .001), physical and
mental health exhaustion (rs = -0.47), medical information burden (rs = -0.46),
healthcare expenses burden (rs = -0.39), medication burden (rs = -0.33); all with
p < .001. Based on these findings, it appears that individuals wh o had lower
perceived competence (e.g., lower DSM capacity) in completion of DSM activities
also experienced greater treatment burdens. Therefore, by exploring factors
associated with patients’ DSM capacity (e.g., patient activation and health
literacy) in addition to treatment burden , strategies can be developed that could
enhance patients’ DSM capacities and reduce their treatment burden s,
subsequently improving their chances of meeting the demands of their DSM
workloads.
In addition to the factors previously described in regard to treatment
burden, some of the burden patients experience stems from changes to patients’
treatment regimens. For example, according to clinical practice guidelines,
diabetic patients who have elevated HbA1c during a hospital admission are
prescribed a more intense outpatient treatment regimen, as compared to the
regimen received during hospitalization (Umpierrez et al., 2012). Thus,
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individuals who have poorly controlled diabetes are likely to have even greater
treatment burdens following a hospitalization. Griffith et al. (2012) conducted a
retrospective cohort study to examine how pre-hospital admission medication
prescriptions for 1,359 Veteran Affairs patients (AA = 19%) differed from the
prescribed outpatient regimen following hospital discharge. Of the 2,2025
admissions that occurred during the study period (indicating that there were
repeat admissions for some patients), 22% (n = 454) of the encounters involved
a change to the post-discharge treatment regimen. The most frequent changes in
treatments included initiating a new insulin medication (44%), initiating a non insulin medication (17%), change from one insulin medication to another (12%),
and increasing medication dosages (34%).
Individuals who are overly burdened with their treatment regimen may
struggle with completing DSM activities (i.e., managing prescribed medications),
leading to partial or complete nonadherence to prescribed DSM activities (Eton
et al., 2012; Lin et al., 2015; Shippee et al., 2012). For example, greater
treatment burden has been found to associate with poorer medication adherence
(Rogers et al., 2017). As nonadherence to prescribed DSM activities places
patients at a greater risk for negative health outcomes, healthcare providers may
respond with the implementation of additional treatments, further increasing the
complexity of patients’ disease management and intensifying treatment burdens
(Eton et al., 2012; Rogers et al., 2017).
Along with treatment burdens, patients with T2D and hypertension may
also experience illness burdens. Even with adequate disease management,
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individuals with T2D and hypertension may still experience daily illness burdens
as a result of associated disease symptomatology. As such, an examination of
potential illness burdens alongside treatment burdens is necessary to achieve a
greater understanding of patient burden.
Illness Burden
Comparable to treatment burden, illness burden reportedly has negative
associations with the performance of DSM activities. Illness burden refers to the
perceived disruption in a person’s life attributed to symptoms (e.g., pain) and
functional limitations (e.g., amputation) that occur as a result of disease
(Adriaanse et al., 2016; Boehmer, Shippee, et al., 2016). The presence of more
than one chronic condition is associated with poorer health, decline in functional
status, lower quality of life, and higher mortality (Adriaanse et al., 2016;
Boehmer, Shippee, et al., 2016; Payne et al., 2013; Rogers et al., 2017). People
with chronic diseases, such as T2D and hypertension, may suffer from numerous
disease-related symptoms and/or functional challenges, ultimately leading to
considerable illness burdens. Rogers et al. (2017) also found that chronic illness
distress was significantly associated with greater medication burden (0.53, p <
.001).
In a cross-sectional study, researchers evaluated the illness burden for
255 patients (AA = 19%) with diabetes who also had diabetic peripheral
neuropathy (Gore et al., 2006). Neuropathy is one of the most common diabetes
complications that causes pain, numbness, and potentially leads to permanent
disabilities (CDC, 2017c). Most of the sample had T2D (86%) and 52% reported
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taking at least two prescription medications specifically for managemen t of
neuropathic symptoms (Gore et al., 2006). Many participants reported declines in
home productivity (59%) and diminished ability to perform activities of daily living
(86%) due to the pain experienced from diabetic neuropathy. For participants
who worked at least part-time (n = 73), 64% reported missing work (M = 13
days), leaving work early, and decreased work productivity as a result of diabetic
neuropathy pain.
Examples of illness burden were also found among people with kidney
disease, a major complication that can result from poorly managed diabetes
and/or hypertension. Boehmer, Shippee, et al. (2016) conducted a crosssectional study of 137 adult dialysis patients to discover associations between
domains of patient capacity and disruptive of illness (i.e., illness burden). The
Illness Intrusiveness Scale was used to measure illness burden. The results
indicated that illness intrusiveness (i.e., perceived impact of illness burden on
daily life) had significant negative associations with capacity measures: selfefficacy (-0.4, p < .001), mental capacity (-0.6, p < .001), and financial capacity
(-0.5, p < .001). They also found that specific illness burden factors had
significant positive associations with overall illness intrusiveness scores: pain
(0.5, p < .001) and fatigue (0.6, p < .001).
In a retrospective population-based cohort study of 530,771 adults with
chronic kidney disease (CKD), it was found that participants with one concordant
comorbid condition (e.g., diabetes and hypertension) had a greater occurrence of
acute myocardial infarctions (HR 1.2; 95% CI: 1.13, 1.19; p < .05) and mortality
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(HR 1.8; 95% CI: 1.73, 1.93; p < .05 ) than participants without a concordant
comorbidity (Tonelli et al., 2015). Diabetes and hypertension were listed as
concordant comorbidities in the study, as they have been indicated as having a
similar pathophysiological profile as CKD, similar care management strategies,
and in many cases, are major contributing factors in the development of CKD
(Aga et al., 2019; Tonelli et al., 2015).
The burden of illness for individuals with diabetes and hypertension also
includes indirect costs stemming from the inability to acquire or maintain
employment due to disease-related disabilities and increased absenteeism from
work due to disease-related symptoms and/or hospitalizations (ADA, 2018a).
AAs with T2D and hypertension reportedly have greater costs associated with
hospital inpatient visits and higher rates of disease-related mortality as compared
with non-Hispanic White patients, indicating a greater burden of illness in this
population (ADA, 2018a; CDC, 2019a; CDC, 2019b). The disparity in illness
burden for AAs may be explained by the higher rates of chronic disease noted in
this population. Gebregziabher et al. (2018) analyzed differences in
multimorbidity magnitude and patterns among a national sample of more than
three million Veterans (n = 1,263,906 for participants with diabetes, 13% AA).
They found that urban non-Hispanic Blacks had an elevated risk of multimorbidity
when compared to urban non -Hispanic Whites (RR 1.05; 95% CI: 1.05, 1.05;
p < .001). Other reports have also supported the higher prevalence of diabetesrelated comorbidities and disease-related complications for AAs as compared to
other racial and ethnic groups (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Lynch
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et al., 2015; Mathur et al., 2011; OMH, 2016), further highlighting the illness
burden for the AA population.
In summary, multiple studies have reported on the illness and treatment
burden experienced by individuals with chronic disease (Brod et al., 2009; Eton
et al., 2012; Gallacher et al., 2018; Griffith et al., 2012; Gupta et al., 2016;
Rogers et al., 2017; Rowley et al., 2017; Shippee et al., 2012; Umpierrez et al.,
2012) and others have highlighted the added burden that occurs in the AA
population (CDC, 2017d; CDC, 2019b; Lin et al., 2015; Lynch et al., 2015;
Mathur et al., 2011; OMH, 2016) and with the presence of more than one chronic
disease (Adriaanse et al., 2016; Aga et al., 2019; Boehmer, Shippee, et al.,
2016; Gebregziabher et al., 2018; Lin et al., 2015; Payne et al., 2013; Tonelli
et al., 2015). Few associations among treatment burden, illness burden, and
performance of DSM activities have been reported (Gore et al., 2006; Rogers
et al., 2017). Only one study was found that discovered associations between
illness burden and DSM capacity measures, with greater illness burden
associating with lower self-efficacy and mental capacity (Boehmer, Shippee,
et al., 2016). However, no studies were found that examined associations among
patient burden, patient activation, health literacy, and medication adherence,
specifically for AA adults with T2D and hypertension.
Considering that multimorbidity has been associated with poor health
outcomes and greater risks of mortality, it can be reasonably inferred that the AA
population with multimorbid conditions (i.e., T2D and hypertension) potentially
experience elevated burdens as compared to other ethnic groups

50
(Gebregziabher et al., 2018; Tonelli et al., 2015). Therefore, the examination of
illness burdens and treatment burdens for AA adults with T2D and hypertension
reveals important factors involved in DSM for this population, ultimately providing
a foundation for the development of methods to address the notable disparities in
patient burden.
Another potential factor that has a role in individuals’ inabilities to meet
their DSM workload demands relates to managing DSM activities in the presence
of catastrophic global public health challenges, such as the current COVID-19
pandemic. This study explored the perceived impact of the COVID-19 pandemic
on DSM performance, including the management of medications for AA adults
with T2D and hypertension. The following section describes DSM performance in
the context of the COVID-19 pandemic.
Potential Impact of the Coronavirus Disease 2019 Pandemic
The Coronavirus Disease 2019 (COVID-19) is a life-threatening infectious
disease with no specific vaccines or treatments (World Health Organization
[WHO], 2020). Although many individuals who become infected with COVID-19
may experience only mild symptoms, certain individuals (e.g., individuals with
underlying cardiovascular disorders or diabetes) are more likely to develop more
serious illnesses from COVID-19 and have greater challenges in recovery (AHA,
2020a; CDC, 2020c; WHO, 2020). Additionally, AAs are disproportionately
impacted by COVID-19, as the hospitalizations and death rates related to
COVID-19 are higher for AAs as compared to other ethnic groups (CDC, 2020d).
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The COVID-19 pandemic has presented many potential challenges in
performance of DSM activities. During a pandemic such as with COVID-19,
individuals may have increased levels of stress. This increased stress may
reduce their ability to concentrate on routine activities, including performance of
DSM. Additionally, since the declaration of pandemic status for COVID-19, the
U.S. has experienced a drastic rise in unemployment rates, with rates increasing
from 3.6% in January 2020 to 14.7% in April 2020 (U.S. Bureau of Labor
Statistics, 2020). This surge in unemployment is likely a consequence of COVID19 related business closures, massive layoffs, and furloughs. Potential
challenges are also presented from changes in patient access to routine
healthcare visits, as many organizations were driven to either postpone nonurgent care visits or transition to telemedicine services, per public health
recommendations (AHA, 2020b). Moreover, the developing nature of COVID-19
has led to uncertainty relating to performance of DSM activities (e.g., managing
medications). For example, Schroeder (2020) discussed erroneous speculations
that the use of angiotensin-converting enzyme (ACE) inhibitors and angiotensin II
receptor blockers (ARBs), both of which are medications used to treat high blood
pressure, increase the risk of illness from COVID-19. Although there have been
no studies that confirm associations between COVID-19 illness and these
medications, the uncertainty of risks and fear of illness may lead individuals
prescribed these medications to stop taking them.
The potential financial strain, changes in access to non-urgent healthcare
services (e.g. telemedicine), and the need to navigate a sea of new and
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potentially conflicting information relating to COVID-19, may present additional
challenges in managing medications for individuals with T2D and hypertension.
There is limited information on how COVID-19 impacts DSM activities for
individuals with chronic disease. Additionally, no studies were found that
examined performance of DSM in the context of COVID-19. Therefore,
exploration of the perceived impact that the COVID-19 pandemic has had on
performance of DSM, namely managing prescribed medications, is of great
importance.
This study examined the associations among DSM capacity (i.e., patient
activation and health literacy), patient burden (i.e., treatment and illness burden),
and medication adherence for AA adults with T2D and hypertension. Additionally,
the perceived impact of the COVID-19 pandemic on the management of
prescribed medications was explored. The importance of DSM, the specific DSM
activity of managing prescribed medications, and factors that influence DSM
performance (i.e. capacity and burden) for individuals with comorbid T2D and
hypertension have been described. The remaining review of literature describes
the dependent variable of this study, medication adherence.
Medication Adherence
Medication adherence is defined as the extent to which an individual’s
medication usage parallels with the prescribed medication regimen (World Health
Organization [WHO], 2003). Medication adherence is a DSM activity that is of
great importance for individuals with T2D and hypertension, as it has been
reported as a vital factor in the prevention of health complications for individuals
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with chronic conditions (Brown & Bussell, 2011). Adhering to medication
prescribed specifically for management of T2D and hypertension has been
associated with reduction in the risk of diabetes complications (e.g., kidney
disease) and reductions in the risk of stroke and heart disease (CDC, 2018b).
Inconsistent medication adherence in the management of T2D and HTN is
associated with failing to achieve glycemic and blood pressure control and
increased risks of cardiovascular disease (CDC, 2018b; Dragomir et al., 2010).
Poor medication adherence has also been found to associate with high perceived
treatment burden (Rogers et al., 2017). More specifically, medication adherence
was poorer for individuals who reported feeling more overwhelmed by medical
information (OR 0.94; 95% CI: 0.90 -0.99) and for individuals with greater
perceived medication burden (OR 0.96: 95% CI: 0.92 -0.99), p < 0.001 (Rogers
et al., 2017). Reportedly, from 2017-2018 approximately 13% of adults
diagnosed with diabetes in the U.S. did not take diabetic medications as
prescribed (Cohen & Cha, 2019). Other reports have indicated that nationwide
measures of medication adherence have varied for individuals with hypertension
and diabetes, from 50% in some states among Medicaid recipients to 85% for
those covered by Medicare Part D (Aitken et al., 2019).
Taking medication as prescribed for T2D and hypertension requires health
literacy skills (e.g., numeracy and reading comprehension), which creates a level
of complexity that may be difficult for some individuals to manage. This
complexity may lead higher occurrences of poor medication adherence (Brown &
Bussell, 2011; Greene et al., 2015; Ylitalo et al., 2018). For example, in a cross-
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sectional study of 395 adult primary care patients (AA = 47%), the abilities of the
patients to understand and demonstrate instructions found on container labels of
common prescription medications were explored (Davis et al., 2006). While 70%
of patients with low literacy were able to verbalize the instructions, only 30%
were able to accurately demonstrate the instructions, implying a lack of
comprehension for some of the patients. Davis et al. (2006) also found that
misunderstanding prescription instructions was more likely to occur for
individuals taking three or four prescription medications (adjusted RR 3.22; 95%
CI: 1.53–6.77; p < 0.001) and for individuals with low literacy (adjusted RR 2.32;
95% CI: 1.26, 4.28; p < 0.001).
Previous studies have explored factors that contributed to medication
adherence, or lack thereof. Weller et al. (2017) found in a qualitative comparative
analysis of 56 adults (AA = 29%) with T2D that there were specific medicationtaking behaviors participants identified that might have influenced glycemic
control outcomes. Individuals with good glycemic control reported greater use of
memory aids to assist with complexity of adherence (e.g., a pillbox organizer),
indicating the use of problem-solving skills in managing the complexity of
medication management. Forgetting to take medications, stopping prescribed
medications to try alternative therapies, and not comprehending medication
administration instructions contributed to poor medication adherence (Weller
et al., 2017). Eton et al. (2012) also described several challenges individuals had
with taking medications including experiencing side effects of medications, being
confused about medication administration (e.g., not knowing the purpose and
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timing of medication administration), managing multiple medications, and dealing
with the interference in daily routines caused by managing medications. Similar
to the Weller et al. study, participants also reported improving medication
adherence by organizing and preparing medications with a pill box.
In another qualitative study, Bockwoldt et al. (2017) explored the
medication-related experiences of fifteen AA adults with T2D to identify factors
that influenced their adaptation to medication adherence. Participants reported
that acute physical changes (e.g., residual effects from a stroke), acquisition of
new knowledge relating to DSM, and changes in life status (e.g., death of a
family member) led to a greater sense of accountability and improved adherence
to their medication regimen. Additionally, the study revealed health promoting
and health impairing factors involved in medication adherence. Health promoting
factors (i.e., factors that facilitated medication adherence) included selfconfidence in performance of DSM, belief in the value of medication adherence,
assuming responsibility for their health, development of a routine for medication
adherence, and maintaining positive relationships with the healthcare team.
Some participants reported coordinating their medication administration with
mealtimes and/or making lifestyle adjustments to improve adherence. Health
impairing factors (i.e., factors that impeded medication adherence) included
feelings of powerlessness, self-blame, and fear relating to taking medication.
Some participants with inconsistent medication adherence reported not taking
prescribed medications due to being fearful of the medication side-effects, while
others reported taking medications only when physical symptoms were
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experienced (Bockwoldt et al., 2017). Kennedy et al. (2008) reported similar
findings from a quantitative study of 1.6 million Medicare beneficiaries. Results of
the study indicated that greater than 4% of the total sample failed to fill or refill at
least one prescription, with the most common reasons being not finding the
medication necessary (18%) and fearing the medication side effects (12%).
In summary, previous studies have reported findings that support the role
of medication adherence in achieving improved disease management outcomes
(Brown & Bussell, 2011; Dragomir et al., 2010; Weller et al., 2017). Individuals
who adhere to prescribed medication regimens have lower risks in the
development of disease-related complications such as neuropathy, kidney
disease, stroke and heart disease (CDC, 2018b). Problem-solving skills and
literacy have been identified as important aspects in adhering to prescribed
medications (Bockwoldt et al., 2017; Brown & Bussell, 2011; Eton et al., 2012;
Greene et al., 2015; Rogers et al., 2017; Weller et al., 2017; Ylitalo et al., 2018).
A few studies were found that examined factors that facilitated and
hindered medication adherence. Individuals who demonstrated poor medication
adherence were found to experience greater perceived treatment burden, have
poorer health literacy, have more difficulty in carrying out written instructions, fear
the medication side effects , and feel more overwhelmed by medical information
and managing their prescribed medications (Bockwoldt et al., 2017; Davis et al.,
2006; Kennedy et al., 2008; Rogers et al., 2017; Weller et al., 2017). Additionally,
individuals with poor medication adherence reported difficulty in managing
multiple medications, remembering to take their medications, understanding
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medication administration instructions, and managing the disruption in daily
routines caused by taking prescribed medications (Eton et al., 2012; Weller et al.,
2017). The use of memory aids, acquiring DSM knowledge, having greater
confidence in performance of DSM, and developing a routine for medication
management were found to increase individuals’ potentials for good medication
adherence (Bockwoldt et al., 2017; Weller et al., 2017). However, no studies
were found that examined medication adherence among in a sample of AA
adults with T2D and hypertension. Additionally, none of the studies examined
medication adherence during a global public health crisis.
Taking medications as prescribed can be complex process, thus it is
imperative to examine factors that potentially impact individuals’ abilities to
manage this DSM activity. In this study, medication adherence was examined
along with DSM capacity (i.e., patient activation and health literacy), patient
burden (i.e., illness burden and treatment burden), and the potential impact of
COVID-19 on medication management. Considering the complexity of adhering
to a prescribed medication regimen and the high prevalence of prescribed
medications for individuals with T2D and hypertension , this study provides
valuable medication adherence associations. These associations may be key in
the development of strategies to improve health outcomes for AAs with comorbid
T2D and hypertension.
Summary
In this chapter, multiple studies were presented that reinforced the need
for further exploration of DSM capacity and patient burden for AA adult patients
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with T2D and hypertension. The existing literature supports the role of DSM
performance in disease management and prevention of disease-related
complications (Beck, 2018; Powers, 2015; Weller et al., 2017). However, the
literature examining medication workloads, DSM capacity, patient burden, and
medication adherence for AAs with T2D and hypertension is fragmented and, in
some cases, non-existent.
This study addressed several gaps in the literature. First, existing literature
describing the role of DSM capacity in DSM performance (Al Sayah et al., 2015;
Bolen et al., 2014; Davis et al., 2009; Greene et al., 2015; Gwynn et al., 2016;
Lubetkin et al., 2010; Mayberry et al., 2010; Ylitalo et al., 2018), provide limited
evidence on associations among patient activation, health literacy, and
medication adherence, particularly for adult AAs with both T2D and hypertension.
Secondly, research on patient burden (Adriaanse et al., 2016; Boehmer,
Shippee, et al., 2016; Eton et al., 2012; Gallacher et al., 2018; Gebregziabher
et al., 2018; Gore et al., 2006; Griffith et al., 2012; Payne et al., 2013; Rogers
et al., 2017; Ylitalo et al., 2018), has provided limited information on associations
with patient activation and health literacy. Furthermore, the studies that were
found on patient burden did not compare associations of illness and treatment
burden with medication workloads, DSM capacity, and medication adherence, for
patients with comorbidities. Treatment and illness burdens have both been
described by participants in previous studies as being barriers to performance of
DSM activities (Eton et al., 2012; Gore et al., 2006).
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Third, the literature on medication adherence for patients with chronic
disease provides some insight on associations among health outcomes, health
literacy, and treatment burden (Aitken et al., 2019; Davis et al., 2006; Dragomir
et al., 2010; Rogers et al., 2017; Weller et al., 2017). However, only one study
was found that examined the associations between an aspect of treatment
burden (i.e. medication burden) and illness distress (Rogers et al., 2017). A few
studies reported on factors that promote and hinder medication adherence h as
been described (Bockwoldt et al., 2017; Davis et al., 2006; Eton et al., 2012;
Kennedy et al., 2008; Rogers et al., 2017; Weller et al., 2017). However, little is
still known on how medication adherence associates with patient activation,
medication workload, or illness burden within the target population.
Lastly, no studies were found that explored medication adherence in the
context of the COVID-19 pandemic. This study extends the current knowledge of
DSM by examining patient activation, health literacy, treatment burden, illness
burden, and medication adherence. The perceived impact of the COVID-19
pandemic on the performance of DSM was also explored.
Managing prescribed medications is an important DSM workload demand
for individuals with T2D and hypertension. Guided by the Cumulative Complexity
Model, the study adds to the body of knowledge for underexamined and
potentially significant factors associated with medication adherence in T2D and
hypertension, specifically for AA adults. By developing a more thorough
understanding of specific DSM capacity factors and the patient burdens from
prescribed treatments and disease symptomatology, additional insight was
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gleaned on the identification of risks for poor medication adherence and
strategies to improve medication adherence for vulnerable populations.

CHAPTER III
METHODOLOGY
This chapter describes the methodology that was used for this study. The
sections included in this chapter are organized as follows: study design, setting,
sample, recruitment, measures and instruments, data collection procedures, data
management, data analysis procedures, potential challenges, and the protection
of human subjects.
Study Design
A non-experimental, predictive, correlational design was used to examine
relationships among disease self-management capacity measures (i.e., patient
activation and health literacy), patient burden measures (i.e., treatment burden
and illness burden) and medication adherence for AA adults with T2D and
hypertension. This study also explored the workload and perceived impact of
COVID-19 in the context of managing prescribed medications.
Setting and Sample
All aspects of this research study were conducted remotely. A non -random
sample of 91 AA adults who met the inclusion criteria were recruited for this
study. Inclusion criteria for this study were: (1) self-identify as African
American/Black, (2) adult aged 18 years or older, (3) diagnosis of T2D and
hypertension for at least one year, (4) ability to read,
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understand, and speak English and provide informed consent, (5) prescribed at
least one medication for diabetes and one for hypertension treatment, (6) ability
to access the study surveys online or receive the surveys via a physical mailing
address, and (7) ability to participate in a scheduled online or telephone session
with the student Principal Investigator (student PI) following completion of online
or mailed surveys. The exclusion criterion for this study was inability to
independently carry out two or more activities of daily living (i.e., eating, bathing,
getting dressed, and toileting). As the ability to perform mental and physical tasks
were examined in this study, participants needed to meet minimum mental and
physical capacity levels, limiting the potential impact of covariates.
Sample Size Calculation
Using an online sample size calculator by Soper (2020), a priori
statistical power analysis for hierarchical multiple regression was
conducted to determine an adequate sample size for this study. The
results indicated that a sample size of 69 participants was needed for a
medium effect size of 0.15, an alpha level of 0.05, a statistical power of
0.80, with two primary predictor variables (set A) and two secondary
predictor variables (set B) (Soper, 2020). Because no similar studies that
provided effect sizes could be identified, the student PI used the ranges
and SD reported previously by similar studies (Boehmer, Shippee, et al.,
2016; Huang et al., 2018; Sheikh et al., 2016; Weiss et al., 2005) to
provide an estimate of the variability and an estimate of the potential effect
size for this current study (Schmidt & Hollestein, 2018). The SDs were all

63
approximately one-third of their respective ranges, therefore, a medium effect
size appears to be an appropriate selection for this study. An additional sample
size calculation was performed to ensure an adequate sample size for the
analyses that was conducted to detect correlations for variables not included in
the hierarchical regression model. Using the G*Power calculator 3.1.9.2 to
determine an a priori sample size for bivariate correlation analyses, a sample
size of 84 participants was needed to have 80% power in detecting a moderate
association, with an alpha level of .05. A moderate association was anticipated
based on findings from two studies (Eton et al., 2012; Gallacher et al., 2018) that
found the management of medications, and specifically the management of
multiple medications, were key factors in the treatment burden participants
reported. Based on these findings, the larger target sample size calculation of 84
was used for this study.
A survey completion rate of 85% was anticipated based on the lowest
response rate observed in a review of previous studies with a similar target
population and variables (Al Sayah et al., 2015; Ylitalo et al., 2018). Therefore,
oversampling to the amount of 99 participants was determined to yield the
needed sample size for this study (N=84 complete survey sets).
Recruitment
Upon receipt of study approval from Georgia State University’s
Institutional Review Board (IRB), participants were recruited remotely from online
settings via a digital recruitment flyer (See the Recruitment Flyer in Appendix A).
Flyers were posted to social media outlets (i.e., Facebook, Instagram, LinkedIn,
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and Pinterest) and disseminated via email and text messaging to
individuals within the student PI’s networks of healthcare professionals
(See email/text messaging script in Appendix B). The Flesch-Kincaid
grade level for the email/text messaging script was 7.3. The student PI
created profiles on each of the identified social media outlets for the
specific purpose of providing study information and facilitating recruitment
(e.g. posting the recruitment flyer). The recruitment flyer included a
description of the study, criteria for inclusion eligibility, honorarium
information, directions for accessing the study information online, how to
receive printed versions of the study surveys if preferred, and the contact
information for the student PI. The Flesch -Kincaid grade level for the
recruitment flyer was 7.4. Participants were recruited and enrolled until the
sample size of 84 with complete surveys was acquired.
Measures and Instruments
Data collected via online surveys included demographic data,
contact information for participants, and participants’ responses to
measures of medication workload, patient activation, treatment burden,
illness burden, medication adherence, and perceived impact of COVID-19
on medication management. Data collected via scheduled telephone calls
(n = 22) or online sessions via Zoom Video Conferencing (n = 69) were
participants’ responses to the health literacy measure. The Flesch -Kincaid
grade level for all survey instruments used in this study was 8 th grade or
below, with the exceptions of two surveys (i.e. health literacy and
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treatment burden measures). The total estimated time of completion for all the
surveys that were used in this study was 35 minutes. Descriptions of the survey
instruments that were used in this study are provided in this section .
Demographic Variables
Using a demographic survey developed by the student PI, fifteen items
were assessed: age, sex, race/ethnicity, level of education, employment status,
household income, marital/relationship status, length of time since diagnosis of
diabetes and hypertension, most recent HbA 1c value, most recent blood
pressure, list of any additional comorbidities, insurance status, primary care
provider status, presence of social support, and activities of daily living status
(See Appendix C). The Flesch-Kincaid grade level for the demographic survey
was 5.9. The estimated time of completion for this survey was three minutes.
Independent Variables
Measures of medication workload, DSM capacity, patient burden , and
perceived impact of COVID-19 on management of medication were independent
variables in this study. A description of each variable and how each variable was
measured is provided below.
Medication Workload
The attributes of individuals’ medication management (i.e. number,
difficulty, route) were examined with the Medication Workload Survey (See
Appendix D). The survey consists of 10 questions that assessed the following:
(1) the number of medications taken for diabetes, hypertension , and other health
issues (e.g. cholesterol), (2) if medications must be taken at separate times each
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day, (3) the difficulty in managing medications at separate times, (4) the
routes prescribed for medication administration (i.e., oral, topical, and or
injection), (5) the difficulty in administering medications via the prescribed
routes, (6) if medication dose(s) had to be adjusted based on glucose or
blood pressure levels taken at home and their perceived difficulty in
performing the necessary assessments and dosage adjustments, (7) if
their healthcare provider made any changes to their medications in the
last 90 days and their perceived difficulty in managing the changes that
were made, and (8) the difficulty they had with eight situations relating to
medication management (i.e., remembering to take their medications,
paying for medications, opening medication containers, getting refills on
time, reading the instructions on medication containers, taking
medications at inconvenient times, understanding what their medications
are for, and dealing with the side effects from their medications). The
Flesch-Kincaid grade level for the Medication Workload Survey was 6.9.
The estimated time of completion for this survey was five minutes.
For the items that assessed level of difficulty, participants selected
a response option from a 3-point Likert scale that corresponded to their
perceived difficulty in dealing with the respective situation. The 3-point
Likert scale consisted of the following options: not hard, a little hard, and
very hard. Responses were scored from 0-2, with higher scores indicating
greater perceived difficulty in the respective situation. Total workload
difficulty scores were calculated by summing the individual scores of all
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items that assessed perceived difficulty in specific aspects of medication
management (total of 13 items). Scores range from 0-26, with higher scores
indicating a greater perceived difficulty in medication workload management. The
questions within this survey were developed by the student PI using th e
Cumulative Complexity Model and the Brief Medication Questionnaire as a
framework (Shippee et al., 2012; Svarstad et al., 1999). The Medication
Workload Survey was reviewed prior to implementation in this study by
healthcare professionals and educators with healthcare backgrounds and
demonstrated good face validity. However, the Medication Workload Survey had
not been administered prior to this study. Therefore, the initial internal
consistency reliability for this measure was assessed during the data analysis
portion of this study.
Disease Self-Management Capacity
Two measures (i.e., patient activation and health literacy) were used in
this study to assess participants’ capacities to complete disease selfmanagement activities. The Patient Activation Measure® (See Appendix E) and
the Newest Vital Sign (See Appendix F) were the specific instruments used to
measure patients’ activation and health literacy, respectively.
Patient Activation. The Patient Activation Measure® (PAM®) is a 13-item
questionnaire that assessed participants’ beliefs, motivation, knowledge, and
skills in managing their diseases and preventing disease-related complications
(Hibbard et al., 2004). The PAM® is a Guttman-like scale, with each question
having one of the following response options: disagree, strongly disagree, agree,

68
strongly agree, or not applicable (N/A). The measure incorporates a 0-100
scoring method, with higher scores indicating greater patient activation.
Insignia Health has rights to the PAM® and does not share the specific
methods used to score individual patient activation items. To obtain PAM®
scores for this study, licensing was purchased to use the PAM® scoring
spreadsheet. Participants’ responses were keyed into the spreadsheet.
The spreadsheet has built-in formulas that analyze participants responses
and yield a corresponding activation score. PAM® scores indicate if
individuals: (1) believe that the patient role is important, (2) have the
confidence and knowledge necessary to take necessary action, (3) take
steps to maintain and improve personal health, and (4) stay adherent to
disease self-management even under stressful circumstances. Scores are
categorized into one of four patient activation levels. Level one (scores =
0-47) is the lowest level of patient activation and indicates that individuals
possibly lack the belief that they have an important role to play in their
health and lack basic knowledge about their condition and their care.
Patients at level two (scores = 47.1 - 55.1) of patient activation have the
knowledge and confidence necessary to manage their health. Level three
(scores = 55.2 - 72.4) patient activation indicates that patients are not only
knowledgeable and confident, but also take the initiative to perform health
promotion and illness prevention activities. Level four (scores = 72.5 100), the highest level of patient activation, involves maintaining
performance of DSM activities even under stressful circumstances
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(Greene et al., 2015; Hibbard et al., 2004). The Flesch -Kincaid grade level for
this document was 4.0. The estimated time of completion for this questionnaire
was five minutes.
The instrument has been used to measure self-management abilities
across differing levels of health status, age groups, racial groups (including AAs),
and different chronic illnesses including T2D (Bolen et al., 2014; Greene and
Hibbard, 2012; Lubetkin et al., 2010; Mayberry et al., 2010; Mitchell et al., 2014;
Skolasky et al., 2011). Previous literature has indicated that individuals with
higher levels of patient activation had significantly lower rates of emergency room
visits and days of hospitalization, supporting criterion validity of the PAM®
(Greene et al., 2015; Mitchell et al., 2014). A Cronbach’s alpha range of 0.81 0.87 has also been reported from studies that included samples of AA adults,
individuals with varying health statuses (including chronic illness), and adequate
and low health literacy levels (Lubetkin et al., 2010; Prey et al., 2016). Thus, the
PAM® has demonstrated very good internal consistency reliability.
Health Literacy. The Newest Vital Sign (NVS) is a 6-item questionnaire
that evaluated participants’ health literacy by: (1) assessing their understanding
of words and numbers and (2) examining their ability to apply reading and
numeracy skills (Weiss et al., 2005). The instrument involved each participant
reviewing a nutritional facts label and answering six corresponding questions.
The NVS was administered by the student PI over the phone or via a Zoom
meeting. For phone administration, participants were emailed the nutritional
label. For Zoom meetings, the student PI shared the screen to display the
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nutritional label. Participants were then asked questions about the
nutritional label and participants responded verbally with their answers.
The NVS has not yet been tested as a self-administered tool. Scores were
calculated on a 0 to 6 scale, with the lowest scores (i.e., 0 to 1) suggesting
a high likelihood (50% or more) of limited literacy, middle scores (i.e., 2 to
3) indicating the possibility of limited literacy, and higher scores (i.e.,
scores of 4 or more) high likelihood of adequate literacy (Weiss et al.,
2005). The Flesch-Kincaid grade level for the nutritional label participants
were expected to read and comprehend is 10.5. The target grade reading
level of this study’s population was eighth grade. Although the reading
level for this instrument was above the 8 th grade level, the nutritional label
reflects real life occurrences that potentially require higher levels of
literacy skills to manage. The estimated time of completion for this
questionnaire was three minutes.
The NVS has been previously used to assess health literacy in the
AA population, including AA patients with diabetes (Ylitalo et al., 2018).
The NVS has also been compared to other validated instruments
considered as gold standards for health literacy measurement (Ylitalo et
al., 2018). The NVS demonstrated good criterion validity when compared
with the Test of Functional Health Literacy for Adults (TOFHLA; r = 0.59, p
< .001). The TOFHLA is an instrument used to measure health literacy
and has been used often in healthcare research. However, the TOFHLA
requires a longer administration time (18-22 minutes) as compared to the
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NVS (three minutes), making the NVS a more appealing health literacy
assessment tool for the inpatient setting (Weiss et al., 2005). Another study
examining a sample of 170 patients with T2D (no report of participant’s
races/ethnicities), indicated that the NVS was useful in predicting risks for
complications from diabetes (e.g., neuropathy; OR 2.3, 95% CI [1.05,5.2], p =
0.037), based on comparisons of individuals with varying health literacy levels
(Mann et al., 2019). Cronbach’s alpha coefficients have been adequate ranging
from 0.76 – 0.91 in samples of AAs, individuals with T2D, and individuals who
were prescribed medications for diabetes management (Huang et al., 2018;
Miser et al., 2013; Weiss et al., 2005). Therefore, the NVS has demonstrated
good internal consistency and was an appropriate variable to include in this study
as a potential predictor of medication adherence.
Patient Burden
In this study, measures of treatment burden and illness burden were used
to assess patient burden. The Multimorbidity Treatment Burden Questionnaire
(See Appendix G) and the Illness Intrusiveness Ratings Scale (See Appendix H)
were the specific instruments used to measure treatment burden and illness
burden, respectively.
Treatment Burden. The Multimorbidity Treatment Burden Questionnaire
(MTBQ) was used to measure treatment burden in this study. The MTBQ is a 13item questionnaire that measures patients’ perceived effort in self-management
of their medical conditions (e.g., managing medication adherence) and the
impact that effort has on their daily well-being (Duncan et al., 2018). Each
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question involves scaled response choices relating to level of difficulty:
extremely difficult, very difficult, quite difficult, a little difficult, not difficult,
or does not apply. The scores range from 0-100, with higher scores
indicating greater perceived treatment burden. In a study of 143 adults
with multimorbidity (predominantly White with no report of AA participants;
44% had diabetes), the instrument had good content validity and construct
validity demonstrating a negative association between MTBQ and quality
of life (r −0.36, p<0.0001) and self-rated health (r −0.36, p<0.0001)
(Duncan et al., 2018). The Cronbach’s alpha reported for the MTBQ was
0.83 demonstrating internal consistency reliability (Duncan et al., 2018).
The Flesch-Kincaid grade level for this document was 10.7. The estimated
time of completion for this questionnaire was five minutes.
Illness Burden. The Illness Intrusiveness Ratings Scale (IIRS) was
used to measure illness burden in this study. The IIRS has been
previously used to assess illness burden among AAs and individuals with
varying chronic diseases including diabetes (Boehmer, Shippee, et al.,
2016; Devins, 2010; Molzon et al., 2013). The IIRS is a 13-item measure
that assessed participants’ perception of the degree of interference in
his/her life attributed to disease (Devins, 2010). The lIRS measured
intrusiveness in the following life domains: health, diet, work, active
recreation, passive recreation, financial situation, relationship with partner,
sex life, family relations, other social relations, self-improvement/selfexpression, religious expression, and community and civic involvements.
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Participants rated the intrusiveness of their illness from one to seven, with one
symbolizing not very much and seven symbolizing very much. Scores range from
13 to 91, with higher scores indicating greater perceived illness intrusiveness
(i.e., illness burden). Good convergent validity has been reported for the IIRS, as
predicted differences in scores were observed for individuals with differing
observable burdens (Devins, 2010). The Cronbach’s alpha coefficients previously
reported for the IIRS were obtained from samples of individuals with diabetes
(0.88) and for AAs with chronic disease (0.93) support reliability of the IIRS and
its usefulness in examining illness burden in a sample of AA patients with chronic
disease (Devins, 2010; Molzon et al., 2013). The Flesch-Kincaid grade level for
this document was 7.2. The estimated time of completion for this questionnaire
was four minutes.
Dependent Variable
The specific outcome measured in this study was medication adherence.
A description of how this dependent variable was measured is provided below.
Medication Adherence
Medication adherence was assessed using the Extent of Adherence
Survey (See Appendix I). This survey consists of two scales totaling fourteen
items. The first scale includes six items that assess self-reported medication
adherence over the prior 30 days. Participants responded with their level of
agreement to medication adherence statements (e.g., “I missed or skipped at
least one dose of my diabetes medications”), with strongly disagree, disagree,
neutral, agree, and strongly agree as response options. Possible scores for each
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item range from one (strongly disagree) to five (strongly agree), with items
numbered one and two being reverse scored. To be considered adherent
to their medication regimens, participants needed to respond with the
highest level of agreement to adherence behaviors and highest level of
disagreement to non-adherence behaviors. For example, participants
needed to respond with strongly agree to “I took all doses of my diabetes
medications” and strongly disagree to “I missed or skipped at least one
dose of my diabetes medications.“ Participants were considered
nonadherent if they received a score of ≥ two on any item. A total score
reflecting adherence was calculated by averaging responses to the six
items. While higher scores indicated greater levels of nonadherence,
lower scores indicated greater levels of adherence (Voils et al., 2012).
The second scale in the survey assessed reasons for non adherence. The eight questions of the reasons for non-adherence scale
presented situations that potentially led to missing or skipping doses of
medications (Voils et al., 2012). Participants responded to each situation
using a Likert-scale with the following options: not at all, a little, or a lot.
Scores for each situation ranged from zero through two, with higher
scores indicating that the situation was perceived to contribute more
greatly to non-adherence. Participants were also presented with an
opportunity to report additional reasons that were not already listed for
their non-adherence. In a study of 202 veterans with hypertension (50%
Black), the Extent of Adherence Survey had good internal consistency
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reliability, Cronbach’s alpha = 0.84 (95% CI: 0.80, 0.87). Concurrent validity was
also demonstrated by correlations between the extent measure, systolic (r=0.27,
p<.0001) and diastolic (r=0.27, p<.0001) blood pressure (Voils et al., 2012). The
Flesch-Kincaid grade level for this document was 7.8. The estimated time of
completion for this survey was five minutes.
Exploratory Variable
COVID-19 Impact on Medication Management
The perceived impact of the COVID-19 pandemic on the management of
medications was measured with the COVID-19 Impact Survey. The 10-item
survey assessed participants’ beliefs on how much the COVID-19 pandemic has
changed situations relating to their medication management. Using a Likertscale, participants responded with one of the following options: strongly disagree,
disagree, neither agree nor disagree, agree, or strongly agree to the survey
questions. Response item scores range from one through five, with higher scores
indicating a greater belief that the presence of the COVID-19 pandemic has
negatively impacted that specific aspect of their medication management. Total
scores range from 10-50, calculated by summing the individual scores, indicating
the overall perceived impact of COVID-19 on their medication management.
Participants were also provided with the option of reporting additional details on
how COVID-19 has affected their medication management (See Appendix J).
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The questions within this survey were developed by the student PI
using the Extent of Adherence and previous COVID-19 related literature
(AHA, 2020b; Schroeder, 2020; Voils et al., 2012). The COVID-19 Impact
Survey was reviewed by healthcare professionals and educators with
healthcare backgrounds and demonstrated good face validity. However,
the COVID-19 Impact Survey was not administered prior to this study,
therefore, reliability measurements were not available. Internal
consistency reliability for this measure was assessed in the data analysis
portion of this study. The Flesch-Kincaid grade level for this document was
7.6. The estimated time of completion for this survey was five minutes.
Data Collection Procedures
Upon IRB approval from Georgia State University, the student PI
began posting, emailing, and text messaging digital recruitment flyers.
Potential participants were directed to the Qualtrics survey page
developed by the student PI to determin e their eligibility for the study. If a
participant met inclusion criteria and did not have any exclusion criteria,
they moved on to the informed consent process. The informed consent
process was conducted via the Qualtrics survey. Informed consent
included: (1) an explanation of the purpose of the research study, (2) the
duration of the research study, (3) a description of the procedures that
were followed, (4) how data confidentiality was maintained, (5) any
potential risks to the participants, (6) an explanation that participants
would not receive any direct benefits from the research findings, (7) whom
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participants would contact if they had questions regarding the research study, (8)
circumstances that required the participant’s termination from the study, (9) how
the data from the study would be used, (10) incentive details, and (11) a
statement that participation in the study was voluntary and participants had the
choice to withdraw from the study at any point they decided to do so. The FleschKincaid grade level for the informed consent was 7.2.
The informed consent process was conducted online. Consent information
was provided in the Qualtrics survey. Eligible participants independently read the
consent form. The student PIs contact information was provided on the Qualtrics
survey if participants had questions about the consent information or the study.
All eligible participants were informed that their participation was voluntary and
could be terminated at any time if they chose to do so. Once the informed
consent document was reviewed, eligible participants responded to the following
question, “Do you have any questions about this form or this study?”. If “yes” was
selected, eligible participants were directed to the contact information for the
student PI and the survey ended. If “no” was selected, the eligible participants
proceeded to a true or false question to assess their understanding of the
information within the consent form. Individuals who did not respond correctly
were redirected to the consent form along with a reminder that the student PI
could be contacted with any questions. They also had the opportunity to respond
to the question again. If answered incorrectly for a second time, eligible
participants were directed to the student PI contact information to assist them
with understanding the details of the study and the survey ended. Eligible
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participants who responded correctly proceeded to selection of one of the
following statements in the Qualtrics survey, “I consent, begin the study”
or “I do not consent, I do not wish to participate.”, with the first statement
indicating their desire to proceed with the survey.
The Qualtrics survey was set up to assign random identification
numbers to all participants following their consent to the study. The
identification numbers were used for data tracking purposes and
protection of participants’ identities. There was no waiting period between
participants providing consent and initiating their participation in the study.
Once was provided, eligible participants proceeded to the survey portion
of the study. For eligible participants who elected not to consent, the
survey ended. A copy of the consent form was made available to each
participant.
For eligible participants who indicated interest in the study but
lacked access to the online documents, a paper version of the consent
was offered to be mailed to them along with an addressed and stamped
envelope for them to return the document. By returning the surveys,
participants would indicate that they were consenting to participate.
Eligible participants who opted to receive a paper version of the study
documents were also provided with the student PI’s contact information in
the event they had any questions or concerns regarding the consent
process or study.
Once consent was provided, participants proceeded to the
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demographic survey portion of the Qualtrics survey. The demographic
information obtained from participants included age, sex, race/ethnicity, level of
education, employment status, household income, marital/relationship status,
length of time since diagnosis of diabetes and hypertension, list of any additional
comorbidities, insurance status, primary care provider status, presence of social
support, and activities of daily living status. The student PI also obtained
participants’ contact information (i.e., telephone numbers, email addresses, and
mailing addresses) per participants’ preferences. The contact information
collected from participants via the Qualtrics survey was used to conduct the
scheduled telephone or online session of the study (i.e., administer the NVS
survey) and as a method for disseminating incentives. For participants who
elected to receive telephone communications, they were asked to provide their
preferred time(s) for contact, the name the student PI should use to address the
participant in telephone communications, and if it was acceptable to leave
voicemail messages.
Following the collection of demographic data and contact information,
participants were asked to complete the Medication Workload Survey, PAM®,
IIRS, MTBQ, Extent of Adherence Survey, and COVID-19 Impact Survey. While
participants had the option to pause the survey and come back to complete at a
later time, participants were encouraged to complete their surveys with in 48
hours of initiating the survey process. Upon completion of the online surveys,
participants were notified via a message in Qualtrics that they would be
contacted within 72 hours, via their preferred contact method, to schedule
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completion of the final survey (i.e., NVS). The completion of the NVS for
each participant took place within one week of them completing the online
surveys. During the scheduled session for completion of the NVS survey,
the student PI reassessed participants for inclusion/exclusion criteria.
Each participant was asked to confirm that they were (1) an AA adult with
T2D and hypertension, (2) diagnosed with T2D and hypertension for at
least one year, (3) prescribed at least one medication for T2D and at least
one medication for hypertension, and (4) able to perform activities of daily
living independently. Additionally, participants were asked to provide any
responses missing from the online survey. Participants were also asked
how they found out about the study for recruitment analysis purposes.
Although the intent was to conduct this study primarily online, alternative
methods of data collection were used when necessary. However, each
participant needed to have access to at least a telephone to complete the
NVS survey. Upon completion of the NVS survey, each participant was
sent a digital gift card of $25. Upon acquiring the required sample of 84
participants with complete survey sets, the Qualtrics survey was closed to
new participants. Participants who started the survey process but had not
completed their surveys and had not had any survey activity for 48 hours
prior to acquiring the sample of 84 completed survey sets, were informed
of the study closure and thanked for their time. Participants that had
activity within the prior 48 hours were notified of the time they had
remaining to complete their study surveys. An additional seven
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participants completed their survey sets and scheduled interviews, resulting in a
total sample size of 91. Participants were advised if they did not complete all
aspects of the study upon study closure they would not receive an incentive.
Data Management
The student PI collected data using self-report measures and one survey
that was administered via a scheduled online or telephone session (i.e., NVS).
Prior to data collection, the student PI developed a code book for the study
variables and two tracking sheets. The code book was created in Microsoft Word
and contained no identifying participant information. The code book was used to
maintain the scoring methods for each of the variables used in this study.
Microsoft excel was used to develop a spreadsheet to track each participant’s
responses on surveys. The student PI maintain ed a separate spreadsheet which
consisted of participants’ identification numbers, participants’ contact information,
a log of the dates and number of times participants were contacted, the
scheduled dates for the administration of the NVS, a log of how the participants
found out about the study, and the record for distribution of incentives. This list
was also maintained on a password protected excel spreadsheet.
All surveys were administered in one of two ways: (1) via an online
Qualtrics survey or (2) through scheduled online or telephone sessions based on
participant preference and instructions from the developers of the instruments
being used in the study. Each survey used in this study was labeled with a
unique identification number in lieu of using participants’ names. Survey
responses were primarily collected online via Qualtrics. The Qualtrics data were

82
password protected. Upon obtaining the completed surveys and contact
information from participants, the student PI transferred the data from the
surveys into a password protected Microsoft excel sheet on a duo
password protected tablet equipped with a 15-minute inactivity timeout,
data storage encryption, automatic data wiping after 10 consecutive failed
login attempts, and ability to remotely wipe the device.
The NVS survey was administered via a scheduled session, per
instructions from the NVS developers. For participants who chose to
complete the NVS via telephone, the nutritional label was emailed or
texted to them. For online sessions, the nutritional label was displayed via
a screen share for them to view. The online platform used included
microphone capability so that the student PI and participant could
communicate verbally. The student PI transcribed participants’ responses
on an electronic copy of the document, labeled with the participant’s study
identification number, and stored on the password protected tablet.
Upon completion of all surveys, the student PI assessed them for
missing responses and followed up with participants as appropriate. All
identifiable information was removed from the study data before reporting
the study results. As this study had exempt status, signatures were not
required on informed consent forms and therefore, did not need to be
retained for three years, in accordance with regulations (U.S. Department
of Health & Human Services [HHS], 2017). The data collected from
participants via the Qualtrics survey were password protected and only
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accessible by the PI (i.e., Dr. Dawn Aycock) and student PI (i.e., Michelle
Gaddis). No study documents were distributed or collected via mail, therefore, no
hard copies needed to be stored in this study. Any data shared via the student
PI’s dissertation defense, research conferences, or publications was deidentified
prior to disseminating.
Data Analysis
IBM SPSS Version 25 software was used to conduct the statistical
analyses for this study. Prior to inputting data into the SPSS database, the data
were assessed to identify errors and missing values. Upon transferring data into
SPSS, the data were rechecked for errors, missing values, an d normality. Errors
were corrected and missing values were handled by following up with the
participants to acquire the missing information. Normality was assessed by using
descriptive statistics then assessing for kurtosis or skewness. Outlier values were
identified by using frequencies, minimum, and maximum. For data that deviated
from a normal distribution, appropriate transformations were conducted. For
variables that did not achieve normality, non -parametric tests were used. The
data were also examined to ensure assumptions to perform the inferential data
analysis were met (i.e., linearity, independent errors, homoscedasticity, and
multicollinearity). Internal consistency reliability was assessed for each of the
scales within the Medication Workload Survey, PAM®, NVS, MTBQ, IIRS, the
Extent of Adherence Survey, and COVID-19 Impact Survey using Cronbach
alpha test. Descriptive statistics (i.e., frequencies, percentages, measures of
central tendency and variability) were used to summarize the demographic
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characteristics of the sample, independent variables, outcome variable,
and the exploratory variable. The data were also analyzed for potential
covariate variables. As potential covariates were identified during data
analysis, the appropriate steps were taken to control for their effects. The
literature indicated that the following demographic variables were potential
covariates for the concepts in this study: age, sex, and socioeconomic
status (Akohoue et al., 2015; Boehmer, Shippee, 2016; Byers et al., 2016;
Gallacher et al., 2018; Osborn et al., 2013; Rovner et al., 2013). In this
study, income and level of education were the measures used to assess
socioeconomic status. The data analyses for addressing the research
questions are described next.
Data Analysis for Research Questions
The research questions were analyzed as follows:
For AA adults 18 years of age or older with comorbid T2D and hypertension who
have been prescribed medications for blood pressure and glycemic control:
RQ1: Are higher levels of illness burden associated with lower levels of patient
activation and health literacy?
RQ2: Are higher levels of treatment burden associated with a higher number of
prescribed medications and greater perceived difficulty in managing prescribed
medications?
The plan for answering the first and second research questions was to use
Pearson’s correlation test if the assumptions were met (e.g., normality) and if not,
a non-parametric alternative (e.g., Spearman’s rank-order correlation) would be
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used. As the variables did not achieve normal distribution upon multiple
transformation attempts, the non-parametric alternative was used to answer
questions one and two. The correlation matrix provided an indication of the
direction of relationships (i.e., either positive or negative correlations), the
strength of the relationships among the variables, and if any of the correlations
were significant.
RQ3: Do patient activation, health literacy, treatment burden, and illness burden
significantly predict medication adherence?
To answer the third research question, a linear regression analysis was
performed. Multiple linear regression analysis uses a model composed of
multiple independent variables (X) to explain or predict variance in one
dependent variable (Y) at a time. Therefore, one linear regression analysis was
performed to test the model consisting of patient activation, health literacy,
treatment burden, and illness burden in predicting the variance in medication
adherence. Hierarchical entry was the method used for the regression analysis,
with potential covariates entered first (i.e., age, sex, income, and level of
education), patient activation entered second, health literacy third, treatment
burden fourth, and illness burden entered last. The decision for hierarchical entry
and the order in which variables were entered was based on the amount of
literature found to support each of the independent variables’ associations with
the dependent variables. The level of significance used for the data analysi s was
α = 0.05. The model summary indicated whether the model that included patient
activation, health literacy, treatment burden, and illness burden significantly
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predicted variance in the dependent variables. The coefficients table displayed
each independent variable’s contribution to predicting the variance in the
dependent variables and the significance of those predictions.
RQ4: Which aspects of medication management are the most challenging?
The fourth research question was addressed by analyzing: (1) the
frequencies of the responses to questions five, seven, eight, nine, and 10 of the
Medication Workload Survey to identify the aspects of managing medications
most frequently identified as being a challenge, and (2) the modes for the Likertscale responses to question #s five, seven, eight, nine, and 10 of the Medication
Workload Survey to determine the extent of the challenge created by medication
management activities. The same analysis was conducted for questions four and
five of the Extent of Adherence Survey. For both analyses, items with higher
frequencies in level 1 and level 2 scale responses (i.e., A little and A lot on the
Medication Workload Survey; A little hard and Very hard on the Extent of
Adherence Survey) indicated they were the more commonly identified
challenges. Items that had modes of zero indicated the situations that were the
least challenging, modes of one indicated situations that were perceived as a
little challenging, and modes of two indicated situations that were found to be the
most challenging in managing medications and medication adherence.
RQ5: What is the perceived impact of the COVID-19 pandemic on medication
management?
To answer the final research question, (1) the frequencies of the
responses to questions from the COVID-19 Impact Survey were analyzed to
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identify the aspects of managing medications most frequently identified as being
impacted by COVID-19, and (2) the modes for the Likert-scale responses to
questions one through 10 of the COVID-19 Impact Survey to determine the
extent of the perceived impact of COVID-19 on medication management
activities. Items with higher frequencies in level four and level five scale
responses (i.e., Agree and Strongly agree) indicated they were the more
commonly identified activities believed to have been impacted by COVID -19.
Items that had modes of zero through three indicated situations that were not
perceived to be impacted by COVID-19, items with modes of four indicated
situations perceived to have been impacted by COVID-19, and modes of five
indicated situations relating to medication management that were found to be the
most impacted by the presence of COVID-19.
Priori Identification of Study Challenges
Prior to conducting the study, potential situations that could cause
challenges in the study were identified. These potential challenges have been
outlined below. Any additional situations that were not identified prior to the study
were addressed as they arose during the study.
Recruitment Challenges
This study was conducted entirely remotely. Potential participants could
have been uncertain in determining that this study’s recruitment efforts were
legitimate, that it was safe to participate in the study, that they were not being
spammed, and that they were not targets of fraudulent attempts to gain access to
their information. To address these problems, the contact information for the

88
student PI was included on all recruitment materials (i.e., social media
posts, recruitment flyer, emails, text messages). The recruitment flyer that
was disseminated also included a picture of the student PI. Potential
participants who contacted the student PI were provided with the study
details along with the informed consent form to review. The consent form
included contact information for the PI, student PI, and GSU IRB. The
student PI allowed adequate time for them to review the consent form and
answered any questions they had for making their decision to participate.
Participants were informed of the privacy protection and data security
measures that were in place. At any point that a potential or active
participant indicated that they no longer desired to be contacted, the
student PI terminated all future contact with that individual. The student PI
conducted weekly analyses to evaluate the recruitment flow and detect
any additional unanticipated challenges with recruitment.
Completion of Study Surveys Questionnaires
There was a total of eight surveys (i.e., Demographic survey,
COVID-19 Impact Survey, Medication Workload Survey, PAM®, NVS,
MTBQ, and IIRS) that participants were asked to complete during this
study. The estimated completion time for all surveys in this study was 35
minutes. For participants who unintentionally skipped questions or left out
information, the student PI evaluated the participants’ responses to the
surveys at least every 72 hours to determine if the participants
demonstrated having difficulty in providing their responses. The student PI
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assisted participants in the completion of their questionnaires during each
scheduled 1:1 session as needed, while ensuring any actions to assist
participants did not conflict with the administration guidelines provided for the
study instruments. As indicated in the informed consent, participants had the
right to skip questions at any time of their choosing. If any participants
intentionally skipped questions for reasons that could not be resolved, the
student PI honored the participant’s choice to not respond.
Additionally, as most of the questionnaires relied on self-reported data,
there was potential for response bias from the participants. To address this issue,
participants were informed of the importance of providing honest responses to
the surveys. Participants were also reminded that the information they provided
in the study would be de-identified prior to sharing any results.
This study involved a small incentive for participants. As such, some
participants possibly attempted to complete the study more than once. To
address this potential issue, the Qualtrics survey was equipped with a “prevent
ballot stuffing” feature, which deterred individuals from joining the study more
than once. Additionally, as this study involved a scheduled telephone or online
session prior to receiving incentives, the student PI also monitored for repeated
attempts to participate in the study.
Retention of Study Participants
As this study involved a scheduled session (i.e., administration of the NVS
survey), for which scheduling took place within 72 hours after completion of the
online surveys, potential problems with retention of participants were anticipated.
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To address potential retention issues, the student PI included information
about the required scheduled session in the informed consent. The
student PI also provided participants with reminders for the session.
Additionally, the student PI planned for oversampling to the amount of 99
to increase the potential of acquiring the completed set of surveys for 84
participants.
Protection of Human Subjects
Prior to initiating this study, IRB approval was obtained from
Georgia State University, in accordance with Human Research Protection
regulations. This study posed no more risks than participants would
experience in a normal day. However, as this study involved participation
of human subjects, the student PI acknowledged potential ethical
concerns. In addition to the activities described in the data management
section regarding protection of participant data (e.g., password protection
of surveys, assignment of Participant ID numbers, locked file cabinet for
hard copy documents), the following human subjects’ protection activities
were performed. The student PI completed required research training
provided by the Collaborative Institutional Training Initiative (CITI) program
for studies involving human subjects. The student PI obtained informed
consent from all study participants. Participants were informed that their
participation was voluntary, and they had the option to withdraw from the
study at any time, even if consent to participate in the research study was
already provided. The student PI ensured that the approved study
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procedures were followed, including assigning participant identification numbers
in lieu of using names on study documents, to maintain participants’ privacy and
confidentiality of the information study participants provided.

CHAPTER IV
RESULTS
The results of this non-experimental, predictive, correlational study of
disease self-management capacity, patient burden, and medication adherence in
African American adults with type 2 diabetes and hypertension are outlined in
this chapter. More specifically, this chapter contains a description of the
recruitment and retention outcomes, demographic characteristics of the sample,
and the reliability of the scales used to quantify the study variables. The
descriptive statistics for all study variables and the results of the analyses of five
research questions are also presented.
Recruitment and Survey Completion Results
A total of 498 Qualtrics survey entries were received from July 4, 2020 to
August 1, 2020 (See Figure 3). Of the 498 entries, 62 (12%) potential participants
did not proceed past the informed consent. Fifty-six (11%) potential participants
indicated they had questions following the review of the consent but did not call
or email the student PI as instructed nor did they provide their contact
information. Two did not pass the assessment for understanding the elements of
the study following the informed consent and were directed via Qualtrics to
contact the student PI for assistance. Neither contacted the student PI to discuss
options for reentry into the study and therefore were not included. Lastly, four
potential participants declined to participate in the study.
92
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Although 436 consents were received, 319 were found to be duplicate
survey entries and were removed. Duplications were identified by examining the
individual survey responses and by examining the re-captcha and relevant ID
duplicate scores provided by Qualtrics. Of the remaining 117 participants who
provided informed consent, 12 did not complete their online surveys and did not
provide contact information for follow up. Three participants did not complete
their online surveys, and although contact in formation was provided, they did not
respond to the student PI’s attempts to reach them. Seven participants upon
reassessment of eligibility criteria, were found to not meet the criteria and
therefore were excluded; five participants indicated on the question that asked
how many medications do they take for T2D and hypertension that they were not
prescribed medications for both T2D and hypertension and two participants
indicated that they were not able to independently carry out activities of daily
living (i.e., eating, bathing, getting dressed, and toileting). Of the remaining 95
participants who completed the online surveys and proceeded to the scheduling
of session two (i.e., telephone/Zoom interview), four were excluded for not
returning emails or calls to schedule the session.
The final sample consisted of 91 African American adults with T2D and
hypertension who completed both data collection sessions, meeting the required
sample size indicated by the priori statistical power analysis (n = 84). The
retention rate for this study, excluding the duplicate responses and potential
participants who consented but did not qualify for the study, was 83% (91/110).
More than half of the sample (51%) were recruited via a social media platform
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(i.e., Facebook). The remainder of the sample were recruited via referrals from
friends, relatives, and co-workers of the participants as indicated by the results of
the survey question that assessed how participants found out about the study.
Figure 3
Diagram for
Dissertation Study
Flow Diagram forFlow
Dissertation
Study
Phase 1:
Assessed for inclusion/exclusion criteria
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* had questions/no contact (n = 56)
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(n = 440)
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Session 1
Data Collection
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PAM, MTBQ, IIRS, Extent of Adherence, &
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Est: 35 min
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Schedule Session 2
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Withdrawal (n = 341)
*Duplicate surveys (n = 319)
*Limited survey responses (n = 12)
*Did not meet inclusion (n = 7)
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95
Data Cleaning
Upon acquiring completed survey sets from 91 participants, the data from
the completed surveys were transferred from Qualtrics to SPSS and checked for
accuracy. All study variables were analyzed for errors and missing values.
Outlier values were assessed using frequencies, minimum, and maximum.
Normality was also assessed by examining the variables for kurtosis or
skewness.
The data were free from errors and excluding “do not apply” items, there
were 13 missing responses. Specifically, nine responses were missing for HbA1c .
The remaining four responses were missing from two participants who did not
provide a recent SBP and DBP. During their health literacy interviews, the 13
participants were asked to provide responses for the missing data (i.e., SBP,
DBP, and/or HbA1c), however, the participants were unable to recall their levels.
Therefore, pairwise deletion was the method used for managing the missing data
for HbA1c, SBP, and DBP. Pairwise deletion involves running the analyses on the
data available for each case. The cases with missing data were not considered in
the analyses for HbA1c , SBP, and DBP. As these variables were not considered
major variables in any of the correlation or regression analyses, this was an
appropriate method for managing these missing variables. All data sets needed
to answer the research questions in this study were complete.
All of the demographic and theoretical variables were skewed. Skewness
was notable (i.e., skewness values greater than one or less than negative one)
for age. The kurtosis measure for several variables (i.e., perceived difficulty in
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managing medication workload, health literacy, medication adherence, and
perceived difficulty in medication adherence) were also out of range. There was a
total of 12 noteworthy outlier values for the major study variables. Outliers were
identified by assessing the box plots for patient activation, health literacy,
treatment burden, illness burden, medication adherence, total number of
prescribed medications, total difficulty in managing medications, and COVID -19
impact scores. While there were 4 outlier values ranging from 27 through 36 for
treatment burden, only one outlier (i.e., 36) was not within one standard deviation
of the mean treatment burden score. Another four outliers ranging from 77
through 88 were found within the illness burden scores, all of which were outside
of one standard deviation of the mean illness burden score. The remaining four
outliers (i.e., four scores of 10) were from the COVID-19 impact scores, with the
scores being more than two standard deviations below the mean COVID-19
impact scores. Shapiro-Wilk tests were conducted on the major study variables
to determine whether the distributions of the variables were significantly different
from a normal distribution. The results indicated that all of the variables
significantly differed from normality based on an alpha of 0.05. Logarithmic,
square root, and reciprocal transformations were conducted on these variables,
but normal distribution was only achieved for illness burden (W = 0.97, p = .066).
Therefore, non-parametric alternatives were used for the analyses, as
appropriate.
Descriptive statistics (i.e., frequencies, percentages, measures of central
tendency and variability) were used to summarize the demographic
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characteristics of the sample, independent variables (i.e., patient activation,
health literacy, treatment burden, and illness burden), outcome variable (i.e.,
medication adherence), and the exploratory variable (i.e., perceived impact of
COVID-19 on medication management). The next section describes the
characteristics of the study sample.
Description of the Sample
For the 91 African American adults with T2D and hypertension who
participated in this study, ages ranged from 25 to 73 years (M = 39.6; SD = 11.9).
The majority of the sample were male (n = 60; 66%), had a college degree
(71%), were employed part-time (53%), had an income of $30,000 or more
(66%), and were married (64%). Additionally, 89% of the sample reported having
some form of health insurance, with the most prevalent being employersponsored (37%) and Medicare/Medicaid (33%). Most participants also reported
having a primary health care provider (78%) and social support (80%).
For clinical characteristics of the sample, most reported having T2D and
HTN for less than five years (respectively, 64% and 75%) and denied having
additional health issues (79%). Most participants (> 91%) were able to self-report
their most recent HbA1c , SBP, and DBP levels. The mean HbA1c value was
slightly above 7.0 % (7.4 %; SD = 1.8), indicating the potential for elevated risk of
vascular complications among participants (American Diabetes Association
[ADA], 2020). Though the mean reported SBP (139; SD = 18.7) and DBP (82;
SD = 10.4) were below the general blood pressure target of 140/90
recommended by the ADA for individuals with T2D and low risk for
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cardiovascular disease, the mean blood pressure in this study was above 130/80
which has been indicated as the BP target for individuals at higher risk for
cardiovascular disease, such as AAs, who may require more intensive blood
pressure control (ADA, 2019; Passarella et al., 2018; Saab et al., 2015; Whelton
et al., 2018). See Table 1 for the full demographic characteristics of the sample.
Table 1
Characteristics of the Sample (N = 91)
Variables
Age (years)
Time Since Diabetes Dx (years)
Time Since Hypertension Dx (years)
HbA1c (%) a
SBP (mmHg) b
DBP (mmHg) c
Variables
Sex
Female
Male
Level of Education
High school graduate
Trade school graduate
College: Undergraduate degree
College: Graduate degree
Employment Status
Full-time
Part-time
Unemployed
Retired
Household Income
< $30,000
≥ $30,000
Marital Status
Single
Married
Separated
Divorced
Widowed
Domestic Partnership
a n = 82; b n = 89; c n = 89.

M (SD)
39.6 (11.9)
4.3 (3.2)
4.4 (5.7)
7.4 (1.8)
139 (18.7)
82 (10.4)
n (%)
31 (34.1)
60 (65.9)
15 (16.5)
11 (12.1)
30 (33.0)
35 (38.5)
32 (35.2)
48 (52.7)
5 (5.5)
6 (6.6)
31 (34.1)
60 (65.9)
17 (18.7)
58 (63.7)
10 (11.0)
4 (4.4)
1 (1.1)
1 (1.1)

Minimum
25
1
1
5.0
100
50

Maximum
73
18
47
14.7
187
98
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Table 1
Characteristics of the Sample Cont’d (N = 91)
Variables
Other Health Issues
Obesity
High cholesterol
Arthritis
Anxiety
Depression
Pain
Heart disease
Kidney disease
Gout
Allergies
Ulcers
Insurance status
None
Private
Employer-sponsored
Medicare/Medicaid
Other (not described)
Primary healthcare provider
Yes
No
Presence of social support
Yes
No

n (%)
5 (5.5)
4 (4.4)
4 (4.4)
3 (3.3)
3 (3.3)
2 (2.2)
2 (2.2)
1 (1.1)
1 (1.1)
1 (1.1)
1 (1.1)
10 (11.0)
16 (17.6)
34 (37.4)
30 (33.0)
1 (1.1)
71 (78.0)
20 (22.0)
73 (80.2)
18 (19.8)

Descriptive Statistics of Study Variables
The descriptive statistics for the major study variables (i.e., patient
activation, health literacy, treatment burden, illness burden, medication
adherence, total difficulty in managing medications, total number of prescribed
medications, and perceived impact of COVID-19) are reported in Table 2. The
Cronbach’s alpha coefficients are also provided, as appropriate. The NVS was
scored based on correct or incorrect responses, thus, Kuder-Richardson (KR) 20
is the recommended method for reliability testing for this measure. In SPSS, the
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Cronbach’s alpha is reported as providing the same result as the KR 20 value.
All coefficient alphas were above .75, indicating adequate internal consistency
reliability of all scales.
Table 2
Descriptive Statistics for Major Study Variables (N = 91)
Variables
M (SD)
Observed
Min - Max

Possible
Min - Max

α

Patient activation

78 (13.3)

54 - 100

0 – 100

.87

Health literacy

2.6 (2.0)

0-6

0-6

.81

20.6 (14.7)

0 - 69

0 - 100

.87

46 (15.8)

13 - 88

13 - 91

.91

4 (1.3)

2-8

≥2

-

Medication adherence (overall)

2.4 (0.9)

1-4

1-5

.78

Total perceived difficulty in
managing medications

10.5 (6.8)

0 - 29

0 - 42

.92

30 (8.8)

10 - 44

10 - 50

.89

Treatment burden
Illness burden
Total # of prescribed medications

Perceived COVID-19 impact
Patient Activation

The Patient Activation Measure ® has a possible score range of 0 - 100
and the mean score was 78 (SD = 13.3), indicating a high level of patient
activation within the sample. Of the four patient activation levels, most
participants’ (63%) were categorized at level four, the highest level of patient
activation (scores of 72.5 – 100), indicating they perceived themselves as being
more proactive and engaged in recommended health behaviors. Table 3 reflects
the distribution of patient activation levels in the sample.
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Table 3
Participants Categorized by Patient Activation Levels (N = 91)
Patient activation levels
N

%

PA Level 1: Disengaged and overwhelmed
(scores = 0 – 47)

0

0

PA Level 2: Becoming aware but still struggling
(scores = 47.1 – 55.1)

2

2

PA Level 3: Taking control and gaining control
(scores = 55.2 – 72.4)

32

35

PA Level 4: Maintaining behaviors and pushing further
(scores = 72.5 – 100)

57

63

As reflected in Table 4, for the individual item responses, strongly agree
was the most frequently observed response, supporting the high patient
activation mean score. The items with the highest prevalence of disagree and
strongly disagree responses were patient activation items number eight (i.e., I
understand my health problems and what causes them; 19%), number 12 (i.e., I
can figure out solutions when new health problems arise; 18%), and number nine
(i.e., I know what treatments are available for my health problems; 13%).
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Table 4
Distribution of Patient Activation Measure® Responses (N = 91)
PAM® Questions

Level of Agreement
Strongly
agree
n(%)

Agree

Disagree
n(%)
-

Strongly
disagree
n(%)
-

Not
applicable
n(%)
-

n(%)

1. I am responsible for my
health.

53(58)

38(42)

2. Taking an active role is the
most important thing that
affects my health.

57(63)

31(34)

3(3)

-

-

3. I can help prevent/reduce
my health problems.

49(54)

38(42)

4(4)

-

-

4. I know what my prescribed
medications do.

43(47)

40(44)

5(6)

3(3)

-

5. I know what I can handle
and when I need to see the
doctor.

44(48)

41(45)

6(7)

-

-

6. I can tell a doctor about my
concerns without being
prompted.

45(49)

40(44)

5(6)

1(1)

-

7. I can follow through on
medical treatments at
home.

44(48)

42(46)

5(6)

-

-

8. I understand my health
problems and what causes
them.

30(33)

44(48)

15(17)

2(2)

-

9. I know what treatments are
available for my health
problems.

26(29)

53(58)

11(12)

1(1)

-

10. I have maintained positive
lifestyle changes.

34(37)

48(53)

8(9)

1(1)

-
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Table 4
Distribution of Patient Activation Measure® Responses Cont’d (N = 91)
PAM® Questions

Level of Agreement
Strongly
agree
n(%)

Agree

Disagree
n(%)

Strongly
disagree
n(%)

Not
applicable
n(%)

n(%)

11. I know how to prevent
health problems.

30(33)

53(58)

7(8)

1(1)

-

12. I can figure out
solutions when new
health problems arise.

24(26)

51(56)

15(17)

1(1)

-

13. I can maintain positive
lifestyle changes even
during stressful times.

42(46)

40(44)

8(9)

1(1)

-

Health Literacy
On average, participants completed the NVS measure by phone or webbased interview within the anticipated time frame of six minutes (M = 5.53
minutes, SD = 2.2). The possible score range for the NVS health literacy
measure is 0 - 6.The mean score for health literacy was 2.6 (SD = 2.0), indicating
low health literacy within the sample. Participants were grouped by literacy
scores as level one (score = 0 - 1), level two (score = 2 - 3), or level three (score
≥ 4), with higher scores indicating higher levels of health literacy. Health literacy
levels varied, but the most frequently observed level was a high likelihood of poor
health literacy (40%), followed by a high likelihood of adequate health literacy
(32%), then possibility of limited literacy (29%). Most participants answered
questions one through four incorrectly, indicating low numeracy and document
literacy. Conversely, most participants provided the correct answers to questions
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five and six, indicating high prose literacy. Table 5 displays the frequencies and
percentages of correct vs. incorrect responses for each of the six health literacy
questions.
Table 5
Distribution of Newest Vital Sign (NVS) Responses (N = 91)
Health Literacy Questions
1. If you eat the entire container, how many
calories will you eat?
2. If you are allowed to eat 60 grams of
carbohydrates as a snack, how much ice cream
could you have?
3. Your doctor advises you to reduce the
amount of saturated fat in your diet. You usually
have 42 g of saturated fat each day, which
includes one serving of ice cream. If you stop
eating ice cream, how many grams of saturated
fat would you be consuming each day?

4. If you usually eat 2,500 calories in a day,
what percentage of your daily value of calories
will you be eating if you eat one serving?

Correct
n (%)
18 (19.8%)

42 (46.2%)

34 (37.4%)

29 (31.9%)

Pretend that you are allergic to the following
substances: penicillin, peanuts, latex gloves,
and bee stings.

5. Is it safe for you to eat this ice cream?

65 (71.4%)

6. Why not?

47 (51.7%)

Note: Items one through four assess document literacy and numeracy. Items five
and six assess document literacy and prose literacy.
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Treatment Burden
The Multimorbidity Treatment Burden Questionnaire has a possible score
range of 0 – 100. The mean score for participants’ treatment burden (M = 20.6,
SD = 14.7) indicated a moderate level of perceived burden from treatment for this
sample. Based on treatment burden scores, nine participants (10%) were found
to have no burden (score = 0), 12 (13%) had low burden (score <10), 34 (37%)
had medium burden (score 10 – 22), and 36 (40%) had high burden (score > 22).
Most participants reported no or little difficulty in several aspects of their
treatment. For example, monitoring medical conditions (n = 83, 91%), getting
clear and up-to-date information about their condition (n = 82, 90%), collecting
prescription medications (n =81, 89%), making recommended lifestyle changes
(n = 73, 80%), and getting healthcare in the evenings or weekends (n = 71,
78%). Conversely, there were some activities that a number of participants found
quite difficult, very difficult, or extremely difficult. For example, taking lots of
medications (n = 46, 51%) and seeing lots of healthcare providers (n = 29, 32%),
indicating a potentially heavy perceived medication burden for half of the
participants and a provider burden for one-third of the participants. Frequencies
and percentages of participants’ responses to the treatment burden questions
are presented in Table 6.
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Table 6
Distribution of Multimorbidity Treatment Burden Questionnaire (MTBQ)
Responses (N = 91)
Variable

Level of Difficulty
Extremely
difficult
n(%)

Very
difficult
n(%)

Quite
difficult
n(%)

A little
difficult
n(%)

Not
difficult/
Does not
apply
n(%)

1. Taking lots of meds

9(10.0)

10(11.0)

27(29.6)

23(25.0)

22(24.0)

2. Remember to take
meds

-

4(4.4)

16(17.6)

29(31.9)

42(46.2)

3. Paying for meds

-

8(8.8)

14(15.4)

29(31.9)

40(44.0)

4. Collecting meds

-

-

10(11.0)

32(35.0)

49(53.8)

1 (1.1)

2(2.2)

5(5.5)

29(31.9)

54(59.3)

-

1(1.1)

10(11.0)

38(41.8)

42(46.2)

7. Seeing lots of
healthcare providers

5(5.5)

7(7.7)

17(18.7)

26(28.6)

36(39.6)

8. Attending appointments

1(1.1)

5(5.5)

14(15.4)

29(31.9)

42(46.2)

9. Getting healthcare in
evenings/weekends

2(2.2)

4(4.4)

14(15.4)

23(25.3)

48(52.7)

10. Getting help from
community services

2(2.2)

5(5.5)

11(12.0)

29(31.9)

44(48.4)

11. Getting clear/up-to-date
info about condition

-

1(1.1)

8(8.8)

35(38.5)

47(51.6)

12. Making recommended
lifestyle changes

3(3.3)

2(2.2)

13(14.3)

25(27.5)

48(52.7)

13. Having to rely on help
from family and friends

1(1.1)

2(2.2)

15(16.5)

29(31.9)

44(48.4)

5. Monitoring medical
conditions
6. Arranging appointments
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Illness Burden
Score on the Illness Intrusiveness Ratings Scale may range from 13 – 91.
On average, total illness burden scores for this sample were moderate (M = 46,
SD = 15.8), suggesting the existence of illness burden for participants, but not
excessively high levels of burden (See Table 7). Participants reported the highest
scores of illness intrusiveness (i.e., illness burden) in health (M = 5.2, SD = 1.6),
diet (M = 4.7, SD = 1.6), and financial situation (M = 4.5, SD =1.9). The factors
that were the least impacted by participants’ illnesses were religious expression
(M = 2.6, SD = 1.7) and social relationships (M = 2.9, SD = 1.6).
Table 7
Mean Scores for Illness Intrusiveness Ratings Scale (IIRS) Responses (N = 91)
Variables

Observed Possible
Min - Max Min-Max

M

SD

Health

5.23

1.59

1-7

1-7

Diet

4.69

1.60

1-7

1-7

Work

3.73

1.67

1-7

1-7

Active recreation

3.69

1.64

1-7

1-7

Passive recreation

3.29

1.78

1-7

1-7

Financial situation

4.47

1.86

1-7

1-7

Relationship w/ sig. other

2.98

1.83

1-7

1-7

Sex life

3.23

2.21

1-7

1-7

Family relationships

2.92

1.80

1-7

1-7

Perceived interference in:
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Table 7
Mean Scores for Illness Intrusiveness Ratings Scale (IIRS) Responses Cont’d
(N = 91)
Variables

Observed Possible
Min - Max Min-Max

M

SD

Social relationships

2.88

1.64

1-7

1-7

Self-improvement

2.93

1.88

1-7

1-7

Religious expression

2.57

1.68

1-7

1-7

Community involvement

3.38

1.65

1-7

1-7

Total illness burden

45.99 15.84

13-88

13-91

Number of Prescribed Medications
As shown in Table 8, the total number of prescribed medications in this
sample ranged from 2 - 8 (M = 4, SD = 1.3). The number of prescribed
medications for diabetes and blood pressure ranged from 1-3 per medication
type. Most participants reported taking two medications for diabetes (n = 53,
58%) and two medications for blood pressure (n = 48, 53%). Thirty-three (36%)
participants reported taking medications for health issues other than diabetes or
blood pressure, with one additional medication being the most frequently
observed response.
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Table 8
Distribution of Prescribed Medications (N = 91)
# of
prescribed
medications
0

Diabetes
n(%)
-

Blood
pressure
n(%)
-

Other
medications
n(%)
58(63.7)

Total
n(%)
-

1

27(29.7)

39(42.9)

16(17.6)

-

2

53(58.2)

48(52.7)

13(14.3)

13(14.3)

3

11(12.1)

4(4.4)

2(2.2)

19(20.9)

4

-

-

1(1.1)

28(30.8)

5

-

-

-

18(19.8)

6

-

-

1(1.1)

9(9.9)

7

-

-

-

3(3.3)

8

-

-

-

1(1.1)

Medication Adherence
The mean medication adherence score was 2.4 (SD = 0.9), indicating the
potential for a lack of adherence within the sample. The possible range of scores
was 1 – 5, with actual medication adherence average scores ranging from 1 – 4.
Participants were grouped by average medication adherence scores as adherent
(scores < 2) or non-adherent (scores ≥ 2). The majority of the sample (66%) were
classified as non-adherent. For this measure, any participants who do not
indicate the highest level of agreement (i.e., strongly agree) for questions one
and two and the lowest level of agreement (i.e., strongly disagree) to the
remaining four questions, are considered non -adherent.
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Most participants agreed or strongly agreed to taking all of their diabetic
(n = 64, 70%) and blood pressure (n = 68, 75%) medications over the prior 30
days. These responses aligned with the low level of agreement to questions
which assessed whether they were “unable” to take all of their diabetes and
hypertension medications. However, responses to whether they missed or
skipped a dose, somewhat conflicted with the level of adherence questions. For
example, 42 (46%) participants disagreed or strongly disagreed to missing or
skipping any of their diabetic medications and only 46 (51%) participants
disagreed or strongly disagreed to missing or skipping any of their blood
pressure medications. This was a difference of 22 conflicting responses for both
diabetes and blood pressure medication adherence. Table 9 displays the
frequencies and percentages of responses to each of the six medication
adherence questions.
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Table 9
Distribution of Extent of Adherence Responses (N = 91)
Medication Adherence
Questions
Over the past 30 days:

Level of Agreement
Strongly Agree
agree
n(%)
n(%)

Neutral
n(%)

Disagree
n(%)

Strongly
disagree
n(%)
-

1. I took all of my diabetes
medications.

19(20.9) 45(49.5) 15(16.5)

12(13.2)

2. I took all of my blood
pressure medications.

24(26.4) 44(48.4)

14(15.4)

1(1.1)

3. I missed or skipped a
dose of my diabetes
medications.

2(2.2)

31(34.1) 16(17.6)

20(22.0)

22(24.2)

4. I missed or skipped a
dose of my blood
pressure medications.

2(2.2)

22(24.2) 21(23.1)

21(23.1)

25(27.5)

5. I was unable to take all of
my diabetes medications.

3(3.3)

20(22.0) 11(12.1)

34(37.4)

23(25.3)

6. I was unable to take all of
my blood pressure
medications.

3(3.3)

21(23.1) 11(12.1)

32(35.2)

24(26.4)

8(8.8)

Perceived Difficulty in Managing Prescribed Medications
Total difficulty in managing medication scores were determined by
aggregating the difficulty scores from participants’ responses on the Medication
Workload Survey (i.e., difficulty in attributes of the medication workload) and the
Reasons for Non-adherence Scale within the Extent of Adherence Survey (i.e.,
barriers in medication adherence). The measure has a possible score range of
0 – 42. As reflected in Table 10, total scores for level of difficulty in managing
medications ranged from 0 to 29, with a mean score of 10.4 (SD = 6.9). This
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finding indicates that participants experienced some difficulty in overall
medication management and further supports the presence of medication burden
indicated by the treatment burden measure. Both instruments measured difficulty
in different aspects of medication management on a three-point scale, with a
maximum difficulty score of 2 for each of the 21 items. Additionally, as some of
the medication difficulty questions from the workload survey did not apply to
some participants, there are fewer responses noted for those questions.
Table 10
Mean Scores for Perceived Difficulty in Managing Prescribed Medications Scales
(N = 91)
M

SD

Observed
Min-Max

Possible
Min - Max

Medication workload

5.8

4.2

0-22

0-26

Medication adherence

4.6

3.4

0-12

0-16

Managing medications (Total)

10.4

6.9

0-29

0-42

Variables
Perceived difficulty in:

Medication Workload Difficulty
The mean medication workload difficulty score was 5.8 (SD = 4.2),
indicating a low perceived difficulty in managing aspects of the medication
workload (e.g., routes of administration, timing of medications, changes to
medication regimen, etc.) among participants. Although overall workload difficulty
was low, 83 participants (91%) reported some level of difficulty in managing
certain aspects of their medication workload. As indicated by frequencies of not
hard, the easiest aspects of participants’ medication workloads, were opening
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medication containers (n = 77, 85%), reading medication labels (n = 72, 79%),
and understanding what prescribed medications are for (n = 72, 79%). The most
difficult aspects of the medication workload, as indicated by higher frequencies of
very hard, were paying for medications (n = 19, 21%), dealing with side effects
(n = 12, 13%), and getting refills on time (n = 7, 8%). The sample responded
equally with not hard and a little hard on how difficult it was to manage taking
medications at inconvenient times (n = 43, 47%). Participants reported taking
medications orally (n = 91,100%), topically (n = 5, 6%), via self-injection (n = 47,
52%), pump (n = 11,12%), and through other routes (n = 1,1%). Thirty-six
participants (40%) reported some level of difficulty with administering their
medications via the prescribed routes.
Sixty-two (68%) participants reported having to alter their blood pressure
or diabetes medications based on blood pressure and glucose readings they
obtain at home. Of these participants, about half indicated they experienced
difficulty in checking their blood pressure and glucose levels at home and in
figuring out how to adjust their dose based on the blood pressure and glucose
readings. Of the 48 participants who indicated their healthcare provider made
changes within the last 90 days to their medication regimens, 40% (n = 19)
reported having difficulty with managing those medication changes. The
distribution of responses to the questions that assessed difficulty in medication
workload are displayed in Table 11.
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Table 11
Distribution of Difficulty in Medication Workload Responses (N = 91)
Levels of Difficulty

Medication Workload Difficulty Questions
Not hard
n(%)

A little hard
n(%)

Very hard
n(%)

30(46)

31(48)

4(6)

route(s)

55(60)

31(34)

5(6)

3.

Checking blood pressure/glucose levels b

29(47)

31(50)

2(3)

4.

Figuring out med doses c

30(48)

28(45)

4(7)

5.

Managing med changes d

29 (60)

19(40)

-

6.

Remembering to take meds

57(63)

31(34)

3(3)

7.

Paying for meds

31(34)

41(45)

19(21)

8.

Opening med containers

77(85)

13(14)

1(1)

9.

Reading med containers

72(79)

17(19)

2(2)

10.

Getting refills on time

35(38)

49(54)

7(8)

11.

Taking meds at inconvenient times

43(47)

43(47)

5(6)

12.

Understanding purpose of meds

72(79)

16(18)

3(3)

13.

Dealing with side effects from meds

33(36)

46(51)

12(13)

1.

Taking meds at different times a

2.

Administering meds via prescribed

a

n = 65; b n = 62; c n = 62; d n = 48.
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Difficulty in Medication Adherence
Overall, the sample reported relatively low perceived difficulty in managing
barriers to medication adherence, with a mean difficulty score of 4.6 (SD = 3.4).
However, the majority had some level of non -adherence attributed to the
medication adherence barriers on the scale (n = 75, 82%). As displayed in Table
12, the most prevalent contributors to non -adherence were being busy (n = 52,
57%), cost (n = 51, 56%), and taking medications more than once a day (n = 48,
53%). Most participants reported that adherence to their medication regimens
was not impacted by feeling too ill to take their medications (n = 60, 66%), feeling
that they did not need their medications (n = 57, 63%), running out of
medications (n = 54, 59%), or having a blood glucose or blood pressure that was
too low to take their medications (n = 52, 57%) . Although 64% of participants
reported some level of difficulty with side effects on the workload survey, for
medication adherence, only 48% reported that side effects impacted their
adherence.
A total of six participants shared comments on additional reasons for non adherence. One participant reported they “ran out of money” and could not pay
for their prescriptions. Another participant commented they were “too tired” to get
up from bed once they realized they had forgotten to take their medications. Two
participants indicated they overslept and were not able to take their medications
at the scheduled times. Lastly, two participants reported that their travel plan
conflicted with them taking their medications as scheduled. One of the two
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participants reported forgetting to pack their medications in their luggage before
departing.
Table 12
Distribution of Reasons for Medication Non-Adherence Responses (N = 91)
Reasons for Non-Adherence

Levels of Contribution

In the past 7 days, how much did each
situation contribute to you missing a dose
of your diabetes or blood pressure

Not at all

A little

A lot

n(%)

n(%)

n(%)

1. I was busy

39(43)

42(46)

10(11)

2. They caused some side effects

47(52)

34(37)

10(11)

3. They cost a lot of money

40(44)

35(38)

16(18)

4. I felt I did not need them

57(63)

28(31)

6(6)

5. I had to take them > once a day

43(47)

30(33)

18(20)

6. I ran out of medication

54(59)

28(31)

9(10)

7. My blood pressure/glucose was too low

52(57)

31(34)

8(9)

8. I was feeling too ill to take them

60(66)

23(25)

8(9)

medication?

Impact of Coronavirus Disease 2019 on Medication Management
Participants were asked how much they believed the Coronavirus disease
2019 (COVID-19) impacted 10 aspects of their medication management.
Participants’ COVID-19 impact scores ranged from 10 – 44, with a mean score of
30 (+8.8), indicating that COVID-19 was perceived to have had a moderate
impact on medication management activities. The items with the most prevalent
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responses of strongly agree and agree to COVID-19’s impact on medication
management were worrying about leaving their homes to get medications, get
supplies, or see their healthcare providers (n = 62, 68%), getting prescription refill
orders from healthcare providers (n = 58, 64%), paying for medications (n =57,
63%), and getting help from others (n = 53, 58%). In contrast, the items with the
least prevalent responses of strongly agree and agree to COVID-19’s impact on
medication management were checking their blood pressure and glucose levels
(n = 22, 24%), remembering to take their medications (n = 23, 25%), and feelings
of uncertainty regarding which medications they should or should not take
(n = 23, 25%). See Table 13 for the frequencies of responses on the COVID-19
Impact survey.
Table 13
Distribution of COVID-19 Impact Survey Responses (N = 91)
COVID-19 Impact Scale
Strongly
agree
n(%)

1. Remembering meds

3(3)

Level of Agreement
Agree
Neither
Disagree
n(%)
agree
n(%)
nor
disagree
n(%)
20(22)
8(9)
35(38)

Strongly
disagree
n(%)

25(28)

2. Paying for meds

16(18)

41(45)

8(9)

15(16)

11(12)

3. Getting prescription
orders

13(14)

45(50)

10(11)

11(12)

12(13)

4. Getting refills

7(8)

44(48)

10(11)

18(20)

12(13)

5. Talking with
healthcare provider

8(9)

38(42)

11(12)

22(24)

12(13)

9(10)

44(49)

11(12)

13(14)

14(15)

6. Getting help from
others
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Table 13
Distribution of COVID-19 Impact Survey Responses (N = 91)
COVID-19 Impact Scale

7. Getting supplies

7(8)

Level of Agreement
Agree
Neither
Disagree
n(%)
agree
n(%)
nor
disagree
n(%)
45(50)
10(11)
15(16)

8. Checking blood
pressure and
glucose levels

1(1)

21(23)

8(9)

28(31)

33(36)

9. Uncertainty about
which meds I should
take

1(1)

22(24)

14(15)

30(33)

24(27)

10. Worry about leaving
the house

20(22)

42(46)

9(10)

10(11)

10(11)

Strongly
agree
n(%)

Strongly
disagree
n(%)

14(15)

Relationships among Major Study Variables
Bivariate correlations between select demographic characteristics (i.e.,
age and level of education) and major study variables (i.e., patient activation,
health literacy, treatment burden, illness burden, medication adherence, total
number of prescribed medications, total difficulty in managing prescribed
medications, and perceived COVID-19 impact on medication management) were
examined. Due to the lack of normality among the study variables, a non parametric correlation analysis was performed (i.e. Spearman’s rho correlation).
The variables met all assumptions for conducting Spearman’s rho correlation
analyses (i.e. levels of measurement, paired observations, and monotonic
relationships).
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Table 14 displays the Spearman’s rho correlation coefficients. Both
increasing age and higher level of education were associated with greater
treatment burden and more difficulty with managing medications. Increasing age
was also associated with lower levels of patient activation and taking more
prescribed medications. Due to the assumptions for Spearman’s rho correlation,
age and education were the only demographic variables appropriate for inclusion
in the correlation analyses.
As an exploratory measure, independent t-tests were performed to
examine the major study variables for significant differences by participants’ sex.
Men reported significantly higher levels of illness burden (M = 48, SD = 15.3)
than women (M = 41, SD =15.9; t(89) = 2.056, p = .04). Men also had
significantly higher COVID-19 Impact scores t(84) = 2.601, p = .01, (M = 31, SD
= 9.5) than women (M = 27, SD = 6.3; t(84) = 2.601, p = .01). There were no
significant differences found between men and women for patient activation,
health literacy, treatment burden, number of prescribed medications, total
medication difficulty, or medication adherence.
The correlation analyses also revealed a significant, negative correlation
between patient activation and health literacy. Patient activation was also
negatively correlated with treatment burden and total difficulty in managing
medications. The negative correlation between patient activation and medication
adherence indicates that as patient activation goes up, the scores on the
medication adherence measure decrease. Lower scores on the medication
adherence measure indicates better medication adherence. The variables
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significantly associated with medication adherence were treatment burden,
patient activation, total difficulty in managing medications, and COVID-19 impact.
Table 14
Spearman’s rho Correlation Coefficients among Study Variables (N = 91)
Variables
1. Age

1
-

2

2. Education

-.07

-

3. Patient
Activation

-.33**

-.01

-

4. Health
Literacy

.09

.02

-.22*

-

5. Treatment
Burden

.24*

.22*

-.31**

.08

-

6. Illness
Burden

-.17

.17

.07

-.29**

.18

-

7. Medication
Adherence

.03

-.05

-.39**

.21

.24*

-.10

-

8. Total # of
prescribed
medications

.22*

-.04

.07

-.04

.14

.25*

-.02

-

9. Total
difficulty in
managing
medications

.24*

.21*

-.48**

.09

.69**

.20

.35**

.29**

-

.15

-.16

.12

.45**

.01

.22*

.16

.56**

10. COVID-19
-.12
Impact
Note. *p < .05. **p < .01.

3

4

5

6

7

8

Data Analyses for Research Questions
Research Question 1: Are higher levels of illness burden associated with
lower levels of patient activation and health literacy?

9

10

-
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To answer research question one, results from the Spearman’s correlation
analyses (Table 14) were examined to determine the correlations between
(1) illness burden and patient activation and (2) illness burden and health literacy.
Cohen's standard was used to evaluate the strength of the relationships, where
coefficients between .10 and .29 represent a small effect size, coefficients
between .30 and .49 represent a moderate effect size, and coefficients above .50
indicate a large effect size. A significant negative correlation was observed
between illness burden and health literacy (rs = -0.29, p = .005), indicating that as
illness burden increases, health literacy decreases. No significant correlation was
found between illness burden and patient activation.
Research Question 2: Are higher levels of treatment burden associated
with a higher number of prescribed medications and greater perceived
difficulty in managing prescribed medications?
To answer research question two, Spearman’s rho correlation coefficients
(Table 14) were examined to determine the associations between treatment
burden and (1) number of prescribed medications and (2) total perceived
difficulty in managing prescribed medications scores. A significant positive
correlation was observed between treatment burden and perceived difficulty in
managing medications (rs = 0.69, p = .000) indicating as treatment burden
increases, perceived difficulty in managing medications also increases. The
correlation coefficient of 0.69 indicated a large effect size. No significant
correlation was found between treatment burden and number of prescribed
medications.

122
Research Question 3: Do patient activation, health literacy, treatment
burden, and illness burden significantly predict medication adherence?
To answer research question three, a hierarchical regression analysis was
conducted to test the model consisting of patient activation, health literacy,
treatment burden, and illness burden in predicting the variance in medication
adherence. The order of entry for the variables was based on existing literature
on the concepts. Several assumptions for this statistical analysis were confirmed.
All predictor variables and the dependent variable were measured at the interval
level. The demographic variables included in the model as covariates were age,
sex, income, and education. Although age and education were the only
demographic variables appropriate for inclusion in the correlation analyses, sex
and income were identified in previous literature as potential confounding
influencers on the major study variables. As such, the regression analyses
conducted in this study adjusted for these potential covariates as well. Age was
measured as a continuous variable. Sex and income were categorical variables
with each having two categories (i.e., $30,000 or ≥ $30,000, male or female).
Each category for the two variables were designated scores of 0 and 1,
respectively. Education was measured as an ordinal variable. As such, dummy
coding was used for each of the education levels assessed, excluding the
reference category (i.e., high school or lower). A sample size of 91 was
determined to be adequate based on the priori analysis performed. Adequate
variance of the predictor variables was determined by examining the descriptive
statics. There were no predictor variables that had the same values for all
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participants. All Variance Inflation Factor values were < 10 and all Tolerance
statistics were > .2, indicating that none of the predictor variables were
excessively correlated with each other and that the assumption of
multicollinearity was met. Examination of residual and scatter plots indicated the
assumptions of normally distributed errors, linearity, and homoscedasticity were
satisfied. Results of the Durbin-Watson test indicated that the assumption of
independent errors was met, as the value of 1.5 is an acceptable value for
indicating non-autocorrelation. Lastly, Cook’s distances were examined. All
values were found to be less than one, indicating that none of the observations
for the predictor variables appeared to have excessive influence on the
regression line.
A five-step hierarchical linear regression was conducted with medication
adherence as the dependent variable. For step one, age, income, education, and
sex were entered as predictor variables into the null model. This was done to
control for their potential confounding impact. Patient activation was added as the
first predictor variable in the model at step two. Health literacy was added into the
model at step three, treatment burden was added at step four, and illness burden
at step five.
As reflected in Table 15, the results of the hierarchical regression analysis
indicated that the full model (i.e., Model 5) that included all of the independent
variables was significant in predicting medication adherence [F ( 10, 90) = 3.11,
p = .002)], accounting for 19% of the variance. Although model 4 explained more
variance in medication adherence (19.6%) than model 5 (19%), model 5 is being
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highlighted because this study sought out to follow the cumulative complexity
model and determine if the model with all four predictor variables would
significantly predict medication adherence. However, of the four predictors, only
patient activation was a significant individual contributor in predicting medication
adherence as indicated by a t-statistic of -3.73 ( p = .000). Additionally,
interpretation of the unstandardized beta coefficient indicated that for each onepoint increase in patient activation, medication non -adherence decreases by .03
(SE = .008; 95% CI: -.047, .014). These results indicate that while patient
activation is a significant predictor of medication adherence, adding the other
variables (i.e., health literacy, treatment burden, and illness burden) to the model
only provided a minimal change (i.e., highest amount of change in adjusted R 2
after model 2 was <.023) in helping to explain the variance in medication
adherence. Additionally, the demographic variables (i.e., age, income, education,
and sex), did not have a significant contribution in explaining medication
adherence.
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Table 15
Results of Hierarchical Regression Analysis Predicting Medication Adherence in
African American adults with T2D and Hypertension (N = 91)
B

SE

β

T

R2

Adj.

R2 Δ

F

R2

B
Model 1
Sex

-.344

.245

-.168

-1.404

Income

.011

.226

.005

.048

Age

-.003

.010

-.039

-.334

Grad

-.084

.315

-.042

-.266

Undergrad

-.082

.321

-.039

-.254

Trade

-.028

.401

-.009

-.069

Model 2
Sex

-.315

.219

-.153

-1.440

Income

.211

.206

.103

1.023

Age

-.015

.009

-.177

-1.637

Grad

-.288

.284

-.144

-1.014

Undergrad

-.408

.294

-.197

-1.389

Trade

-.317

.363

-.106

-.874

Patient Activation

-.037

.008

-.495

-4.764***

Model 3
Sex

-.286

.218

-.139

-1.310

Income

.261

.208

.127

1.255

Age

-.014

.009

-.175

-1.621

Grad

-.284

.282

-.142

-1.006

Undergrad

-.439

.293

-.212

-1.498

Trade

-.272

.362

-.091

-.751

Patient Activation

-.035

.008

-.470

-4.479***

Health Literacy

.068

.049

.140

1.383

.027

-.042

.027

.392

.236

.172

.209

3.665**

.254

.181

.017

3.481**
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Table 15
Results of Hierarchical Regression Analysis Predicting Medication Adherence in
African American adults with T2D and Hypertension Cont’d (N = 91)
B

SE

β

T

R2

Adj.

R2 Δ

F

R2

B
Model 4
Sex

-.258

.217

-.126

-1.188

Income

.321

.209

.156

1.532

Age

-.015

.009

-.185

-1.731

Grad

-.368

.285

-.184

-1.292

Undergrad

-.500

.293

-.241

-1.707

Trade

-.236

.360

-.079

-.656

Patient Activation

-.032

.008

-.429

-4.008***

Health Literacy

.077

.049

.159

1.582

Treatment Burden

.011

.007

.166

1.597

Model 5
Sex

-.249

.218

-.121

-1.139

Income

.306

.211

.149

1.449

Age

-.017

.009

-.202

-1.827

Grad

-.345

.288

-.173

-1.200

Undergrad

-.478

.296

-.231

-1.615

Trade

-.177

.373

-.059

-.474

Patient Activation

-.031

.008

-.413

-3.736***

Health Literacy

.068

.051

.141

1.335

Treatment Burden

.012

.007

.185

1.705

Illness Burden
-.005 .007
Note. **p < .01. ***p < .001.

-.074

-.642

.276

.196

.023

.280

.190

.004

3.436**

3.111**
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Research Question 4: Which aspects of medication management are the
most challenging?
To answer research question four, the responses from the Medication
Workload Survey and the Reasons for Non -Adherence Scale from the Extent of
Adherence Survey were examined. The five most challenging aspects of
medication management, listed in order of most challenging to least challenging
were (1) paying for medications, (2) dealing with side effects, (3) getting refills on
time, (4) managing medication schedules (i.e., preventing a busy schedule from
interfering with medication adherence, taking medications at different and/or
inconvenient times), and (5) managing medication dosing (i.e., taking a
prescribed medication more than once a day and figuring out medication doses).
Research Question 5: What is the perceived impact of the COVID-19
pandemic on medication management?
To answer research question five, responses to the COVID-19 Impact
Survey were examined. From greatest to least perceived impact, participants
reported the following impact of COVID-19 on medication management: (1)
worrying about leaving their homes (68%), (2) getting refill orders from their
healthcare providers (64%), (3) paying for medications (63%), (4) getting help
from others (59%), (5) getting supplies (58%), (6) getting refills from the
pharmacy (56%), (7) talking with their healthcare provider abou t their
medications (51%), (8) being uncertain about what medications they should or
should not take (25%), (9) remembering to take their medications (25%), and
(10) checking their blood pressure or blood glucose levels (24%).
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Eight participants shared additional details about how COVID-19 impacted
situations relating to their diabetes and hypertension. Four participants described
how COVID-19 impacted their income sources, making it more difficult to pay for
medications and supplies. One participant also described how they had to rely
more on the financial support from family and friends. Two participants described
how COVID-19 impacted their daily routines. One described how working from
home, due to COVID-19 public health concerns, created additional difficulty in
remembering to take medications as scheduled. The participant described how
physically going into work created a daily structure for them, helping them with
remembering to take their medications. The other reported that the restrictions
relating to COVID-19 public health concerns impacted their ability to continue
with their normal exercise routine at the gym. Another participant described how
they are consistently worried about their potential for becoming ill from COVID 19. Lastly, a participant described how they had recently suffered from a stroke
and during their hospital admission discovered that they were positive for
COVID-19. During their admission, their healthcare provider prescribed a
medication for management of their diabetes. The medication was one that the
participant had previously taken and one that created unpleasant side effects.
The participant reported that they decided to take the medication, however, they
reduced the daily dosage of the medication in hopes that it would reduce the side
effects from the medication.
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Summary
In this study of young to older African American adults with Type 2
diabetes and hypertension, most were male, college graduates, employed parttime, and had health insurance and a primary care provider. The time since
diagnosis of diabetes and hypertension averaged four years each and most were
able to provide their recent HbA 1c , SBP, and DBP levels. All of the scales used to
measure the major study variables in this study demonstrated adequate internal
consistency reliability, with Cronbach’s alpha coefficients of >.70.
On average, participants had high levels of patient activation. Their health
literacy scores were somewhat split over the three health literacy categories, but
the highest prevalence indicated a high likelihood of poor health literacy. The
mean number of medications taken by participants was four, with a range of two
to seven prescribed medications. The overall treatment burden was low;
however, the medication burden aspect of the treatment burden scale was high
for about one-third of the sample. Illness burden was moderate, with the highest
impacts reported for health, diet, and financial status. The majority of the sample
was found to be non-adherent to their medication regimen based on adherence
scores ≥ 2, although the majority responded with some level of agreeance to
taking all of their diabetic and blood pressure medications over the prior 30 days.
The major demographic variable of interest was participant age, and
increasing age was significantly associated with lower patient activation and
greater treatment burden, greater number of prescribed medications, and
increased difficulty in managing medications.
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Five research questions were answered in this study. Illness burden was
significantly associated with health literacy but not with patient activation, while
treatment burden was significantly associated with perceived difficulty in
managing medications but not with the number of medications prescribed. The
results of the hierarchical regression analysis revealed that the model explained
19% of the variance with patient activation being the only predictor variable
significantly explaining the variance in medication adherence. The participants’
total perceived difficulty in managing prescribed medications on average was
low. The aspects of medication management that participants found the most
challenging were paying for medications, dealing with side effects, getting refills
on time, managing medication schedules, and managing medication dosing. The
mean COVID-19 impact score indicated a moderate perceived impact among
participants. Most participants reported that paying for medications, getting refill
orders, getting medications from the pharmacy, and getting supplies were harder
to do than they were prior to the rise of the COVID-19 pandemic in March 2020.
Additionally, participants shared how the changes from the COVID-19 pandemic
created disruptions in their routines, making it more difficult to remember to take
their medications.

CHAPTER V
DISCUSSION AND CONCLUSIONS
The purpose of this non-experimental, predictive correlational study was to
examine relationships among disease self-management capacity, patient burden,
and medication adherence in African American adults with T2D and
hypertension. This study also explored the perceived impact of the COVID-19
pandemic on the management of medications. This chapter provides a
discussion of the study findings, study limitations, and strengths. The implications
for practice and recommendations for future research are also described followed
by the conclusion.
Recruitment and Characteristics of the Sample
Targeted advertising facilitated recruitment efforts for this study.
Approximately half of the participants (n = 46) were recruited from a social media
platform (i.e., Facebook). Potentially more people being at home due to the
COVID-19 pandemic and greater accessibility and use of computers and cell
phones may have also contributed to the successful online recruitment rates. In
general, this sample was composed of mostly college-educated, males. Social
media may also explain why the sample was composed of more collegeeducated and younger participants than anticipated.
Based on the employment-to-population ratio for males aged 25 – 54
(81.5%) in comparison to females in the same age group (68.7%), the U.S.
131
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workforce has a greater representation of males (U.S. Department of Labor.,
2020). Thus, the greater number of male participants in this study may be due to
a greater prevalence of increased availability during the pandemic (e.g., COVID19 related employment challenges). Furthermore, the use of social media vs.
traditional recruitment settings (e.g., clinics or doctor’s offices) may have
provided greater opportunity to recruit AA males in this study, as AA males have
been found to be less likely than AA females to have a usual source of
healthcare (Stewart et al., 2019).
Most participants (>91%) were able to self-report their most recent HbA 1c ,
SBP, and DBP levels, which may be explained by participants being mostly
young and college educated. Average HbA1c readings (M = 7.4%) were above
recommended levels (CDC, 2018e). Though the mean SBP (139; SD = 18.7) and
DBP (82; SD = 10.4) were below the general blood pressure target of 140/90
recommended by the American Diabetes Association (ADA) for individuals with
T2D and that have lower risks for cardiovascular disease, the mean blood
pressure in this study was above 130/80 (ADA, 2020). A target BP goal of <
130/80 has been suggested as a more favorable BP target for individuals at
higher risk for cardiovascular disease, such as AAs, who may require more
intensive blood pressure control (ADA, 2020; Passarella et al., 2018; Saab et al.,
2015; Whelton et al., 2018). These findings support the presence of blood
pressure levels and T2D that may lead to an increased risk for cardiovascular
and neurological complications among these participants (AHA, 2015; CDC,
2018b; NIDDK, 2017; Petrie et al., 2018).
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Few participants reported having additional health issues other than T2D
and hypertension. This may be due to the sample’s low average for years since
diagnosis of T2D (M = 4.3) and hypertension (M = 4.4) and low mean age (39.6).
The mean age in this study is lower than what was found in similar studies that
included AAs with T2D and/or hypertension (Rogers et al., 2017; Skolasky et al.,
2011; Ylitalo et al., 2018). This mean age supports the previous research
indicating that AAs tend to develop these diseases at earlier ages than other
racial or ethnic groups, and as a result experience cardiovascular diseases,
stroke and other complications at earlier ages.
Of the participants (n = 19) that reported additional health issues (n = 19),
obesity (n = 5), high cholesterol (n = 4), and arthritis (n = 4) were the most
frequently identified. These additional health issues are in line with previous
studies, as Lin et. al (2015) found that obesity, hyperlipidemia, and arthritis were
some of the most common components of the multiple morbidity clusters for
individuals with T2D and hypertension. However, in a sample of adults with both
T2D and hypertension, it was anticipated that there would be higher rates of
obesity. The low rates of obesity in this sample may be related to underreporting.
Participants may not be fully aware of their body mass index levels or perceive
themselves to be “obese”, and as such, may not have reported this health issue.
A previous study also found that participant report of obesity was low, as only
22.2% of obese women and 6.7% of obese men were able to correctly classify
themselves as obese (Truesdale & Stevens, 2008). Future studies should include

134
inquiries of waist circumference or waist-to-hip ratio to help with determining
rates of obesity.
Illness Burden, Heath Literacy, and Patient Activation
Illness burden was significantly associated with health literacy but not with
patient activation; the higher the illness burden, the lower the level of health
literacy. As illness burden has been described as being a barrier to performance
of DSM activities in previous studies, findings in this study suggest that
challenges created by illness burdens may be offset by greater health literacy
(Eton et al., 2012; Gore et al., 2006). Additionally, Boehmer, Shippee, et al.
(2016) found that greater illness burden related to diminished mental capacity.
This further supports the link between health literacy and illness burden and
emphasizes the importance of providing additional health literacy support to AA
with co-morbid T2D and hypertension.
Previous studies also reported that increased illness burden related to
diminished ability to perform activities of daily living, decreased productivity, and
less self-efficacy (Boehmer, Shippee, et al., 2016; Gore et al., 2006). As these
are functions similar to those measured in this study with patient activation, it was
anticipated that higher illness burdens would be related to lower patient
activation. This was not found and may indicate that individuals who have greater
patient activation, but not adequate health literacy, may not have the same ability
to overcome challenges from the illness burden they experience.
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Treatment Burden and Medication Workload
While increased treatment burden related to greater perceived difficulty in
managing medications (rs = 0.69, p = .000), no association was found between
treatment burden and number of prescribed medications. These findings
indicated that while individuals perceived increases in their treatment burden and
greater difficulty in managing medications, the number of medications they
reported taking did not largely factor into their overall perceived treatment
burden. Additionally, as a high level of patient activation was found in this study
and patient activation was significantly associated with treatment burden, it is
possible that greater activation eased the impact from taking a greater number of
medications in overall treatment burden.
Although no association was found between number of medications and
treatment burden, taking more medications was associated with greater difficulty
in managing medications. As a high level of medication burden was found for
some participants in this study, the association between number of medications
and difficulty in medication management implies that individuals taking multiple
medications may need more guidance on managing their medication workload.
Application of the Adapted Cumulative Complexity Model in Predicting
Medication Adherence
As proposed by the adapted CCM, the regression model that included all
of the independent variables (i.e., patient activation, health literacy, treatment
burden and illness burden) was significant in predicting medication adherence;
explaining 19% of the variance. However, only patient activation provided a
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significant individual contribution in predicting medication adherence. This finding
suggests that individuals who perceived themselves as more capable in
managing their DSM workloads (i.e., higher patient activation) also perceived that
they were more adherent to their prescribed medication regimens (i.e., had lower
scores on the Extent of Adherence Survey). Skolasky et al. (2011) also found in
their cross-sectional study of 855 multimorbid participants (46% AA) that higher
patient activation related to improved medication adherence.
Based on the available literature, it was anticipated that health literacy
would also provide a significant contribution in predicting medication adherence.
Al Sayah et al. (2015) found that a health literacy item that measured difficulty
understanding written information was significantly associated with worse
medication adherence (Al Sayah et al., 2015). Additionally, Ylitalo et al. (2018)
examined health literacy using the Newest Vital Sign (NVS) among 406 patients
(39% had diabetes; 41% non-Hispanic Blacks) and found attending scheduled
medical appointments was significantly lower for patients with limited health
literacy as compared with individuals with adequate health literacy. Although
attending office visit appointments is a different activity than adhering to
medication, the study provided support that health literacy is linked with
performance of disease management activities. A different study (Bains et al.,
2011) reported that they did not find associations between health literacy and
medication adherence, however, the lack of association in that study was thought
to be due to that study not using a tool such as the NVS that measures numeracy
and reading comprehension.
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The lack of contribution from health literacy in the regression model may
be related to response bias of participants. While health literacy examined actual
ability to solve numerical problems and make decisions based on written
information, the medication adherence tool captured participants perceived level
of adherence. Essentially, participants may have overestimated their adherence
to their medication regimens. Additionally, it is possible that by modifying the
medication adherence tool to capture adherence over the prior 30 days, instead
of the original 7 days, may have created challenges for participants to accurately
recall their adherence.
Patient burden (i.e. illness burden and treatment burden) also did not
significantly contribute to explaining the variance in medication adherence. This
finding suggests that while individuals who demonstrate poor adherence may
also be experiencing higher levels of treatment burden, other factors or
relationships should be considered in explaining adherence to their medication
regimen. Possibly, focusing more on the burden of their medication workloads
rather than their entire disease-related burden may be beneficial.
Additionally, although burden was not significant in the model, in bivariate
correlation analysis, greater treatment burden was significantly associated with
poorer medication adherence, but not illness burden. Individuals who believed
their prescribed treatments were less burdensome (i.e., lower treatment burden
scores) perceived themselves as being more adherent to their medication
regimens. Rogers et al. (2017) also found significant associations between
treatment burden and medication adherence. The negative bivariate correlation
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observed between patient activation and treatment burden provides further
support for the CCM, as it posits that patient burdens (e.g., treatment burden)
work against capacity factors (e.g., patient activation) in an individual’s attempt to
carrying out DSM activities. Therefore, by addressing an individual’s burden,
increases in patient activation may be observed leading to greater medication
adherence.
Exploratory Findings
Two concepts examined in this study but were not included in the model
explaining medication adherence were difficulty in managing medications and the
impact of COVID-19 on managing medications. Examination of how attributes of
individual medication workloads (e.g., level of perceived difficulty) provided
additional insight into the workload demand of managing prescribed medications
for AA adults with T2D and hypertension and highlighted situations that add to
the complexity individuals encounter when attempting to meet the DSM workload
demand of managing prescribed medications. Additionally, as this study
considered factors that may create challenges in individual medication
workloads, it was fitting to also incorporate an exploration of the potential impact
of the COVID-19 pandemic on medication management.
Perceived Difficulty in Managing Medications
Overall, participants reported little perceived difficulty in their medication
management (i.e., difficulty in managing prescribed medication workloads and
overcoming potential barriers to medication adherence). However, 45% of
participants had total perceived difficulty scores that exceeded the sample mean.
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The challenges in medication management that participants generally perceived
the most difficult related to managing medication costs, side effects, getting
refills, taking medications at inconvenient times, and medication frequency (i.e.,
taking medications more than once a day). These findings are in line with
previous studies that also found participants with T2D and/or hypertension had
challenges in their medication management relating to the side effects they
experienced, being confused about medication administration (e.g., timing of
medication administration), managing multiple medications, and dealing with the
interference in daily routines caused by managing medications (Bockwoldt et al.,
2017; Eton et al., 2012; Rogers et al., 2017; Weller et al., 2017). Additionally,
studies have examined how feelings of powerlessness and fear can hinder
individuals from taking their medications as prescribed (Bockwoldt et al., 2017;
Kennedy et al., 2008). Considering that dealing with side effects was one of the
more challenging aspects of medication management for participants, it is very
possible that the fear from experiencing side effects lead to inconsistencies in
their medication management.
Managing prescribed medications require various skills. This complexity
potentially created challenges for participants in meeting their medication
workload demands (Brown & Bussell, 2011; Greene et al., 2015; Ylitalo et al.,
2018). Of the participants in this study who had to self-monitor their blood
pressure and glucose at home, 53% reported having some difficulty in selfmonitoring their blood pressures and glucose levels (53%). Also, 52% of this
same group reported difficulty in adjusting their medication dosing based on
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those levels. In these situations, participants must use technical skills (i.e.,
operating blood pressure and glucose monitoring equipment, handling an insulin
syringe), health literacy skills (e.g., reading and interpreting medication
instructions), and problem-solving skills (e.g., what to do if they run out of
medications, supplies, etc.). Individuals who have deficiencies in the skills
needed to manage these tasks (i.e., deficient DSM capacity) likely have greater
challenges in carrying out their medication workload activities and achieving their
blood pressure and glucose goals.
Of the participants that had provider-initiated changes to their medication
regimen, 40% of them reported difficulty in managing those changes. These
findings indicate that participants also need skills in adapting to medication
changes. Previous studies have found that diabetic patients who have elevated
HbA1c during a hospital admission are typically prescribed a more intense
outpatient medication regimen, as compared to what they receive during
hospitalization (Umpierrez et al., 2012). Griffith et al. (2012) also found that the
most frequent changes in patients medication regimens were initiating a new
insulin medication (44%), initiating a non -insulin medication, change from one
insulin medication to another, and increasing medication dosages. These
findings highlight the importance of assessing individual abilities in managing
medications, providing clear instructions on managing changes to their
medication regimens, and providing them with resources for managing their
medication management challenges.
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Perceived Impact of the COVID-19 Pandemic
The mean COVID-19 impact score indicated participants perceived a
moderate impact on their medication management. Participants felt most strongly
about COVID-19 impacting their abilities to get prescription refill orders from their
healthcare providers, pay for medications, and receive help from others. Most
participants also reported worrying more about leaving their homes to get
medications and supplies and to see their healthcare providers. Considering that
COVID-19 is life-threatening infectious disease, transmitted through contact with
infected individuals, and has no specific vaccines or treatments, it is
understandable that individuals would have concerns with performing activities
that may increase their potential for contracting the illness (World Health
Organization [WHO], 2020). In line with the impact on pay reported by
participants, a review of U.S. unemployment reports indicated a dramatic rise,
with rates increasing more than threefold from January 2020 to April 2020 (U.S.
Bureau of Labor Statistics, 2020). The additional stress and concerns that come
from the presence of the COVID-19 pandemic may have created additional
challenges for individuals in performing their DSM activities (e.g., managing their
medication workloads). The activities that the participants reported were least
impacted by COVID-19 (i.e., monitoring blood pressure and glucose levels,
remembering to take their medications, and having uncertainty regarding which
medications they should or should not take), were activities that did not typically
require them to leave their homes or interact with other individuals.
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Furthermore, although only a small portion of the sample, 10% of
participants indicated not believing they could maintain positive lifestyle changes
during stressful times. Considering the current presence of the COVID -19
pandemic, these participants may have great difficulty in carrying out the DSM
activities necessary for their T2D and hypertension. This concept is further
supported by the results of the correlation analysis performed in this study which
indicated that greater perceived impact from COVID-19 associated with greater
treatment burden and poorer medication adherence. Although the COVID -19
impact was not included in the adapted CCM, this finding suggests the potential
impact that the COVID-19 pandemic may have on the existing burden individuals
with T2D and hypertension experience and on their abilities to carry out their
DSM workload activities. Additionally, as the perceived COVID-19 impact as well
as illness burden were found to be significantly greater for men as compared to
women, this may indicate that men with T2D and hypertension may need greater
support (e.g., emotional support, financial support) in managing their diseases
including meeting their medication workload demands.
The Cumulative Complexity Model
The Cumulative Complexity Model (CCM) guided the selection of
variables for examination of associations among DSM capacity (i.e., patient
activation and health literacy), patient burden (i.e., treatment and illness burden),
and a DSM outcome measure (i.e., perceived medication adherence) for AA
adults with T2D and hypertension . The abilities individuals have in meeting the
demands of their workload were examined with patient activation and health
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literacy measures. The burdens that individuals experience in meeting their
workload demands and the perceived level of disruption in aspects of day-to-day
life attributed to their chronic diseases were measured with treatment burden and
illness burden measures. Imbalances between medication workload and DSM
capacity, specifically when capacity fails to meet the demands of the workload,
individuals are more likely to have deficiencies in their disease management
performance, such as poor medication adherence (Boehmer, Shippee, et al.,
2016). As poor medication adherence may lead to poor health outcomes, greater
illness and more burden of treatment is likely to ensue (Bodde et al., 2013;
Shippee et al., 2012;). An explanation of the findings from the application of the
CCM in this study are described next.
Disease Self-Management Capacity
Disease self-management capacity is an individual’s ability to complete
the activities involved in their individual disease workload (e.g., taking prescribed
medications). Patient activation (i.e., an individual’s perceived knowledge,
motivation, and DSM skills relating to managing healthcare activities) and health
literacy (i.e., the ability to obtain, process, and understand health and healthcare
service information) were measures used to examine the disease selfmanagement capacity of the participants in this study.
Patient Activation
Overall, mean patient activation (PA) scores were high (M = 78, SD =
13,3), with the majority (63%) of the sample categorized in the highest level of
patient activation (level 4). Level 4 patient activation indicates that individuals
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proactively engage in recommended disease self-management (DSM) behaviors,
such as medication adherence (Greene et al., 2015). The mean patient activation
scores were similar to those found in previous studies examining patient
activation, with mean scores ranging from 66 – 80 in diverse samples, some of
which included AAs and individuals with T2D (Fowles et al., 2009; Hibbard et al.,
2008; Mayberry et al., 2010). The high level of patient activation reported in this
study may be explained by the younger age of participants. This finding is
supported by previous studies that found a correlation between lower patient
activation scores and older age in diverse populations (Chubak et al., 2012;
Gerber et al., 2011; Gleason et al., 2016; Hendricks & Rademakers, 2014).
Essentially, participants may feel less confident in performing some of their DSM
activities as they age.
Despite the high levels of PA, there were survey items for which
participants generally reported lower levels of agreeance (e.g., understanding
their health problems and what causes them, knowing what treatments were
available for their health problems, figuring out solutions when new health
problems arise). This suggests there are opportunities to enhance PA among
AAs with T2D and hypertension. Several studies have reported differences in
DSM behaviors and patient outcomes as PA scores change (Bolen et al., 2014;
Fowles et al., 2009; Greene et al., 2015; Hibbard at al., 2008; Lubetkin et al.,
2010; Mayberry et al., 2010; Skolasky et al., 2011). For example, individuals who
had increases in PA scores have been found to have greater reductions in
systolic blood pressure, body weight, and cholesterol (Bolen et al., 2014).
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Health Literacy
In general, participants had low health literacy scores; 69% did not
demonstrate a high likelihood of adequate health literacy (NVS scores <4). The
mean NVS score of 2.6 was lower than scores in previous studies of AAs from
diverse age groups, ranging from 3.2 to 3.7 (Huang et al., 2018; Miser et al.,
2013; Weiss et al., 2005). The lower health literacy scores found in this study
may be related to the low mean years for time since diagnoses of T2D (M

years

=

4.3) and hypertension (M years = 4.4). Although no studies could be found that
examined associations between health literacy and the amount of time since
diagnosis of any chronic disease, it is possible that the amount of time individuals
have to adjust to DSM tasks plays a role in their development of health literacy
skills.
The majority of incorrect responses in this study were for questions that
assessed numeracy and document literacy. Numeracy and document literacy are
essential components of the health literacy skills individuals with T2D and
hypertension need to adequately carry out their DSM activities. For example,
numeracy skills are needed when performing quantitative tasks (e.g., figuring out
insulin dosage based on glucose levels or calculating carbohydrates) and
document literacy skills are needed to search for and comprehend information
presented in non-continuous text such as what may be found on medication or
food labels (National Assessment of Adult Literacy [NAAL], n.d.). Although 71%
(n = 65) of participants demonstrated prose literacy by correctly answering the
prose-related question (i.e., Is it safe to eat the ice cream?), 48% (n = 44) were
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not able to answer the corresponding question correctly (i.e., Why not?). This
indicates that participants likely were unable to comprehend the information
presented in the ingredients section (i.e., demonstrate document literacy skills)
and instead, considered factors outside of the scenario (e.g., potential impact the
ice cream may have on their glucose or blood pressure levels) to determine the
appropriateness of consuming the food product. Although it is promising that the
participants considered the impact of their choices on their health, failure to
identify the rationale for their decisions leaves an opening for misinterpretation of
instructions or lack of compliance in DSM activities. For example, a prescription
may provide information on interactions with food or drug items and if participants
are unable to comprehend this information, they may inadvertently create
additional complications in their health. Individuals may also have instructions
that direct them to take their medications with food. Inadequate interpretation of
this information may lead individuals to decide that they should skip a medication
dose because they did not eat, rather than eating so they can take their
medications.
Overall, the sample had insufficient disease self-management capacity in
regard to patient activation and health literacy. Although patient activation scores
were high, there was area for improvement, and average health literacy scores
were less than adequate. Inadequate health literacy has been found to associate
with less disease-related knowledge, greater risk of misinterpreting prescription
instructions, and worse medication adherence (Al Sayah et al., 2015; Davis et al.,
2009). Interventions are needed to improve knowledge and critical thinking skills
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for individuals with T2D and hypertension, particularly those with inadequate
health literacy. Adequate health literacy and having a good understanding of
health problems, prevention measures, and problem-solving are essential
components to DSM. Interventions that enhance these components may further
support efforts in reducing health complications associated with the presence of
T2D and hypertension.
This study also examined the relationship between patient activation
levels and health literacy. As these variables were measures of DSM capacity,
with higher scores indicating greater capacity, and based on previous research
(Gwynn et al., 2016; Lubetkin et al., 2010; Mitchell et al., 2014; Sheikh et al.,
2016) it was anticipated that they would be positively associated. In contrast with
previous studies, patient activation and health literacy had a negative correlation
in this study. This unanticipated finding may be related to the use of a different
health literacy measure in this study (i.e., NVS) than what was used in the
previous studies (i.e., Rapid Estimate of Adult Literacy in Medicine and the Short
Test of Functional Health Literacy in Adults). The major difference between the
NVS and the Rapid Estimate of Adult Literacy in Medicine (REALM) is that the
latter does not incorporate measures of numeracy (Dumenci et al., 2013). While
the Short Test of Functional Health Literacy in Adults (S-TOFLA) indicates that
numeracy is examined, a previous study found that there were limitations in the
S-TOFLA identifying individuals with poor numeracy as compared to other tools
(Housten et al., 2018). This suggests that other measures of health literacy
should be explored when examining DSM capacity in this population.
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Patient Burden
Disease self-management capacity can be impacted by the burden that
patients experience. In this study, burden was measured in respect to
participants’ treatment burden and illness burden. Research has demonstrated
that while having high levels of patient activation is beneficial, if high levels of
burden are also present, individuals may have considerable challenges in
managing their medication workloads (Boehmer, Shippee, et al., 2016).
Treatment Burden
There was a moderate level of perceived treatment burden among
participants; 40% had scores above 22, indicating a high level of treatment
burden. The item response with the highest burden score was “taking lots of
medications”. This was similar to previous studies (Eton et al., 2012; Gallacher
et al., 2018; Rogers et al., 2017), that found one of the most substantial aspects
of greater treatment burden is taking multiple medications. The mean number of
medications taken by participants in this study was 4 with a range from 2-8; half
reported taking two medications for T2D and two for hypertension.
The number of prescribed medications reported in this study was not
associated with medication adherence. However, a previous study by Davis et al.
(2006), found that misunderstanding prescription instructions was more likely to
occur for individuals taking three or four prescription medications. As
misinterpretation of prescriptions may lead to poorer adherence, individual’s
perceived difficulty in managing their number of medications should be
considered. Greater treatment burden was foun d to associate with greater
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difficulty in medication management and worse medication adherence. These
findings suggest that higher perceived treatment burden may impact DSM
productivity (e.g. medication adherence), warranting the need to incorporate
measures to reduce this burden when possible for patients (Rogers et al., 2017).
Illness Burden
Overall, the perceived illness burden in this sample was moderate and
comparable with other studies that examined illness burden in samples of
primarily White individuals with chronic disease (Boehmer, Shippee, et al., 2016;
Molzon et al., 2013). The highest levels of illness burden reported were for
health, diet, and finances, indicating a greater perceived disruption in these
aspects of the participants’ lives related to their diseases. This is not surprising
as patients with two major chronic diseases, such as T2D and hypertension may
perceive their overall health poorer than others and have dietary restrictions (e.g.
reduced carbohydrate and sodium). Previous studies have reported that illness
burden arises from the presence of more than one chronic disease and the
symptoms that coincide with those comorbidities (Adriaanse et al., 2016; Aga
et al., 2019; Boehmer, Shippee, et al., 2016; Gebregziabher et al., 2018; Lin
et al., 2015; Payne et al., 2013; Tonelli et al., 2015). Illness burden was
potentially intensified for some participants in this study, as 21% reported having
a health issue other than T2D and hypertension.
Additionally, the higher reports for intrusiveness in finances were likely
related to the associated costs of living with these diseases (e.g., paying for
multiple medications). Furthermore, the ADA (2018b) described how individuals
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with greater illness burden may be financially impacted, as they may have
challenges in acquiring or maintaining employment due to their disease-related
complications. The majority of participants in this study reported being employed
part-time (n = 48; 53%); this underemployment further supports the presence of
financial challenges for participants.
Religious expression and social relationships were the least impacted
factors in illness burden. Although no previous studies were found that examined
the impact of these concepts on illness burden in AAs with chronic disease,
these factors may serve as buffers to illness burden and warrant additional
exploration.
While illness burden did not associate with medication adherence, greater
illness burden was found to associate with a higher number of prescribed
medications. This is similar to the findings reported by Rogers et al. (2017) that
greater illness burden associates with greater medication burden. Overall burden
among participants in this study was moderate. Identifying strategies to reduce
the burdens of living with co-morbid T2D and hypertension may improve DSM
and patient outcomes.
Disease Self-Management: Medication Adherence
The primary outcome for this study of disease self-management was
medication adherence. On average, medication adherence scores were above
two, indicating the presence of medication non -adherence among participants.
Based on the medication adherence grouping, 66% of participants were
classified as not adhering to their medication regimens. The level of non -
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adherence found in this study falls within the range of non -adherence (15% 85%) reported by previous studies that examined medication adherence among
AAs with T2D (Al Sayah et al., 2015; Weller et al., 2017) and in diverse samples
(Aitken et al., 2019; Brown & Bussell, 2011). Non-adherence to medication has
been found to associate with not achieving glycemic and blood pressure control
goals, increased risk for disease-related complications, and greater treatment
burden (CDC, 2018b; Dragomir et al., 2010, Rogers et al., 2017). The mean
Hba1c readings in this study were above recommended levels, potentially due to
the lack of medication adherence among participants.
Participants’ reporting on the Extent of Adherence tool indicated that 70%
had taken all of their prescribed diabetic medications and 74% took all of their
prescribed anti-hypertensive medications in the prior 30 days. However, when
asked if they missed or skipped any of their prescribed medications, 53%
indicated that they may have missed some of their diabetic medications and 49%
said they potentially missed or skipped taking some of their anti-hypertensives.
These percentages for missed or skipped medications were greater than what
was anticipated based on the high reports of taking all medications. The higher
percentages of missed or skipped medications in this sample suggests that while
participants may have had a higher level of confidence in reporting that they were
adhering to their medication regimens, they felt less certain about whether they
may have missed or skipped a dose. The reports of missing or skipping
medications may also be higher than anticipated due to participants including the
medications they skipped in accordance with medication instructions (e.g.,
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medication instructions that advise not to take the medication if their glucose is
below a certain level). The number of participants who missed or skipped
medication doses based on their medication instructions was not tracked in this
study. Future studies should delineate between participants who missed or
skipped doses per medication instructions and those who did so for other
reasons (i.e., side effects relating to sexual performance).
Associations of Demographic Characteristics with Capacity, Burden and
Medication Management
Of the demographic characteristics assessed in this study, age correlated
with the most study variables. Associations were found between age and one of
the capacity variables (i.e., patient activation), one of the burden factors (i.e.,
treatment burden), and attributes of the DSM workload (i.e., number of
prescribed medications and difficulty in managing medications). Associations
were also found between level of education and two of the major study variables
(i.e., treatment burden and total difficulty in managing medications). When
examining differences by sex, males had significantly higher illness burden than
females. Previous studies with diverse samples have found similar associations
with age, socioeconomic status (e.g., income, level of education), and sex,
identifying these demographic characteristics as confounding variables (Akohoue
et al., 2015; Boehmer, Shippee, 2016; Byers et al., 2016; Gallacher et al., 2018;
Neto et al., 2019; Osborn et al., 2013; Rovner et al., 2013). These findings
suggest that age, sex, and level of education may impact the cumulative
complexity of managing a DSM workload and should be taken into consideration
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when developing treatment plans for individuals who are older and have lower
education attainment.
Limitations
This study had limitations that affect generalizability and should be
considered when interpreting the findings. The first limitation relates to the
sample selection. Convenience sampling was the recruitment method used in
this study, with a large number of participants being recruited from a social media
platform. Participants also self-screened and self-identified as being AA, having
T2D and hypertension, and taking prescribed medications for their T2D and
hypertension. It is possible that some participants may have provided inaccurate
information. To reduce the amount of false or inaccurate information, the student
PI conducted daily quality checks on the data. Any information that appeared
erroneous was reviewed with participants during their follow up call and revised
as applicable. Prior to the conclusion of each participant’s interview session for
administration of the NVS, the student PI verified eligibility of the participants by
having them confirm their chronic disease status, age, the number of medications
and the names of the medications they were taking.
A second limitation is that, during the time of recruitment for this study, the
effects of COVID-19 on employment and financial status were likely very present.
The perceived impact of COVID-19 on medication management was explored in
this study and found that there was an overall moderate perceived impact
reported by participants. It is possible that participants who chose to volunteer for
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this study may have been motivated more greatly by the small financial incentive
as compared to times prior to the pandemic.
A third limitation was that most of the instruments used in this study were
self-report measures which created a space for recall and response bias.
Potentially, participants may have intentionally, or unintentionally, provided
inaccurate responses to some of the study questions (e.g., most recent blood
pressure reading or whether they took all of their T2D and blood pressure
medications). Incorporating more objective measures may have provided
verification of the potential of recall and response bias and greater clarity into the
accuracy of the reports provided by participants.
Strengths of the Study
While limitations of this study were observed, there were several strengths
as well. This study adds to the limited body of literature describing disease-self
management for AAs with comorbidities. This is the first known study that
examined associations among patient activation, health literacy, treatment
burden, illness burden, medication workload, and medication adherence for AA
adults with comorbid T2D and hypertension. Also, the perceived impact of a
pandemic on the management of prescribed medications was explored. The
ability to recruit younger participants and male participants is also a major
strength of this study. Furthermore, there was limited missing data and each
instrument used in this study was found to have adequate internal consistency
reliability.
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Implications for Nursing Practice
Nurses have essential roles in supporting patients’ DSM efforts. The
findings from this study suggest several implications for nursing practice in
furthering the support provided by nurses to patients who have DSM
responsibilities. First, this study highlighted factors that created burdens and also
counteracted burdens in medication management for AA adults with T2D and
hypertension. Lower patient activation was primarily associated with worse
medication adherence, but treatment burden and difficulty in medication
management may contribute to nonadherence directly or through patient
activation.
Assessing levels of patient activation may provide useful information for
healthcare professionals, as patient activation was found to predict medication
adherence. The patient activation tool used in this study provides an assessment
measure and also a framework for implementing strategies to assist patients in
achieving the highest level of activation. For example, a patient who is at the
lowest level of patient activation (i.e., level one) would likely benefit most from
receiving basic knowledge about their condition and their treatment plan and
establishing with them the role they have in improving their health (Greene et al.,
2015; Hibbard et al., 2004).
Without a basic understanding of their condition and their treatment plan,
the patient may make choices that they believe will have positive outcomes, but
not have an adequate understanding of how certain decisions may impact their
health. Therefore, it is essential that patients are not just instructed on how to
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carry out their medication management tasks, but also on why certain tasks must
be performed. For example, when instructing patients about taking their
medications at certain times of day, providing them with rationales as to why the
medications need to be taken as prescribed may be beneficial in fostering their
desire and abilities to adhere to their medication regimen s.
To boost activation, patients may also benefit from having problem-solving
strategies incorporated into the education they receive from their healthcare
providers. For example, patients could be presented with various scenarios that
may occur as they navigate their medication management tasks alongside their
other responsibilities. This will create an opportunity to identify potential
challenges patients have in their medication management as well as facilitate
discussions that can empower them to overcome those challenges.
Additionally, as both treatment burden and difficulty in managing
medications were associated with medication adherence, using measures to
assess the more burdensome and/or difficult areas in managing medications for
patients may provide guidance on how to best facilitate individualized adherence
to medication regimens. For example, more than half of the sample reported
difficulty in taking medications at inconvenient times. These individuals may
benefit from receiving assistance for incorporating strategies in their day such as
structuring their mealtimes to coincide with their medication times or mapping out
their daily routines to incorporate the times for their scheduled medications.
Additionally, the patient’s daily routine could be considered when healthcare
providers are prescribing their medication regimen, thereby reducing the level of
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inconvenience experienced with their medications and potentially improving their
medication adherence. Helping patients identify strategies that facilitate better
medication management may promote a greater sense of accountability for them
in their medication management and increase the likelihood of them achieving
their treatment goals.
When educating patients, healthcare providers should consider those
characteristics that increase patients’ risk for poor disease self-management in
relation to the CCM. This study suggests that patients who are older in age, male
and less educated may need greater support in building capacity and reducing
perceived burden including workload. Health literacy was low in this sample.
Although health literacy was not found to correlate with medication adherence, a
clinical practice implication remains for assessing health literacy, as individuals
who have poor health literacy may have difficulty in other aspects of disease self management. Additionally, participants in this study found the financial aspect of
their medication workloads, particularly in the face of the COVID-19 pandemic, to
be one of the most difficult aspects of managing their medications. As such,
these participants could benefit from healthcare policy that provides financial
support or reduced costs for the purchasing of prescriptions and/or supplies
needed for management of T2D and hypertension.
Recommendations for Future Research
Although several significant correlations were found in this study, more
research is needed on DSM among AAs with T2D and hypertension. All of the
instruments in this study demonstrated good internal consistency reliability, thus,
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future research may benefit from using the measures in studies that examine
other DSM activities (e.g., healthy eating habits). Additionally, future studies
could include more objective measures of capacity, and medication adherence.
For example, in addition to assessing participants’ self-reported patient activation
and perceived level of adherence, studies could incorporate administrative refill
data to substantiate participants’ perceptions. Furthermore, studies may benefit
from using the S-TOFHLA and/or the REALM as measures of health literacy to
examine if either of these measures significantly predict medication adherence.
The different aspects of health literacy (e.g., reading comprehension, numeracy,
document literacy) could also be incorporated in the regression analyses to
examine how those specific elements of health literacy correlate to other
independent variables and outcome measures.
Future studies should include inquiries of waist circumferences or waist-tohip ratios for examining adiposity and to help determine rates of obesity more
accurately. While cardiometabolic variables were assessed in this study, they
were also through self-report and only the most recent reading for blood pressure
and HbA1c. Longitudinal studies that assess trends in blood pressure and HbA1c
to determine correlations with capacity and burden measures may provide more
insight into the impact that DSM performance has on treatment goals. Further
research is also needed in examining DSM capacity, patient burden, and DSM
outcomes among AA adults with chronic comorbid conditions in various
situations (e.g., following a hospital discharge) and settings (e.g., rehabilitation
facility).
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Lastly, the findings from this study suggest that there may be benefit in
further exploration of differences in age, sex, length of time since diagnoses,
religious practices, and social relationships among AA adults with chronic
disease. Further exploration of these variables may provide greater insight into
DSM performances, intervention designs, and potential outcomes for this
population.
Conclusions
In this study of AA, mostly educated, younger men, self-reported glucose
and blood pressure readings were elevated. Non-adherence to medication may
help to explain this finding as more than half of the sample reported skipping or
missing medications within the prior 30 days. While low levels of health literacy,
moderate treatment burden, and moderate illness burden were found in this
study, only patient activation significantly contributed to predicting medication
adherence, explaining only a small percentage of variance. This finding suggests
that while patient activation may be an effective tool for identifying AA patients at
risk for poor medication adherence, additional concepts for DSM capacity and
burden should be considered for this population, as the model that incorporated
all measures only accounted for 19% of the variance in medication adherence.
Greater illness burden was associated with lower health literacy, while
greater treatment burden was associated with lower patient activation and higher
perceived difficulty in managing medications. These findings imply that certain
aspects of capacity may counteract the burdens from illness and treatment in this
population. Paying for medications, dealing with side effects, getting refills on
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time, managing medication schedules, and managing medication dosing were
the most challenging aspects of medication management for this sample.
Additionally, COVID-19 had the greatest perceived impact on getting refill
orders, paying for medications, getting medications from the pharmacy, and
getting supplies. These findings suggest the need for DSM support services that
emphasize reduction of financial burdens, adequate management of side effects,
efficient acquisition of medication refills, and minimization of disruptions from
medication schedules. By considering the various factors that may hinder or
promote medication adherence, strategies can be implemented to help this
vulnerable population, particularly older, male and less educated AAs improve
their adherence, achieve their treatment goals and ultimately, live longer and
healthier lives.
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Appendix A
Recruitment Flyer

VOLUNTEERS NEEDED FOR A
STUDY OF AFRICAN AMERICANS
WITH TYPE 2 DIABETES AND HYPERTENSION
A PhD nursing student at Georgia State
University is working on a research study to
learn more about skills and burdens of African
American/Black adults with diabetes and
hypertension.
Seeking African American/Black adults who
have had Type 2 diabetes and hypertension for
at least 1 year.
You will be asked to complete online surveys
about how you manage your diabetes and
hypertension. You will also be asked to take
part in a short phone call or online chat to
assess your skills. It may take a total of 45
minutes for you to complete this study.
You will receive a $25 electronic gift card for
completing this study.
Interested?
Please visit https://gsu.qualtrics.com/jfe/form/SV_bCJr1YY9mcNET2Z
for more information

• Have you
had Type 2
diabetes and
high blood
pressure for
1 year or
longer?
• Are you
African
American/
Black?
• Are you 18
or older?
• Do you take
medications
for diabetes
and high
blood
pressure?

If you have any questions about this study or prefer to
receive printed copies of the surveys, please contact:
Michelle Gaddis, MSN-ED., RN-BC
at 404-855-0815
or mgaddis1@gsu.edu

If so, you may
be able to
participate in
this study.
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Appendix B
Email/Text Message Script

Dear [name will be inserted here],
My name is Michelle Gaddis and I am a PhD student at Georgia State University. I am
writing to invite you to join a research study. The purpose of this study is to find out
about the skills, burdens, and medication practices of African Americans with diabetes
and hypertension. The total estimated time for you to complete this study is 45 minutes.
Your email (or phone number) was obtained from [source will be inserted here] because
of your potential interest in the study.
You may be eligible for this study if you:
• Are African American
• Are 18 years or older
• Have Type 2 diabetes and high blood pressure for 1 year or longer
• Take at least 1 medication for diabetes and 1 medication for high blood pressure
If you decide to join this study, you will:
• Complete an online consent form
• Complete seven short online surveys
• Complete a 10-minute phone call or online chat to assess your skills
• Receive a $25 electronic gift card once you have completed the study
If you do not have access to complete the online surveys, please call or email Michelle
Gaddis. It may still be possible for you to join the study. Remember, this study is
voluntary. You can choose to be in the study or not. If you'd like to join the study, you
can visit the following link to get started:
https://gsu.qualtrics.com/jfe/form/SV_bCJr1YY9mcNET2Z
If you have any questions about the study, please contact Michelle Gaddis:
phone at 404-855-0815 or email mgaddis1@gsu.edu
If you know of anyone else that may be interested in this study, please provide them
with my contact information.
Thank you very much.
Sincerely,
Michelle Gaddis
Student Investigator
Georgia State University
Study Title: Disease Self-Management Capacity, Patient Burden, and Medication
Adherence for African American adults with Type 2 Diabetes and Hypertension
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Appendix C
DemographicSURVEY
Survey
DEMOGRAPHIC
ID: __________________
(1) Age ______________

DATE: ____________
(8) When did you find out that you had:

□
□
□

(2) Sex/Gender
Female
Male
Other (please describe) ____

Diabetes? ___________________

(3) Race/Ethnicity (select all that apply)
Black/African American
Other (please describe) _________

(9) Most recent HbA1c value _________

□
□

(4)
□
□
□
□
□
□

Highest level of education completed
Did not attend school
Elementary school
Middle school
High school
Trade school
College

(11) Other health issues

(5)
□
□
□
□
□
□
□

Employment status
Fulltime
Part-time
Unemployed
A homemaker
Military
Retired
Unable to work

Hypertension? ________________

(10) Most recent blood pressure _________

________________________________
(12)
□
□
□
□
□

Insurance status
No insurance
Private insurance
Employer-sponsored insurance
Medicare/Medicaid
Other (please describe) ____________

(13)

Do you have a primary health care
provider?
Yes
No

□
□
(14)

(6) Household income
□ < 30,000
□ ≥ 30,000
(7)
□
□
□
□
□
□

Marital status
Single (never married)
Married
Separated
Widowed
Divorced
Domestic partnership

□
□

Do you have social support in doing the
things you need to do to manage your
health? (For example, a friend,
church member, or family member
who drives you to your doctor visits.)
Yes
No

(15)
Are you able to complete
three or more of the following activities of daily
living on your own: eating, bathing,
getting dressed, or toileting?
□
Yes
□
No
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Appendix D
Medication Workload Survey
ID: ___________________

DATE: ____________

Your responses to the questions in this survey will help us learn about the work that goes
into managing your medications.

How many medications do you take for diabetes? ________________
How many medications do you take for high blood pressure? ________________
Do you take medications for things other than diabetes or high blood pressure? (For
example, do you take medications for cholesterol, pain, or any other health issue).
□ Yes
□ No
How many different medications do you take for these other health issues? (Do
not include your diabetes and hypertension medications in this count).
_____________
Do you have to take any of your medications at separate times each day?
□ Yes
□ No
How hard is it for you to take medicines at different times? [Select one response]
Not hard

□

A little hard

□

Very hard

□

The list below includes different ways you might have to take your medications. Which of
the following describe how you take your medicines? [Select all that apply to you]
□
□
□
□
□

Oral (For example, pills or liquid)
Topical (For example, creams or ointments)
Injection (For example, you have to give yourself a shot through your skin)
Pump (For example, an insulin pump)
Other (please describe) ___________

How hard is it for you to take your medication in the way(s) you listed? [Select one
response]
Not hard

□

A little hard

□

Very hard

□
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Do you have to change the amount of medication you take based on blood sugar or blood
pressure levels you check at home? (For example, you might have to check your blood sugar
level each day and give yourself a certain amount of insulin based on your blood sugar).
□ Yes
□ No
(By responding “yes”, the following two questions will be displayed)
a. How hard is it for you to check your blood pressure and/or blood sugar levels at
home? [Circle one response]
Not hard

□

A little hard

□

Very hard

□

b. How hard is it for you to figure out the amount of medication you should take
based on the levels you check at home? [Select one response]
Not hard

A little hard

□

Very hard

□

□

Has your healthcare provider made changes in the last 90 days to the medications you take?
□ Yes
□ No
□ Does not apply to me (Select this one if you do not have a primary healthcare
provider)
(By responding “yes”, the following question will be displayed)

How hard has it been for you to deal with the changes made to your prescriptions?
[Select one response]
Not hard

□

A little hard

□

Very hard

□
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How hard it forHow
you tohard
deal with
situations?
is it the
for following
you to deal
with the following situations?

[Select
one response for each situation]
[Select one response for each
situation]

Not hard

A little hard

Very hard

Remembering to take my medications . . . . . . . . . . . . . . . . . .

□

□

□

Paying for my medications . . . . . . . . . . . . . . . . . . . . . . . . . . . .

□

□

□

Opening my medication containers . . . . . . . . . . . . . . . . . . . . .

□

□

□

Reading the words on the medication containers . . . . . . . . .

□

□

□

Getting my refills on time. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

□

□

□

Taking medication at inconvenient times . . . . . . . . . . . . . . . .

□

□

□

Understanding what my medications are for . . . . . . . . . . . . .

□

□

□

Dealing with the side effects from my medications. . . . . . . . .

□

□

□
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Appendix E
Patient Activation Measure® (PAM®)

(Hibbard et al., 2004)
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Appendix F
Newest Vital Sign (NVS)
PARTICIPANT ID: _____________________

(Weiss et al; 2005)

DATE: ____________
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Appendix G
Multimorbidity Treatment Burden Questionnaire (MTBQ)
PARTICIPANT ID: _____________________

(Duncan et al; 2018)

DATE: ____________
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Appendix H
Illness
Intrusiveness
Ratings
Scale
Illness
Intrusiveness
Ratings
Scale
(IIRS)
PARTICIPANT ID: _____________________
PARTICIPANT ID: _____________________

DATE: ____________
DATE: ____________

The following items ask about how much your illness and/or its treatment interfere with
different aspects of your life. Please circle the one number that best describes your
current life situation. If an item is not applicable, please circle the number one
(1) to indicate that this aspect of your life is not affected very much. Please do not
leave any item unanswered. Thank you.
How much does your illness and/or its treatment interfere with your:
1. Health
Not Very Much

1

4

5

6

7

Very Much

2. Diet (i.e., the things you eat and drink)
Not Very Much
1
2
3

4

5

6

7

Very Much

3. Work
Not Very Much

3

4

5

6

7

Very Much

3

4

5

6

7

Very Much

5. Passive recreation (e.g., reading, listening to music)
Not Very Much
1
2
3
4
5

6

7

Very Much

6. Financial situation
Not Very Much
1

6

7

Very Much

1

2

2

4. Active recreation (e.g., sports)
Not Very Much
1
2

2

3

3

4

5

7. Relationship with your spouse (girlfriend or boyfriend if not married)
Not Very Much
1
2
3
4
5
6
7

Very Much

8. Sex life
Not Very Much

1

2

3

4

5

6

7

Very Much

2

3

4

5

6

7

Very Much

3

4

5

6

7

Very Much

11. Self-expression/self-improvement
Not Very Much
1
2
3

4

5

6

7

Very Much

12. Religious expression
Not Very Much
1

4

5

6

7

Very Much

4

5

6

7

Very Much

9. Family relationships
Not Very Much
1

10. Other social relationships
Not Very Much
1
2

2

3

13. Community and civic involvement
Not Very Much
1
2
3

(Devins, 2010)
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Appendix I
Extent of Adherence Survey
PARTICIPANT ID: ___________________

DATE: ____________

Please rate your agreement with the following statements.

Over the past 30 days…
1. I took all doses of my diabetes medications.

Strongly disagree Disagree Neutral

Agree Strongly agree

2. I took all doses of my blood pressure medications.

Strongly disagree Disagree Neutral

Agree Strongly agree

3. I missed or skipped at least one dose of my diabetes

Strongly disagree Disagree Neutral

Agree Strongly agree

Strongly disagree Disagree Neutral

Agree Strongly agree

5. I was not able to take all of my diabetes medications.

Strongly disagree Disagree Neutral

Agree Strongly agree

6. I was not able to take all of my blood pressure

Strongly disagree Disagree Neutral

Agree Strongly agree

medications.
4. I missed or skipped at least one dose of my blood
pressure medications.

medications.
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Reasons for Nonadherence
Situations come up that make it difficult for people to take their diabetes and blood pressure medications as prescribed by their
doctors. Below is a list of those situations. We want to know how much these situations contributed to you missing a dose of
your medication. Only one of these situations may apply to you, or many may apply to you.
In the past 7 days, how much did each situation contribute to you missing a dose of your diabetes or blood pressure medication?
Not at all

A little

A lot

1. I was busy

o

o

o

2. They caused some side effects

o

o

o

3. They cost a lot of money

o

o

o

4. I felt I did not need them

o

o

o

5. I was supposed to take them more than once a day

o

o

o

6. I ran out of medication

o

o

o

7. My blood pressure or blood sugar was too low

o

o

o

8. I was feeling too ill to take them

o

o

o

Were there other reasons why you missed taking your medications?
□ Yes
□ No
If you selected “yes” in question #8, please use the space below to list other reasons for why you did not take your diabetes or
blood pressure medications.

(Voils et al., 2012)

199
Appendix J
COVID-19 Impact Survey

